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ABSTRACT 
 
LuxR-type proteins are responsible for density-dependent transcriptional regulation in 
quorum-sensing systems that employ acyl-homoserine lactones (acyl-HSLs) as signal 
molecules.  The Vibrio fischeri lux operon, which includes LuxR, has been well studied 
and shown to function in E. coli. The components of the lux operon have recently been 
used to engineer de novo genetic circuits because they provide a versatile intercellular 
communications system.  We have used directed evolution to engineer LuxR to expand 
the “toolbox” of components available for engineering synthetic circuits with a wide 
range of communications functions and to explore the evolution of LuxR specificity and 
response. 
 
 We developed and validated a screening system to identify mutants of LuxR that activate 
gene expression with noncognate acyl-HSLs, based on LuxR-mediated gene expression 
of GFP.  We screened libraries of luxR mutants for variants exhibiting increased gene 
activation in response to octanoyl-HSL (C8HSL), with which wild-type LuxR interacts 
only weakly. Eight LuxR variants were identified that showed a 100-fold increase in 
sensitivity to C8HSL; these variants also displayed increased sensitivities to a broadened 
range of acyl-HSLs, including straight-chain acyl-HSLs, while maintaining a wild-type or 
greater response to LuxR’s cognate acyl-HSL, 3-oxo-hexanoyl-homoserine lactone 
(3OC6HSL).    
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LuxR and its homologs respond to their cognate acyl-HSL signals with exquisite 
specificity.  To generate a LuxR with a new signaling specificity, we used a dual 
selection system to identify LuxR variants that either activate gene expression (ON) or do 
not (OFF) under desired sets of conditions.  The dual selection system was evaluated 
prior to its use, and a 490-fold enrichment in functional clones per round of ON/OFF 
selection was observed.   We subsequently used the dual selection system to identify a 
new LuxR variant that retains the response to straight-chain acyl-HSLs attained by 
screening for activation with C8HSL, but no longer responds to 3OC6HSL.  A single 
mutation in the N-terminal signal-binding domain reduces the response to acyl-HSLs 
having a carbonyl substituent at the third carbon of the acyl chain.  The specificity-
enhancing mutation does not affect LuxR response to straight-chain acyl-HSLs and 
would not have been identified by positive selection alone.  
 
We also used the dual selection system to identify LuxR variants that activate 
transcription upon binding to a promoter containing a mutated operator site, at which 
LuxR is unable to activate transcription.  An amino acid position critical for modulating 
the DNA-binding specificity of LuxR for the new DNA target was identified.  The dual 
selection system provides a rapid and reliable method for identifying LuxR variants that 
have the desired response, or lack thereof, to a given set of acyl-HSL signals or DNA 
targets.  LuxR variants with new specificities identified in this work are potentially useful 
components for constructing artificial cell-cell communication systems that program 
population-level behaviors. 
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THESIS SUMMARY 
Many species of bacteria use the synthesis and recognition of small molecules to assess 
changes in their local population density and alter the expression of key genes 
accordingly.  The components of these systems have been harnessed for engineering 
synthetic genetic circuits that include elements of intercellular communication.  We have 
used directed evolution to engineer LuxR, a transcriptional activator from Vibrio fischeri 
responsible for density-dependent signal recognition and modulation of gene expression.  
Both the signal binding and signal binding specificities of LuxR have been engineered in 
order to  expand the ‘toolbox’ of components available for engineering synthetic circuits 
with a wide range of communications functions and to explore the evolution of LuxR 
specificity and response. 
 
Chapter 1 of this thesis provides an introduction to LuxR and its homologs and to the 
methods used in the studies described in this thesis.  The general mechanism and 
components required for acyl-homoserine lactone (acyl-HSL)-based quorum sensing 
(QS) will be presented using the Vibrio fischeri lux regulon as a model system.  Similar 
QS systems have been identified within the Gram-negative phylum Proteobacteria and 
the synthesis and recognition of diverse acyl-HSLs provides different bacterial species 
with their own chemical languages.  Engineering of the QS transcriptional regulator 
LuxR is the subject of this work and the studies previously used to characterize this 
protein will be reviewed in detail.  The diversity of LuxR homologs found in species of 
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α-, β-, and γ-Proteobacteria will also be introduced.  Previous efforts to engineer LuxR, 
its homologs, and other transcription factors will also be discussed.   
 
The lux system has been used to engineer de novo regulatory circuits requiring 
intercellular communication.  LuxR homologs have been investigated, but these can show 
significant crosstalk and often also behave differently from LuxR in other ways.  For 
applications in synthetic biology, it would be useful to have a set of ‘standardized 
parts’—for example, a series of LuxR variants that respond to different chemical signals 
or activate gene expression at different promoters from which new networks can be 
assembled.   
 
A postdoc in our laboratory, Yohei Yokobayashi, initiated the work towards applying the 
techniques of directed evolution to the engineering of transcription factors and synthetic 
genetic circuits.  He showed that a detuned regulatory network, wherein the λ repressor 
CI was ubiquitously preventing expression at a target promoter, could be converted to a 
functional signal-dependent inverter through directed evolution of the CI protein.  In the 
process, a library of genetic devices, with a range of new behaviors, was generated.  I 
decided to apply a similar approach to the engineering of LuxR and initiated the project 
by targeting its response to a non-cognate acyl-HSL, octanoyl-HSL (C8HSL). LuxR 
requires 200-fold higher concentrations of C8HSL to achieve levels of activation 
observed with LuxR’s cognate signal, 3-oxohexanoyl-homoserine lactone, 3OC6HSL.   
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Chapter 2 describes the implementation of a LuxR-dependent screen and the 
identification of LuxR variants with increased sensitivity to C8HSL.  A LuxR reporter 
system in which gene activation leads to the production of green fluorescent protein 
(GFP) was constructed wherein high-throughput screening of LuxR-expressing colonies 
is achieved by exciting a plate of colonies with ultraviolet light and visually inspecting 
colonies for emission of green light. A library of luxR mutants was generated by random 
mutagenesis and screened for gfp activation with 200 nM C8HSL.  Wild-type LuxR 
requires approximately 2 μM C8HSL to achieve the level of gene activation obtained 
with 10 nM 3OC6HSL.  Six C8HSL-responsive LuxR variants were identified from a 
library of approximately 20,000 clones.  These mutants were recombined and a library of 
approximately 1200 clones was screened for their ability to activate gene expression with 
50 nM C8HSL.  Eight LuxR variants were identified that showed a 100-fold increase in 
sensitivity to C8HSL; these variants also displayed increased sensitivities to pentanoyl-
HSL and tetradecanoyl-HSL, while maintaining a wild-type or greater response to 
3OC6HSL. The most sensitive variants activated transcription as strongly with C8HSL as 
the wild type did with 3OC6HSL.  Three ‘hypersensitive’ variants were also identified 
that showed increased activation with 3OC6HSL.   
 
All of the C8HSL-responsive LuxR variants identified showed broadened acyl-HSL 
specificity profiles and all responded to 3OC6HSL as well, or better, than wild type.  We 
wanted to continue the process of engineering LuxR variants by increasing its specificity 
for a new acyl-HSL signal.  To do this we needed to be able to identify LuxR variants 
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that both activate gene expression with the new target and do not respond to 3OC6HSL.  
Chapter 3 describes the implementation and evaluation of a dual selection system capable 
of identifying LuxR variants that either activate gene expression (positive selection, ON) 
or do not (negative selection, OFF) under desired sets of conditions.  The ON/OFF 
selection system was adapted from a system developed by Y. Yokobayashi for use with 
the λ CI repressor.  Modification of the dual selection system for use with an activator 
was required.  To test the modified ON/OFF selection system we selected a plasmid 
encoding wild-type LuxR from a background of nonfunctional clones and showed that a 
single round of ON/OFF selection yields a 490-fold enrichment of functional clones.  
This result, which suggests that a functional LuxR variant can be identified from a library 
of 100 million in only three rounds of ON/OFF selection, demonstrated the potential of 
our dual selection system and led us to begin selecting libraries for LuxR variants 
exhibiting new acyl-HSL specificities with confidence that we could identify the desired 
variant if it existed in the library.    
 
The parent used for the evolution of acyl-HSL specificity was LuxR-G2E, which 
activates gene expression upon binding a broadened range of acyl-HSLs, including 
C10HSL.  The application of the ON/OFF selection system to identify a LuxR variant 
that retains the increase in sensitivity to C10HSL achieved by LuxR-G2E, but that has 
lost its ability to recognize and respond to LuxR’s cognate signal 3OC6HSL is presented 
in chapter 4.  A library was generated by random mutagenesis and LuxR variants were 
selected for the ability to survive ON rounds of selection with C10HSL and OFF rounds 
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of selection with 3OC6HSL.  A single mutation, arginine 67 to methionine in the N-
terminal signal-binding domain, reduces LuxR-G2E’s response to acyl-HSLs having a 
carbonyl substituent at the third carbon of the acyl chain.  This mutation has a similar 
effect when introduced into a LuxR homolog that responds to a different 3-oxo-HSL 
(3OC12HSL), LasR from Pseudomonas aeruginosa.  This specificity-enhancing mutation 
does not affect LuxR response to straight-chain acyl-HSLs and would not have been 
identified by positive selection for activation by these signaling molecules.  This work 
demonstrates that accumulation of a small number of point mutations is sufficient to 
switch specificity from one signal to another, passing through a broadly-specific 
intermediate.  We expect that this dual selection system could be used to further refocus 
the specificity towards a single acyl-HSL by selecting for the absence of gene activation 
with multiple acyl-HSLs during OFF rounds of selection. 
 
While LuxR and its homologs specifically recognize very diverse acyl-HSL signal 
molecules, they can often activate gene expression at each other’s promoters.  LuxR 
variants with new DNA binding specificities would be a powerful addition to the 
components available to synthetic biologists.  The ability to use a single cell type to 
recognize and specifically respond to different acyl-HSLs by activating gene expression 
at different promoters would increase the capabilities of current communications systems.  
Also, by generating the components in the lab from a well-characterized, well-behaved 
starting point, one can target the desired properties from the beginning.   To address this 
challenge, we applied our dual selection system to modify the DNA-binding specificity 
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of LuxR.  Chapter 5 describes the selection of LuxR variants that activate gene 
expression at a mutated lux promoter at which LuxR does not activate gene expression.  
We generated a library by random mutagenesis and selected mutants activate gene 
expression at the new promoter. We also selected for decreased activation at the wild-
type lux promoter.  The two LuxR variants identified contain a mutation at amino acid 
position 212, from an arginine to either a histidine or a cysteine.  The R212C mutation 
was accompanied by a second mutation, Q232H, and these two mutations are shown to 
act synergistically to confer the desired change in DNA-binding specificity.  The 
promoter specificity of LuxR-R212C/Q232H was broadened while LuxR-R212H showed 
a preference for the new promoter.  Both variants required approximately 100-fold higher 
concentrations of 3OC6HSL to achieve levels of activation observed with wild-type 
LuxR and the lux promoter.  We have generated the first LuxR variants that respond to a 
new promoter and shown that random mutagenesis can be used to identify residues 
critical for DNA-binding specificity.   
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CHAPTER 1 
 
Introduction 
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A.  Genetic circuit engineering and intercellular communication 
 
The ability to sense and respond to chemical stimuli is essential for the survival of all 
living organisms.  Recognition of a chemical signal leads to a response that, hopefully, 
allows an organism to adapt and thus increase its probability of survival.  Often, changes 
in gene expression occur following recognition of a specific chemical signal.  Regulation 
of gene expression is crucial for interactions with the environment and for complex 
processes including development, apoptosis, circadian rhythms and biofilm formation.  
Pieces of the regulatory machinery required for modulating gene expression, including 
promoters, repressors and activators, have been borrowed from these complex regulatory 
networks in order to build simple networks commonly called ‘genetic circuits.’  
Constructing genetic circuits de novo provides new opportunities to understand the 
governing principles and design strategies inherent in functional regulatory systems 
[1, 2].  By combining regulatory components from unrelated systems and generating 
simple regulatory circuits, researchers can gain an understanding of how more complex 
natural systems function in a controlled manner where perturbing a single component or 
condition leads to more easily interpreted results.   
 
Initial work towards engineering synthetic genetic circuits has combined regulatory 
elements to produce simple circuits including toggle switches and a genetic oscillators 
[2-5].  Combining regulatory elements and generating a new, functional circuit, however, 
is not a trivial endeavor.  These circuits are assembled from unrelated elements that have 
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not been optimized to work in the new configuration.  An important challenge in 
engineering genetic circuits is to tune the components to function optimally in the new 
network.  One way to address this problem is to apply what is known about the regulatory 
components and network design from previous biochemical, genetic and systems 
analyses to rationally adjust the parameters of the circuit components [6, 7].  A 
complenentary approach is to use directed evolution, the iterative process of generating 
genetic diversity and screening or selecting for a desired function, to identify functional 
circuits [8].    
 
As circuit engineers become more competent at generating functional systems, 
increasingly complex circuits will become more feasible design goals [9].  Engineering 
increasingly complex behaviors, such as those that mimic developmental processed like 
pattern formation and tissue development or assembly of microbial communities such as 
biofilms, become a more attainable goal with the addition of elements of intercellular 
communication systems [10].  Bacterial ‘quorum sensing’ components can be used to 
send and receive chemical signals from one cell to another.   Quorum sensing (QS) refers 
to the ability of a bacterium to perceive and respond to fluctuations in cell-population 
density.  In general, bacteria produce and release small chemical signal molecules that 
increase in concentration as a function of cell density [11, 12].  The detection of these 
signal molecules leads to changes in gene expression that presumably increase the fitness 
of the host organism.   
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QS systems found in bacteria from the Gram-negative phylum Proteobacteria use the 
synthesis and detection of acyl-homoserine lactones (acyl-HSLs) [11, 13, 14].  In these 
systems an acyl-HSL synthase produces the diffusible signaling molecule and an acyl-
HSL-responsive transcription factor activates transcription following signal binding [12].  
The levels of acyl-HSL synthesis in these organisms are sufficiently low to prevent 
accumulation of the signals at low cell densities.  At high cell densities, acyl-HSL 
accumulates in the cell and is bound by the transcriptional activator leading to changes in 
gene regulation.  The potential for these components to be used in synthetic intercellular 
communications circuits was demonstrated by Weiss and Knight, who expressed the 
acyl-HSL-responsive activator in E. coli to produce ‘receiver’ cells that would respond to 
signals produced by ‘sender’ cells synthesizing the acyl-HSL signal [15]. 
 
The components used by Weiss and coworkers are from the lux QS system found in 
Vibrio fischeri.  The acyl-HSL synthase found in V. fisheri, LuxI, produces 3-oxo-
hexanoyl-homoserine lactone (3OC6HSL), which is recognized by the 3OC6HSL-
dependent transcriptional activator LuxR.  We chose to target the lux system as the 
starting point for engineering novel intercellular signaling components.  The lux system 
was first discovered in 1970 and has since become one of the best characterized QS 
systems [11, 13, 16]. By evolving the quorum-sensing signal response regulator, LuxR, 
we hoped to explore the evolution of signal specificity and response in acyl-HSL-based 
QS systems and to develop generally applicable tools for the identification of 
transcriptional response regulators that are optimized to function in a new context.  
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The components of the lux QS system have been successfully incorporated into synthetic 
genetic circuits requiring cell-cell communication [15, 17-20].  One of these examples 
used a LuxR variant identified in this work [17].  Using ‘receiver’ cells containing a 
LuxR-based band-detect circuit that express a fluorescent protein over a limited range of  
signaling molecule concentrations, Basu et al. [17] demonstrated that an undifferentiated 
lawn of the ‘receiver’ cells generated a ring of gene expression around a central colony of 
‘sender’ cells producing 3OC6HSL.  A second band-detect circuit was generated by 
replacing wild-type LuxR with a ‘hypersensitive’ LuxR variant that requires lower 
concentrations of 3OC6HSL to activate gene expression.  Plating a mixture of two strains 
containing the two band-detect circuits, each controlling the expression of different 
fluorescent reporter, led to the production of a bull’s-eye pattern around a colony of 
sender cells (see appended publication [17]).  The band of fluorescence observed with the 
evolved LuxR variant was further away from the sender cells, and therefore at lower 
concentrations of 3OC6HSL, than the band of fluorescence from the cells containing 
wild-type LuxR.  This work demonstrated both the feasibility of using bacterial 
communication components to engineer systems that emulate complex processes such as 
pattern formation, and that LuxR variants with new behaviors are useful additions to the 
toolbox of components available for engineering genetic circuits. 
 
In this chapter, I will briefly review the components involved in acyl-HSL-dependent QS 
and previous work towards engineering these systems and other transcription factors.  
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Particular emphasis will be placed on LuxR and its homologs, specifically their signal 
and DNA-binding specificities.   
 
 
B. Acyl-homoserine lactone dependent transcriptional activation 
 
The lux system from Vibrio fischeri was the acyl-HSL-based QS system discovered [16].  
V. fisheri is a bioluminescent marine bacterium that colonizes the light organs of a variety 
of marine fish and squid, where it is found at very high cell densities (1010 cells/mL) and 
produces light.  Nealson et al. were the first to report the role of a chemical signal 
molecule in the regulation of the light-producing enzyme luciferase [16].  This signal was 
later determined to be 3-oxo-hexanoyl-L-homoserine lactone (3OC6HSL) by 1H NMR 
spectroscopy [21]. 
 
 
B.1. Mechanism of QS activation in V. fischeri 
 
In V. fischeri, the 3OC6HSL signal is synthesized by the acyl-HSL synthase, LuxI.  In 
environments of low cell density, the amphipathic acyl-HSL diffuses out of the cell 
through the membrane [22].  As the local environment becomes more crowded, the acyl-
HSLs accumulate in the cell, where they bind to the acyl-HSL-dependent transcriptional 
activator, LuxR [23, 24].  Upon signal binding, LuxR activates transcription at the lux 
promoter leading to light production through the transcription of the luciferase (lux) 
  7 
genes.   Transcription of the lux genes is essential for V. fisheri’s symbiotic relationship 
with marine eukaryotes [25].  In exchange for light production, Euprymna scolopes, the 
Hawaiian bobtail squid, provides V. fischeri with branch chain amino acids to support 
dense populations and luminescence.   
 
 
 
Figure 1.1.  Schematic of the Vibrio fischeri quorum sensing system.  The left panel 
depicts the regulatory state at low cell density.  Low, basal expression of LuxI produces a 
small amount of 3OC6HSL, which diffuses out of the cell.  The right panel shows that at 
high cell density accumulation of 3OC6HSL leads to its binding by LuxR.  LuxR-
3OC6HSL complexes dimerize and activate gene expression at the lux promoter leading 
to increased expression of the lux genes required for light production, luxCDABE, as well 
as luxI and luxR.   
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B.2. Homologous acyl-HSL dependent QS systems from the α-,β- and γ-Proteobacteria 
 
Pairs of LuxI/LuxR homologs have been identified in many species of Gram-negative 
Proteobacteria (Fig. 1.2) [26, 27] where they regulate genes with diverse functions in 
response to changes in population density [28-33].  Different species of Proteobacteria 
synthesize and respond to acyl-HSLs with acyl chains of varying lengths and chemical 
modifications [34, 35] (Fig. 1.3).  Due to the diversity of acyl-HSL signals used by 
different bacterial species and the high degree of specificity of both acyl-HSL production 
by LuxI homologs and acyl-HSL response by LuxR homologs, this type of QS has been 
postulated to be species specific [11].   
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Figure 1.2. Diversity of LuxR homologs and acyl-HSLs found in Nature.  Illustration of 
the divergence of selected LuxR homologs.  Homologs are listed with both species and 
cognate acyl-HSL signal molecule. The tree was adapted from Gray and Garey, and Lerat 
and Moran [26, 27].   
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Figure 1.3.  Structures, non-IUPAC names and abbreviations of the acyl-HSLs that 
activate the homologs listed in Fig. 1.2., as well as the acyl-HSLs used in these studies, 
are shown.  
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C.  Elements of acyl-homoserine lactone-dependent quorum sensing systems 
 
 
The essential elements for acyl-HSL-dependent quorum sensing are an acyl-HSL 
synthase, an acyl-HSL-responsive transcriptional regulator and a target promoter.   A 
LuxR homolog typically responds to an acyl-HSL synthesized by its partner LuxI 
homolog.   The precise arrangement and regulation of these QS systems vary from 
organism to organism, and there appear to be exceptions to every rule.  We will focus on 
the lux system to introduce these essential elements.  Important work regarding 
homologous systems will also be presented. 
 
 
C.1. The lux operon 
 
The lux operon was first characterized following its cloning into E. coli [36].  As shown 
in Figure 1.4, the lux genes are arranged into two divergently transcribed promoters 
separated by 155 base pairs (bp).  One promoter, PluxR, contains luxR and the other, PluxI, 
contains luxI and the six other lux genes, luxCDABEG, required for light production.  
Gene expression from PluxI is activated by LuxR and requires the presence of 3OC6HSL.  
Expression of luxR was shown to depend on cyclic-AMP receptor protein (CRP) [37, 38], 
and a CRP-binding site was subsequently identified between luxI and luxR [39].  LuxR 
also appears to regulate its own expression, both positively and negatively, and depends 
on cellular LuxR concentrations and a downstream element in the DNA encoding luxD 
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[37, 40-42].  The precise mechanisms of luxR autoregulation have not been fully 
elucidated. 
 
 
 
 
Figure 1.4.  Vibrio fischeri lux gene organization.  The luxR gene encoding the acyl-
HSL-dependent transcriptional activator is transcribed from PluxR.  PluxI contains luxI, 
which encodes the acyl-HSL synthase, followed by the five lux genes required for light 
production, luxCDABE, and an additional gene of unknown function luxG.  The luxA and 
luxB genes encode the α- and β-components of luciferase.  The luxC, luxD and luxE 
genes encode an acid reductase required for the production of the luciferase substrate, 
tetradecanal, from tetradecanoic acid.   
 
 
  
LuxR activation of PluxI requires a 20 bp inverted repeat centered 42.5 bp upstream of the 
PluxI transcriptional start site called the lux box [43, 44].  Both halves of the lux box’s 
inverted repeat are required for LuxR-mediated gene activation, and the precise 
positioning of the lux box relative to the transcriptional start site is also imperative [44].  
The lux box was first implicated as the LuxR binding site by the demonstration that point 
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mutations in the lux box could eliminate PluxI activation in E. coli [43].  Similar 
nucleotide sequences have been identified upstream of many promoters regulated by 
LuxR homologs.  TraR, the LuxR homolog from Agrobacterium tumefaciens, was the 
first homolog shown to directly bind to the tra box in DNAseI protection assays [45].  
Recently, purified LuxR was shown to directly protect the lux box in vitro [46].  LuxR 
homologs TraR, LasR, QscR and CepR have also been shown to bind to lux-type boxes 
in vitro [47-50].   
 
 
C.2.  Acyl-HSL synthesis by LuxI  
 
LuxI catalyzes acyl-HSL formation from S-adenosyl-L-methionine (SAM) and acyl-acyl-
carrier protein (acyl-ACP) [51], both of which are readily available in the cell.  SAM is 
acylated by acyl-ACP and its methionine moiety lactonized to produce acyl-HSLs (Fig. 
1.5).  LuxI homologs synthesize acyl-HSLs with acyl chains from 4 to 16 carbons in 
length [35, 52].  The third carbon of the acyl chain is often modified to a carbonyl or, less 
frequently, a hydroxyl group [52].  Acyl-HSLs containing a single degree of unsaturation 
have also been identified [53].  The formation of acyl-HSLs with specific acyl chains by 
LuxI proteins is a result of their ability to specifically recognize only ACPs charged with 
the “correct” acyl moieties.   The crystal structure of EsaI, the LuxI homolog from 
Pantoea stewartii that produces 3OC6HSL, identified a hydrophobic cavity that 
recognizes the acyl chain of the acyl-ACP [54].  The size of this pocket was hypothesized 
to confer EsaI’s preference for acyl chains six carbons in length.  In contrast, the crystal 
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structure of LasI, the LuxI homolog from Pseudomonas aeruginosa responsible for 3-
oxo-dodecanoyl-homoserine lactone (3OC12HSL) production, contains a hydrophobic 
tunnel for acyl chain recognition that places no apparent restriction on acyl chain length 
[55].  Molecular modeling and mutagenesis studies indicate that the recognition of the 
ACP may play a role in recognizing acyl-ACPs with longer acyl chains.  Gould et al. [55] 
hypothesize that, because longer acyl chains will have intrinsically higher binding 
affinities for the hydrophobic tunnel than shorter acyl chains, the required contribution 
from the ACP for binding by the enzyme is lower.  Recognition of acyl-ACPs by LuxI 
homologs that make acyl-HSLs with shorter acyl chains likely requires the ACP to make 
a larger contribution to binding affinity.  However, binding of acyl-ACPs carrying long 
acyl chains are sterically precluded from binding. 
 
 
Figure 1.5.  Schematic of acyl-HSL synthesis by LuxI from acyl-acyl-carrier protein and 
S-adenosyl-L-methionine. 
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A LuxI homolog was recently engineered to produce an acyl-HSL with a longer acyl 
chain [56].  The sequences of closely related LuxI homologs from Erwinia strains 
producing either 3OC6HSL or 3OC8HSL were examined to identify amino acids that 
differed between the two groups.  Two mutations were shown to be sufficient to change a 
3OC6HSL synthase to a 3OC8HSL synthase.  An alignment with the crystal structure of 
EsaI indicates that the two changes may increase the size of the binding pocket, however, 
the precise molecular mechanisms that control the specificity of acyl-HSL production 
remain elusive.  Furthermore, attempts at switching the specificity from 3OC8HSL to 
3OC6HSL by targeting the same residues produced nonfunctional enzymes.   
 
 
C.3. Acyl-HSL-mediated gene activation by LuxR homologs 
 
LuxR recognizes the acyl-HSL synthesized by LuxI, 3OC6HSL, and activates gene 
expression by increasing the affinity of RNA polymerase for the lux promoter [57].  Early 
mutagenesis studies showed that the N-terminal domain of LuxR is responsible for acyl-
HSL binding while its C-terminal domain is responsible for DNA binding and activation 
[24, 58-60].    The mutations critical for LuxR function clustered in two regions, between 
residues 79 to 127 and residues 184 to 230 [24, 60].  Some of the LuxR variants 
containing mutations to the N-terminal domain were shown to be capable of activating 
gene expression with elevated levels of 3OC6HSL and were hypothesized to be involved 
in acyl-HSL binding.  Subsequent studies verified the role of the C-terminal domain in 
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DNA binding and activation [58, 59]. A region between residues 116 and 160 was 
implicated in multimerization [61].   
 
 
C.3.1.    Acyl-HSL response  
 
Following the identification of LuxR’s cognate signal molecule as N-3-oxo-hexanoyl-L-
homoserine lactone [21], similar chemical structures were used to probe the specificity of 
the response.  Analogs were tested with V. fischeri for their inducing activity and for their 
ability to inhibit LuxR’s ability to respond to 3OC6HSL [62]. Gene activation by LuxR 
was greatest in the presence of 3OC6HSL.  However, acyl-HSLs with similar structures 
were also able to stimulate LuxR-mediated activation.  The ability to study recombinant 
LuxR in E. coli led to a second set of studies that examined both binding and activation 
by LuxR with a set of acyl-HSL analogs [34].  Binding studies measured the amount of 
tritium-labeled 3OC6HSL (3H-3OC6HSL) that remained associated with the E. coli cells, 
and presumably bound by LuxR, following incubation with the signal and washing to 
remove any unbound or loosely bound acyl-HSLs [63].  Acyl-HSL analogs were assessed 
for their ability to prevent the accumulation of 3H-3OC6HSL in LuxR-expressing cells.  
3H-3OC6HSL accumulation was observed to decrease as the acyl-chain length became 
increasingly shorter or longer than six carbons [34].  A preference for acyl-HSLs 
containing a 3-oxo moiety was also observed.  Compounds with substitutions in the 
homoserine lactone ring were not found to bind to LuxR, with the exception of 
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compounds with a homocysteine thiolactone ring.  Compounds observed to bind to LuxR 
were tested for their ability to stimulate gene transcription by LuxR.  None of the analogs 
tested was as active as 3OC6HSL.  Compounds with acyl side chains between five and 
nine carbons in length have slight activity, while compounds with 10 or more carbon 
atoms showed little or no activity.   Comparisons of gene activation by acyl-HSLs with or 
without the 3-oxo moiety showed that 3-oxo-containing acyl-HSLs are much more potent 
inducers.  Notably, a few of the acyl-HSLs tested did not stimulate gene expression 
despite being able to decrease 3H-3OC6HSL accumulation.  The analogs shown to bind 
to LuxR but do not stimulate gene activation were shown to inhibit LuxR-mediated gene 
expression in the presence of 3OC6HSL.   
 
The acyl-HSL binding and response specificities of TraR, LasR, CarR and CepR have 
also been investigated [49, 64-66].  Similar observations were made in each study:  acyl 
chain length, and the presence or absence of the 3-oxo group, are the major determinants 
of specificity.    
 
The precise mechanism of 3OC6HSL binding and the conformational changes that occur 
prior to activation are only beginning to be elucidated.  It has been consistently observed 
that LuxR and its homologs accumulate in vivo as functional proteins only in the presence 
of their target acyl-HSL [45, 46, 48, 49].  Overexpression of these proteins in the absence 
of acyl-HSL leads to the formation of insoluble inclusion bodies [45, 48, 49, 67].  Acy-
HSL binding by purified LuxR has been shown to be reversible, whereas LasR and TraR 
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appear to bind the acyl-HSL sufficiently tightly to be considered irreversible.  Each of 
these proteins requires nanomolar concentrations of acyl-HSL to activate gene expression 
indicating that there may be a difference in the way these proteins bind their cognate 
signals.   
 
The crystal structure of TraR has been determined and the residues that make contact 
with the acyl-HSL have been identified [68, 69].  Mutations of the amino acid residues 
predicted to form hydrogen bonds with 3OC8HSL were shown to be essential for wild-
type protein function [70].   The amino acid residues responsible for recognition of 
specific acyl-HSLs have been more difficult to predict.   Residues of TraR predicted to 
interact with the carbonyl moiety of 3OC8HSL were mutated with the goal of stimulating 
the response of this protein to an analog, octanoyl-HSL (C8HSL) [70]. Rather than 
showing improved sensitivity to C8HSL, these variants lost the strong response that wild-
type TraR displays towards 3OC8HSL. The attempts of Chai and Winans to shift the 
specificity of TraR towards 3OC6HSL by introducing bulkier hydrophobic amino acids, 
and thereby reduce the size of the acyl binding site, also led, in all but one case, to 
variants with greatly decreased acyl-HSL affinities.   
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C.3.2.  DNA binding and activation 
 
The C-terminal domain of LuxR is responsible for DNA binding and gene activation.  
When the N-terminal, regulatory domain is absent, it is also capable of activating gene 
expression in the absence of 3OC6HSL [58].  This positive-control mutant, LuxRΔN, 
requires RNA polymerase (RNAP) for DNA binding.  LuxRΔN and σ70-bound RNAP 
were subsequently shown to be the only proteins required for transcription from 
PluxI [71], indicating that LuxR activates gene expression by recruiting RNAP to PluxI.  
Initiation of transcription by LuxRΔN has since been shown to require the C-terminal 
domain (CTD) of RNAP in vitro and activation by both LuxRΔN and full-length LuxR 
was drastically decreased by the overexpression of a truncated RNAP lacking the CTD 
[72]. Therefore, LuxR activates gene expression by recruiting RNAP to PluxI through 
direct binding to its CTD.   
 
Amino acid sequence analysis identified a helix-turn-helix (HTH) motif within the C-
terminal domain of LuxR [73, 74].  Two alanine scanning mutagenesis experiments have 
identified residues involved in DNA binding and activation by LuxR [75, 76].  Several 
mutants unable to bind DNA or activate transcription were identified, including alanine 
substitutions at positions 191, 193, 212, 217, 225, 229, 230, 238, and 240.  DNA binding 
was assessed indirectly by measuring the ability of each variant to repress a lac promoter 
containing a lux box [77].  It is impossible to determine from these results which of the 
mutations yields folded proteins that are unable to bind DNA and which mutations 
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prevent activation by affecting other properties such as protein stability, folding or 
dimerization.  The DNA-binding HTH motif in LuxR is predicted to occur between 
residues 200 and 224, suggesting that several of the residues identified may be directly 
involved in DNA binding.   Alanine substitutions at positions 201 and 206 affect 
transcriptional activation but not DNA binding.  These residues are hypothesized to make 
direct contact with RNA polymerase.   
 
The DNA sequence requirements for specific DNA-binding by LuxR have not been 
assessed as thoroughly as acyl-HSL specificity.  The observation that LuxR and LasR are 
capable of activating gene expression at each other’s cognate promoter suggests that the 
DNA-binding specificities of these proteins have not significantly diverged [78].  This is 
not entirely surprising because the ability to respond to species-specific signals occurs at 
the level of acyl-HSL binding.  The ability to bind a different DNA target than another 
LuxR homolog becomes important when more than one LuxR homolog is present in the 
same cell.  P. aeruginosa, for example, has three LuxR homologs, RhlR, LasR and QscR.  
Each of these homologs has been shown to bind to different target sites, although all of 
the sites are considered lux-type boxes [47, 48, 79].    Substitutions at positions 8 and -8 
of the lux-type boxes recognized by LasR and QscR are sufficient to switch their 
responses between the two sites [47].  LasR is the only LuxR homolog whose DNA-
binding specificity has been investigated with several potential target sites [48].  LasR 
was shown to bind several promoters that had previously been identified las-responsive.  
LasR did not bind to all of the predicted sites and was shown to bind at unexpected sites.  
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Interestingly, the sites that were bound by LasR did not show a large degree of overall 
sequence similarity and did not require dyad symmetry.       
 
Prior to this work, LuxR had not been engineered to respond to new acyl-HSLs or to 
activate gene expression at a new promoter.  A lac promoter had been modified to include 
a lux box, converting LuxR from an activator to a repressor.   However, LuxR itself was 
not modified.  As discussed above, an attempt to engineer TraR to recognize a new 
autoinducer based on structural information yielded proteins that showed broadened 
specificity but were very poor activators. 
 
 
D.  Engineering bacterial transcription factors 
 
Some of the most successful examples of transcription factor engineering have come 
from engineering eukaryotic zinc-finger (Zn-finger) proteins [80, 81].  The modularity of 
Zn-fingers has made these DNA-binding proteins good targets for engineering 
experiments.  Each finger is responsible for binding three consecutive bp of the DNA 
target and they can be “strung” together to bind longer DNA sequences.  The 
functionality of Zn-fingers is also modular in that an activating domain or repressor 
domain need only be attached to the protein to confer its function at the target DNA site.  
Small molecule binding to the effector domain then affects the rate of transcription from 
the target promoter.   In contrast, many bacterial transcription factors, including HTH-
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containing proteins like LuxR, are switched ON and OFF by conformational changes that 
affect the whole protein.  This means that engineered proteins must maintain the 
mechanism of signal transduction from regulatory region to DNA-binding domain and 
may render these proteins more challenging targets with regards to engineering new 
functions.  Whether targeting a Zn-finger or a bacterial HTH protein, the available 
strategies are similar and are introduced in the following section.  Examples of bacterial 
transcription factor engineering are then discussed. 
 
 
D.1.  Directed evolution and rational design 
 
Directed evolution is an iterative process of mutation or recombination and selection or 
screening.  It mimics the process of natural evolution by creating genetic diversity and 
then identifying genes encoding the “fittest” proteins based on the goals of the project.  
Rational design, on the other hand, uses structure and sequence information, which can 
be analyzed via computational methods, to identify mutations that are likely to confer the 
desired change in function. 
 
In general, sequence diversity is generated for directed evolution experiments by random 
mutagenesis or by recombining multiple parental sequences.  Libraries of mutant genes 
produced by random mutagenesis are especially useful when there is little or no structural 
information available for a target protein.   We chose to use random mutagenesis to target 
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the acyl-HSL specificity of LuxR because, at the time, there were no structures of LuxR 
homologs available and, more importantly, because the sequence identity between LuxR 
and its homologs is very low (<25%), identifying amino acids responsible for modulating 
acyl-HSL specificity was not feasible from sequence information alone.   
 
 A semi-rational approach is commonly used for engineering transcription factors [82-
85].  In general, structural or functional information is used to identify residues predicted 
to modulate the target activity, and libraries that randomize these residues are screened or 
selected for the desired behavior.   
 
 
D.2. Screening and selection 
 
Identification of proteins that exhibit the desired behavior from a library of variants 
requires the ability to relate the desired protein function to a measurable output.  In a 
screen, a functional protein yields an easily measured product.  Directed enzyme 
evolution experiments have often relied on the use of surrogate substrates, i.e., substrates 
that are chemically similar to the substrate of interest and whose products can be easily 
quantified colorometrically, or the use of additional enzymes that selectively convert the 
desired product to a readily detectable compound.   One of the advantages of working 
with transcription factors is that protein function can easily be tied to the production of a 
reporter protein that generates a measurable output.   Commonly used reporter proteins 
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include β-galactosidase, luciferase and fluorescent proteins such as green fluorescent 
protein (GFP) and red fluorescent protein (RFP).   
 
Selections differ from screens in that they tie the survival of the host cell to the desired 
protein function.  It is often the production of an essential metabolite or an increase in 
antibiotic resistance that leads to survival.   The upregulation of a gene conferring 
antibiotic resistance is commonly used to identify transcription factors that are on or off 
under a specific set of conditions.  Most antibiotic resistance proteins chemically 
inactivate the antibiotic through enzymatic cleavage or derivatization.  For example, β-
lactamase (Bla) catalyzes the opening and hydrolysis of the lactam ring of β-lactam 
antibiotics [86] and chloramphenicol acetyl transferase (CAT) inactivates 
chloramphenicol by acetylating the antibiotic [87].   TetA, on the other hand, is a pump 
and confers tetracycline resistance by exporting the antibiotic from the cell [88].   
 
The major advantage to using a selection instead of a screen is potential library size.  
Selections can easily cover libraries containing >106 variants, while screens are often 
laborious and can limit library size to ∼104.  Screens, however, remain the more popular 
method because selections are often plagued by false positives.  While false positives 
occur regardless of the choice between screening and selection, they occur more 
frequently when cells are placed under selective pressure.  Any solution that leads to 
survival will be selected, even if it is not the solution that has been targeted by the 
experimenter.  As will be discussed in Chapter 3, a successful selection requires an 
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approach that ensures the surviving bacteria express mutant proteins with the targeted 
properties.  Another advantage to using a screen is that the output is often measured, 
quantitatively or qualitatively, such that mutants can be easily ranked.  The graded 
output, as opposed to simply being alive or dead, makes it easier to identify the best 
variant from a pool of variants that perform the desired function.     
 
The use of negative screening or selection also figures prominently into this work. The 
screens and selections described above are generally used for identifying gain-of-function 
mutations.  As will be discussed in Chapters 3 through 5, identifying variants with loss-
of-function mutations is essential for evolving specificity [89].  The absence of reporter 
production can be used in screens but one runs the risk of identifying nonfunctional 
proteins.  By screening for proteins that confer a desired function prior to screening for 
the absence of function under a different set of conditions, one can limit the prevalence of 
the nonfunctional proteins.  Selecting for loss-of-function mutations is more complicated 
because it is impossible to retrieve DNA encoding a protein of interest from a dead 
bacterium.  The most common way to implement negative selections is through the use of 
a repressor protein as an inverter.  In this case, gene activation leads to the production of 
a repressor, which prevents the production of an antibiotic resistance gene, leading to 
antibiotic sensitivity.   Toxic protein production can be employed in negative selections.  
In general, the basal level of expression of most toxic proteins leads to a prevalence of 
false positives and the use of a repressor to invert the signal provides an additional target 
at which the selection system can be undermined.  Yokobayashi and Arnold have 
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developed a dual selection system that employs an inhibitor of Bla to directly target the 
protein that confers the ability to survive with β-lactam antibiotics [90].  
 
 
D.3. Engineering signal binding  
 
The tetracycline repressor (TetR) is a well-studied bacterial transcription factor that has 
been engineered to both recognize new small molecules and to bind to new DNA 
sequences [83, 85, 91, 92].  TetR is responsible for repressing the expression of TetA 
[93].  Because overexpression of TetA is toxic to cells, TetR has evolved a very high 
affinity for a DNA site located upstream of the tetA gene to prevent its expression.  TetR 
also has a high affinity for tetracycline (tc, Fig. 1.5) and releases its DNA target to allow 
tetA expression before tc concentrations become toxic.    
 
Variants of TetR that bind to an analog of tc that does not affect wild-type TetR, 4-
dedimethylamino-6-demethyl-6-deoxy-tetracycline (cmt3, Fig.1.6), were identified by 
screening libraries generated by random mutagenesis for cmt3-dependent expression of 
β-galactosidase [85].  Recombination by DNA shuffling and another round of screening 
identified a single variant with improved cmt3-inducibility.  Almost half of the mutations 
found in the best clones from the first round were located close to or in the tc-binding 
region.  A new library targeting amino acid positions shown to be close to the sites that 
differ between tc and cmt3 was generated, using the wild type as parent, and screened for 
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cmt3-inducibility.  A single mutation was identified that was partially inducible with 
cmt3 but was still showed a preference for tc.  Recombination with a mutation identified 
by random mutagenesis identified a relaxed specificity variant that is induced by cmt3 at 
levels comparable to wild-type TetR with tc, and that shows decreased induction with tc.  
A final round screened a library, generated by randomizing the same amino acids as the 
previous round but with the best double-mutant as parent, for a decrease in response to a 
potent tc analog.  Variants exhibiting the desired improvements in specificity were 
identified.   
 
 
Figure 1.6.  Chemical structures of tetracycline derivatives used in the directed evolution 
of TetR.   
 
 
Engineering TetR to respond to cmt3 successfully incorporated both random and semi-
rational library design strategies.  Mutations critical for modulating TetR’s response to tc 
and its cmt3 analog were identified.  The relaxed specificity variant identified while 
screening for cmt3 was subsequently used as a parent to identify a TetR mutant inducible 
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by a different tc analog [92].  Two residues were targeted for randomization due to their 
proximity to the moiety that differs between tc and the new analog in the TetR.  A single 
mutation was identified that conferred a 200-fold switch in specificity.   
 
A eukaryotic activation domain has been fused to TetR to generate a hybrid tc-dependent 
transcriptional activator (tTA) that functions in mammalian cells [94].  This system is 
widely used as an inducible expression system in eukaryotes ranging from yeast to mice 
[95].  Furthermore, a set of eukaryotic, TetR-based transactivators that respond to cmt3 
but not tc were developed from the cmt3-specific TetR variants to allow selective 
regulation of two genes by the different inducer molecules [96].  
 
The majority of studies for the modification of signal-dependent transcription factors 
have altered the binding specificity of eukaryotic activation domains [97].  Further 
examples of engineering signal binding by bacterial transcription factors are unavailable.   
     
D.4.  Engineering DNA-binding interactions 
 
The HTH DNA-binding motif, which is found in LuxR, is commonly found in 
prokaryotic transcriptional regulators.  Examples of HTH engineering in the literature are 
scarce and the examples that are available have relied on structural information regarding 
the interactions between the protein and its target site [82, 84, 98-106].  Many published 
HTH engineering experiments have used solutions already present in Nature, including 
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swapping an entire DNA recognition helix [104] or replacing all of the amino acids that 
contact a specific DNA target recognized by a close homolog [105].  This strategy is not 
always successful [98] and does not generate DNA-binding proteins that recognize novel 
DNA sequences.  Attempts at engineering HTH proteins that bind to previously 
unrecognized sequences have generally relied on libraries that randomize the amino acids 
shown to make specific contacts with DNA [82-84, 91].  In most cases, modest gains can 
be accomplished in this manner, however, new specificities are rare.   Occasionally, 
mutations at residues that are not targeted have arisen adventitiously and are critical for 
binding the new target [91].   
 
One of the successful strategies for engineering HTH proteins is to engineer single-chain 
proteins.  Single-chain proteins that are covalent dimers of the DNA-binding domains 
from different transcription factors have also been shown to bind to hybrid operators 
[107-110].  Single-chain proteins that bind to new asymmetric DNA targets have been 
identified by screening [111] and phage display [102].  More recently, Liang et al. [112] 
constructed several single-chain heterodimers using engineered 434 repressor DNA-
binding domains (identified in previous rational design and selection experiments), which 
also bound operators made up of half-sites bound by the individual domains. To achieve 
high DNA-binding affinities (Kd = 10-10-11 M), the single-chain proteins developed by 
Liang and colleagues require that the six base pair (bp) sequence between the two half-
sites contains mostly A and T nucleotides. 
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 The most successful efforts towards engineering the DNA-binding specificities of 
prokaryotic proteins have switched the DNA-binding specificity of Cre and Flp 
recombinases.  Work from two independent laboratories used screens incorporating 
positive and negative selection pressure to identify variants that recombine only at a new 
target site [113-115].  In one of these experiments,  directed evolution of the DNA-
binding specificity of a Cre recombinase using positive screening alone and a 
combination of positive and negative screening showed that both positive and negative 
selective pressure were required to switch Cre’s DNA-binding specificity [113].  
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CHAPTER 2 
   
Directed Evolution of Vibrio fischeri LuxR for Increased 
Sensitivity to a Broad Spectrum of Acyl-homoserine Lactones 
 
 
 
 
 
 
 
 
 
 
Material from this chapter appears in:  Collins, C. H., Arnold, F. H., and Leadbetter, J. R. 
(2005) Directed evolution of Vibrio fischeri LuxR for increased sensitivity to a broad 
spectrum of acyl-homoserine lactones. Mol Microbiol 55: 712-723, and is reprinted with 
permission of Blackwell publishing. 
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A.  Abstract 
 
LuxR-type transcriptional regulators play key roles in quorum-sensing systems that 
employ acyl-homoserine lactones (acyl-HSLs) as signal molecules. These proteins 
mediate quorum control by changing their interactions with RNA polymerase and DNA 
in response to binding their cognate acyl-HSL. The evolutionarily-related LuxR-type 
proteins exhibit considerable diversity in primary sequence and in their response to acyl-
HSLs having acyl groups of differing length and composition. Little is known about 
which residues determine acyl-HSL specificity, and less about the evolutionary time 
scales required to forge new ones. To begin to examine such issues, we have focused on 
the LuxR protein from Vibrio fischeri, which activates gene transcription in response to 
binding its cognate quorum signal, 3-oxohexanoyl-homoserine lactone (3OC6HSL). 
Libraries of luxR mutants were screened for variants exhibiting increased gene activation 
in response to octanoyl-HSL (C8HSL), with which wild-type LuxR interacts only 
weakly. Eight LuxR variants were identified that showed a 100-fold increase in 
sensitivity to C8HSL; these variants also displayed increased sensitivities to pentanoyl-
HSL and tetradecanoyl-HSL, while maintaining a wild-type or greater response to 
3OC6HSL.  The most sensitive variants activated gene transcription as strongly with 
C8HSL as the wild type did with 3OC6HSL.  With one exception, the amino acid 
residues involved were restricted to the N-terminal, “signal-binding” domain of LuxR. 
These residue positions differed from critical positions previously identified via “loss-of-
function” mutagenesis.  We have demonstrated that acyl-HSL-dependent quorum-sensing 
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systems can evolve rapidly to respond to new acyl-HSLs, suggesting that there may be an 
evolutionary advantage to maintaining such plasticity.  
 
 
B.  Introduction 
 
Several mechanisms have evolved to allow diverse bacterial species to detect changes in 
their  local population density, and to modulate their gene expression accordingly [1, 2]. 
An opinion that quorum sensing is actually a form of diffusion sensing has recently been 
articulated [3], however, it is the view of many that the two stances are not necessarily 
mutually exclusive. The population-density-based control of gene expression in bacteria 
has been termed “quorum sensing” [4].  A paradigm of the quorum-sensing control of 
gene regulation within the Gram-negative phylum Proteobacteria has been the 
luminescence (lux) operon in Vibrio fischeri.  In addition to the luciferase genes required 
for light production, this operon encodes LuxR, an acyl-homoserine lactone (acyl-HSL)-
dependent transcriptional activator, and LuxI, an acyl-HSL synthase that catalyzes the 
production of 3-oxohexanoyl-homoserine lactone (3OC6HSL) [5].  Each bacterium 
expresses the Lux proteins at low basal levels throughout its entire lifecycle.  At low cell 
densities, the small amounts of the amphipathic 3OC6HSL signal that are produced 
diffuse away from the cells [6, 7].  However, as a local population increases in density, 
3OC6HSL concentrations increase. This results in a shift of the LuxR equilibrium 
towards its 3OC6HSL-bound, active state.  Acyl-HSL binding leads to dimerization of 
LuxR and binding to the lux box, a 20-base pair inverted repeat located in the Plux 
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promoter [8].  There the acyl-HSL-bound LuxR dimer activates expression of the lux 
genes after the recruitment of RNA polymerase [9, 10].   
 
To date, genes encoding more than 50 LuxI/LuxR pairs have been identified in diverse 
species belonging to the α-, β-, and γ-subdivisions of the Proteobacteria [11].  While the 
basic quorum-sensing mechanism has been fairly well conserved in most species studied, 
the physiological functions controlled by acyl-HSL-based quorum-sensing systems are 
varied and include virulence [12, 13], antibiotic synthesis [14, 15], and biofilm formation 
[16, 17].  A LuxR homolog typically responds to an acyl-HSL synthesized by its partner 
LuxI homolog.  Known quorum-sensing systems are tuned to preferentially synthesize 
and respond to a specific acyl-HSL having an acyl side group that may range in length 
from four to 16 carbons, may contain a degree of unsaturation, and may be modified with 
a carbonyl or hydroxyl functional group at carbon position 3  [18, 19].   
 
Are LuxR homologs evolutionarily pliable, i.e., able to move into new signaling niches 
on short time scales? We are interested in this issue and in identifying how the specificity 
of acyl-HSL response is determined.  The ability of LuxR to regulate gene expression in 
response to an acyl-HSL depends on signal recognition and binding; it may also include 
acyl-HSL-specific dimerization and DNA-binding mechanisms.  Because LuxR 
homologs generally share low amino acid sequence identities (≤25%), however, it is 
difficult to determine precisely how they discriminate between various acyl-HSL 
molecules, or how this discrimination evolves and changes as a result of varying selective 
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pressures. In a recent study on acyl-HSL-binding specificity, residues of TraR (a LuxR 
homolog) predicted to interact with the carbonyl moiety of its cognate signal, 3-
oxooctanoyl-HSL (3OC8HSL) were mutated with the goal of stimulating the response of 
this protein to an analog, octanoyl-HSL (C8HSL) [20]. Rather than showing improved 
sensitivity to C8HSL, these variants lost the strong response that wild-type TraR displays 
towards 3OC8HSL. The attempts of Chai and Winans to shift the specificity of TraR 
towards 3OC6HSL by introducing bulkier hydrophobic amino acids, and thereby reduce 
the size of the acyl binding site, also led, in all but one case, to variants with greatly 
decreased acyl-HSL affinities. Thus, alternative approaches may be more successful at 
altering the acyl-HSL specificities of LuxR or its homologs. To identify LuxR variants 
with altered acyl-HSL specificity, and to identify key residues which modulate this 
property, we have developed and implemented a system to direct the evolution of LuxR-
mediated gene activation.  Variants of LuxR were generated and screened to identify 
those that are highly responsive to acyl-HSL signals to which this transcriptional 
activator does not normally respond.    
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C.  Results 
 
C.1. Cloning vectors and screening tools
 
Modifications to a commercial two-plasmid system were made to allow for rapid cloning 
of luxR mutant libraries and screening for gene activation in response to exogenous 
signal molecules. The first plasmid, pLuxR, contains wild-type luxR under the control of 
a Plac/ara-1 hybrid promoter.  The luxR allele is constitutively expressed when placed in E. 
coli strains lacking lacI and araC.  The second plasmid, pluxGFPuv, contains the gene 
gfpuv placed under the control of the PluxI promoter. The gfpuv gene encodes a green 
fluorescent protein variant, GFPuv, which becomes visible when excited with standard, 
long-wavelength ultraviolet light [21]. GFPuv expression from the PluxI promoter of 
pluxGFPuv is dependent upon the degree of activation that occurs as a result of a 
functional LuxR variant binding to a specific acyl-HSL signal molecule. The relative 
levels of gene activation observed with wild-type LuxR and the acyl-HSLs used in this 
study were similar to those previously reported in V. fischeri [22] and E. coli [23].  
 
 
C.2.  First-generation laboratory evolution—error-prone PCR 
 
We used the two-plasmid system to identify LuxR variants that showed an increased 
ability to activate gene transcription in response to C8HSL.  Past studies have shown that 
low-micromolar concentrations of C8HSL were required to achieve the same level of 
gene expression achieved by 5 nM of 3OC6HSL, the cognate signal of LuxR [22].  In the 
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current system, a C8HSL concentration of approximately 2 μM was required to achieve 
the level of gene activation obtained with 10 nM 3OC6HSL. Random mutations were 
introduced into wild-type luxR by error-prone PCR.  E. coli hosts containing pluxGFPuv 
were transformed with pLuxR vectors containing the mutagenized PCR products. 
Transformants were initially plated onto LB-agar amended with 50 nM C8HSL and 
antibiotics as appropriate. However, initial screening with this concentration of acyl-HSL 
yielded only one mutant, LuxR-G1A.  Subsequently, the library was screened for 
activation with 200 nM C8HSL.  Colonies were screened under illumination with 365 nm 
ultraviolet light. Most colonies appeared dark under such illumination, indicating the 
expression of LuxR variants having either wild-type or non-functional properties. Of the 
~20,000 colonies that were screened, nine fluorescent colonies were identified. These 
nine colonies were isolated and verified by re-screening, which identified one as a false 
positive.  The remaining eight alleles were amplified and cloned into fresh background 
plasmids and strains to ensure that the observed phenotype was due to changes within 
luxR.  An additional false positive was identified by doing so. 
 
Of the seven remaining alleles, two were shown to be identical by DNA sequence 
analysis.  The six LuxR variants from this first generation of laboratory evolution were 
designated LuxR-G1A through LuxR-G1F (Fig. 2.1).  Quantitative characterization of the 
response of these mutants to 3OC6HSL and C8HSL was performed in liquid-phase 
assays by monitoring fluorescence levels using a microtiterplate spectrofluorimeter. As 
shown in Table 2.1, all six variants showed increased gene expression in the presence of 
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100 nM C8HSL as compared to wild-type LuxR.  Amino acid substitutions identified in 
the first generation are shown in Figure 2.1. 
 
 
Figure 2.1. Amino acid sequence changes to first- and second-generation LuxR variants 
showing increased gene activation in response to C8HSL.  The six first-generation 
variants were identified from a library of approximately 20,000 clones generated by error-
prone PCR.  Second-generation variants were generated by DNA shuffling of alleles from 
the first generation.  Eight second-generation variants showing additional increases in 
gene activation in response to C8HSL were identified after screening 1,200 clones.  The 
positions of amino acid substitutions within the 250 amino acid LuxR protein are 
indicated as black rectangles (refer to Table 2.1 for nucleotide sequence changes). 
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Table 2.1.  Nucleotide and amino acid changes in the recovered luxR/LuxR mutants
luxR plasmid  luxR gene 
base and substitution 
LuxR protein 
amino acid residue and substitution 
First Generation    
pLuxR-G1A A97→G 
A159→G 
Thr33→Ala 
Synonymous 
pLuxR-G1B 
 
A133→T 
T501→C 
Ile45→Phe 
Synonymous 
pLuxR-G1C A284→G 
A414→C 
Asn95→Ser 
Synonymous 
pLuxR-G1D A286→G 
G405→A 
Ile96→Val 
Met135→Ile 
pLuxR-G1E T346→G 
A683→G 
Ser116→Ala 
Thr228→Ala 
pLuxR-G1F T162→A 
A403→G 
A522→G 
Synonymous  
Met135→Val 
Ile174→Met 
Second Generation   
pLuxR-G2A A133→T 
A403→G 
Ile45→Phe 
Met135→Val 
pLuxR-G2B A133→T 
G405→A 
A522→G 
Ile45→Phe 
Met135→Ile 
Ile174→Met 
pLuxR-G2C T346→G 
G405→A 
Ser116→Ala 
Met135→Ile 
pLuxR-G2D A97→G 
T162→A 
A286→G 
G405→A 
A414→C 
Thr33→Ala 
Synonymous  
Ile96→Val 
Met135→Ile 
Synonymous 
pLuxR-G2E A97→G 
T162→A 
T346→G 
G405→A 
Thr33→Ala 
Synonymous  
Ser116→Ala 
Met135→Ile 
pLuxR-G2F A97→G 
A133→T 
T162→A 
T346→G 
Thr33→Ala 
Ile45→Phe 
Synonymous  
Ser116→Ala 
pLuxR-G2G A97→G 
A286→G 
T346→G 
Thr33→Ala 
Ile96→Val 
Ser116→Ala 
pLuxR-G2H A97→G 
A284→G 
T346→G 
A522→G 
Thr33→Ala 
Asn95→Ser 
Ser116→Ala 
Ile174→Met 
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Table 2.2.  Activation of gfpuv gene expression by LuxR variants with four different 
acyl-HSLs
 
 Fluorescence (AU)a
LuxR type No acyl- 
HSL 
3OC6HSL C8HSL C5HSL C14HSL 
  10 nM 100 nM 10 nM 100 nM 100 nM 500 nM 
LuxR wt <50 1400 3000 <50 100 <50 <50
First Generation        
LuxR-G1A <50 2200 3300 <50 800 100 <50 
LuxR-G1B <50 2600 3200 <50 800 500 <50 
LuxR-G1C <50 2100 3000 <50 700 <50 <50 
LuxR-G1D <50 400 2000 100 1500 700 200 
LuxR-G1E <50 2200 3200 <50 500 <50 100 
LuxR-G1F <50 600 2700 <50 700 600 100 
Second Generation      
LuxR-G2A <50 1600 3200 200 1700 2200 100 
LuxR-G2B <50 2400 3500 900 2900 3000 400 
LuxR-G2C <50 500 1900 200 1900 1000 700 
LuxR-G2D <50 1300 3200 800 3100 2300 1300 
LuxR-G2E <50 1400 3200 1100 3600 3200 2200 
LuxR-G2F <50 3100 2900 800 2900 2600 900 
LuxR-G2G <50 3300 3500 500 2800 1400 1500 
LuxR-G2H <50 3300 3400 900 2500 1200 1500 
aUnits of fluorescence represent the fluorescence due to GFPuv production obtained with  
a given LuxR variant and pluxGFPuv.   Fluorescence values were corrected with the 
background fluorescence obtained without a LuxR expressing plasmid.  Both values were 
normalized to their cell densities prior to correction.  All values are the mean of triplicate 
measurements.  Variation was less than ± 15% for all reported values. 
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C.3.  Second-generation laboratory evolution—DNA shuffling of mutant luxR alleles
 
To investigate whether the mutations could be combined to yield further improvements in 
C8HSL response, a new library of luxR alleles was generated via DNA shuffling of the 
six from the first generation, under conditions designed to minimize new point mutations 
[24]. As with the first generation, transformants were screened for GFPuv production on 
LB-agar, in this case amended with 50 nM C8HSL.  Of 1200 colonies transformed with 
this library, 102 exhibited fluorescence. To identify those variants most sensitive to 
C8HSL, these 102 strains were screened using 10 and 20 nM C8HSL.  Ten exhibited 
fluorescence under these conditions and were picked for further characterization.  One 
false positive was identified after re-amplification and re-cloning of the alleles into fresh 
background materials.  Sequence analysis revealed two of the alleles to be identical. 
Quantitative liquid-phase characterization of the eight remaining mutants showed that all 
exhibited remarkable increases in fluorescence output in response to not only 100 nM but 
also 10 nM C8HSL, as compared to either wild-type LuxR or any of the first-generation 
LuxR variants (Table 2.2). Sequencing revealed that no additional residue positions had 
been changed; the second-generation sequences were all recombinants of the parent 
sequences (Fig. 2.1). 
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C.4.  C8HSL and 3OC6HSL dose responses   
 
We compared the influence of a range of 3OC6HSL and C8HSL concentrations on 
transcriptional activation by wild-type LuxR and each of the second-generation variants 
(Fig. 2.2). Wild-type LuxR required approximately 2 μM C8HSL to elicit half the 
maximum GFPuv fluorescence observed using saturating amounts of 3OC6HSL, whereas 
only 10 nM 3OC6HSL was required for half-maximal activation (Fig. 2.2A). In 
comparison, all second-generation LuxR variants showed an increased sensitivity to 
C8HSL, requiring only 15 to 50 nM to achieve the half-maximal 3OC6HSL-induced 
fluorescence of the wild-type.  Thus, C8HSL sensitivity and response by these LuxR 
variants increased by 20- to 100-fold.  Variants LuxR-G2D and LuxR-G2E responded as 
sensitively and strongly to C8HSL as wild-type LuxR did to 3OC6HSL (Fig. 2.2E, F).   
The acquisition of this trait had little or no deleterious impact on the sensitivity of these 
variants to 3OC6HSL.  Three variants, LuxR-G2A, LuxR-G2D and LuxR-G2E 
(Fig. 2.2B, E, F), showed responses to 3OC6HSL indistinguishable from that of wild-
type LuxR.  Variants LuxR-G2F, LuxR-G2G and LuxR-G2H (Fig. 2.2G–I) showed 
5-fold increased sensitivity to 3OC6HSL, exhibiting significant levels of fluorescence 
with concentrations as low as 1 nM.   
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Figure 2.2. Detection of C8HSL and 3OC6HSL by wild-type LuxR and eight second-
generation LuxR variants.  For each panel and variant (A through I), data for 3OC6HSL 
are represented by closed squares (■), data for C8HSL are represented by open triangles 
(∆).   Fluorescence data reported are normalized to optical density, and corrected by 
subtracting background fluorescence from a control strain carrying pPROLar.A122 with 
pluxGFPuv.  All measurements were performed in triplicate. Error bars indicate either the 
range of values or the standard deviation, whichever was greater. 
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C.5. Increased sensitivity to 3OC6HSL can be attributed to increases in LuxR protein 
concentration   
 
To investigate whether increases in expression were responsible for observed increases in 
gene activation in response to 3OC6HSL, concentrations of the variant LuxR proteins 
were measured.  Fusions of the c-myc epitope to the C-termini of wild-type LuxR and 
each of the second-generation variants were constructed.  All c-myc LuxR variants 
functioned well, i.e., exhibited responses to acyl-HSLs which were similar to the variant 
lacking the c-myc epitope.  Protein concentrations were monitored under different 
incubation conditions by Western immunoblot assay and compared.  
 
We tested the accumulation of wild-type LuxR and the second-generation variant 
proteins after incubation in the absence or presence of saturating amounts of 3OC6HSL.  
In the absence of acyl-HSL, the amount of protein detected by Western immunoblot for 
each of the variants differed by less than two-fold from wild-type LuxR; however, in the 
presence of 1 μM 3OC6HSL, the four variants with increased responses to 3OC6HSL, 
LuxR-G2B, -G2F, -G2G and -G2H, also showed increased amounts of protein as 
compared to wild type (Fig. 2.3).  Thus mutations leading to higher LuxR levels may lead 
to the increased sensitivities of these variants to 3OC6HSL and, in part, C8HSL.   
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Figure 2.3.  Protein concentrations of second-generation LuxR variants.  The 
immunoblot was performed on a SDS-PAGE display of the total proteins harvested from 
strains expressing c-myc tagged second generation LuxR variants incubated in the 
presence of 1μM 3OC6HSL.  Myc-coupled fluorescence for each of the variants varied 
by less than 10% in the presence and absence of acyl-HSL (latter not presented).  In the 
absence of acyl-HSL, the amount of LuxR protein detected for each variants was within 
two-fold of that for the wild-type LuxR-myc fusion.
 
The amount of wild-type LuxR detected in the presence of 3OC6HSL was approximately 
two-fold more than was detected in the absence of signal.  The increase in protein levels 
observed with the addition of 3OC6HSL is similar to that observed for TraR [20], 
consistent with the notion that acyl-HSL binding enhances the folding and/or stability of 
LuxR.  If so, acyl-HSL binding and protein stability are inextricably linked. 
 
 
C.6.  Response of LuxR variants to acyl-HSLs with long and short acyl chains 
 
The ability of the C8HSL-responsive LuxR variants to activate gene expression with 
other acyl-HSLs was also investigated. The response of each variant was examined using 
100 nM pentanoyl-homoserine lactone (C5HSL) and 1 μM tetradecanoyl-homoserine 
lactone (C14HSL), two acyl-HSLs to which wild-type LuxR exhibits essentially no 
response (Table 2.2). Four first-generation variants (LuxR-G1A, -G1B, -G1D and -G1F) 
 57
showed small, yet significant, responses to C5HSL, as did three (LuxR-G1D, -G1E and 
-G1F) to C14HSL.   
 
The second-generation variants all showed marked improvements in their sensitivity and 
response to both C5HSL and C14HSL.  LuxR-G2A showed a three-fold and LuxR-G2B a 
>four-fold improvement in sensing C5HSL when compared to the best of the first-
generation mutants.  LuxR-G2G and LuxR-G2H showed a >seven-fold increase in gene 
activation in the presence of C14HSL when compared to the best of the first-generation 
mutants. LuxR-G2D, -G2E, and -G2F all showed broadened acyl-HSL specificity, 
exhibiting strong responses to both C5HSL and C14HSL.  The most responsive mutant, 
LuxR-G2E, showed an ~five-fold increase in fluorescence with C5HSL and an 11-fold 
increase with C14HSL, while maintaining a wild-type level of response to 3OC6HSL.     
 
 
C.7.  Acyl-HSL specificity of the second-generation variants
 
The ratio of the 3OC6HSL and C8HSL concentrations required to attain half-maximal 
gene expression, termed the specificity, S, was used to assess changes in acyl-HSL 
responses (Table 2.3).  While wild-type LuxR has an S of 200, indicating that it requires 
200-fold more C8HSL than 3OC6HSL to reach half-maximal fluorescence levels, all of 
the second-generation mutants have S < 20.  The variant with the largest increase in 
response to C8HSL, LuxR-G2E, has S = 1: it responds equally to both HSLs.  This 
variant is also sensitive to C5HSL and C14HSL (see above). The variants which showed 
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increased protein concentration (LuxR-G2F, -G2G and -G2H) also exhibited a more than 
10-fold decrease in S as compared to wild type.  Whereas increases in protein 
concentration can increase response to all acyl-HSLs, they can not account for changes in 
specificity.  Acyl-HSL specificity has been significantly altered in the all of the variants.      
 
 
 
 
 
Table 2.3.  Specificity of second-generation LuxR variants 
 
LuxR type [3OC6HSL]50 (nM)a [C8HSL]50 (nM)a Sb
LuxR wt 10 2000 200 
LuxR-G2A 10 50 5.0 
LuxR-G2B 5 20 4.0 
LuxR-G2C 20 35 1.8 
LuxR-G2D 10 15 1.5 
LuxR-G2E 20 20 1.0 
LuxR-G2F 1.5 20 13.3 
LuxR-G2G 2.5 30 12.0 
LuxR-G2H 1.5 25 16.7 
a[3OC6HSL]50 and [C8HSL]50 are the concentrations of these 
acyl-HSLs required to reach half-maximal gene activation as 
measured from the fluorescence output of GFPuv. 
bThe specificity constant, S, corresponds to the ratio of the 
concentrations of 3OC6HSL and C8HSL required to achieve 
half-maximal gene activation, or [C8HSL]50/[3OC6HSL]50.   
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C.8.  Single mutants identify six mutations that increase C8HSL response by LuxR
 
Because every first-generation luxR mutant contained more than one nucleotide 
substitution, further information is required to determine which lead to increased 
response to C8HSL.  Single mutants with each of the 13 nucleotide substitutions 
identified in the six first-generation variants, including four synonymous mutations, were 
prepared using site-directed mutagenesis.  Quantitative liquid-phase characterization 
showed that amino acid substitutions at positions 33, 45, 95, 116, 135 and 174 confer 
increases in sensitivity to C8HSL (Table 2.4).  Fluorescence levels similar to those 
obtained with wild-type LuxR were found for substitutions at amino acid position 228 
and synonymous mutations at nucleotide positions 162, 414 and 501.  Two mutations, 
one leading to substitution of I96 by valine and the synonymous mutation at nucleotide 
position 159, are slightly deleterious, causing small decreases in gene activation.  The 
single-mutant containing only the T33 to alanine substitution was more sensitive to 
C8HSL than LuxR-G1A which contains both the T33A substitution and the synonymous 
mutation at position 159.  However, the response of LuxR-G1D, which contains both the 
I96V and M135I substitutions, was indistinguishable from the single-mutant containing 
only the M135I mutation, suggesting that the deleterious effects of the I96V mutation 
may be masked by the presence of a beneficial substitution.   
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Table 2.4.  Activation of gfpuv gene expression by luxR single mutants 
 
 Fluorescence (AU)a
Nucleotide  Amino acid No acyl- 3OC6HSL C8HSL 
substitution substitution HSL 10 nM 100 nM 10 nM 100 nM 
luxR wt LuxR wt <50 1700 3000 <50 200
A97→G Thr33→Ala <50 2500 3000 200 1200 
A133→T Ile45→Phe <50 3100 3100 300 1400 
A159→G Synb <50 300 1000 <50 <50 
T162→A Syn <50 2000 2800 100 500 
A284→G Asn95→Ser <50 2300 2600 200 1000 
A286→G Ile96→Val <50 900 1200 <50 200 
A346→G Ser116→Ala <50 2600 3000 200 700 
A403→G Met135→Val <50 900 2100 100 700 
G405→A Met135→Ile <50 700 1800 200 1100 
A414→C Syn <50 1300 2700 <50 200 
T501→C Syn <50 2000 2600 100 400 
A522→G Ile174→Met <50 2300 2800 100 700 
A683→G Thr228→Ala <50 1800 2400 100 300 
aUnits of fluorescence represent the fluorescence due to GFPuv production obtained with  
a given LuxR variant and pluxGFPuv as described for Table 2.2.    
b Syn denotes a synonymous mutation, i.e. a nucleotide change which does not encode an 
amino acid change. 
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D.  Discussion 
 
The results of this study indicate that LuxR can evolve rapidly to sense and respond to a 
diversity of acyl-HSL signal molecules.  By screening for changes in gene activation in 
the presence of C8HSL, we were able to identify variants of this signal-dependent 
transcriptional activator that respond strongly to this molecule and two additional acyl-
HSLs.  Only two generations and three or fewer residue changes were required to 
generate LuxR variants that activate gene expression in response to C8HSL with 
sensitivity equal to its response to the natural signal, 3OC6HSL.  
 
The variants identified in this study may be altered in more than one of a number of 
properties and processes involved in gene activation by LuxR.  LuxR-mediated gene 
activation involves key events of signal binding, dimerization, conformational changes, 
DNA binding, and transcriptional activation via interactions with RNA polymerase and 
other proteins [1].  Changes to LuxR stability (in the presence and absence of a 
competent acyl-HSL molecule), folding, solubility, and expression could also affect its 
ability to activate genes.  Indeed, the stability of TraR (a LuxR homolog) in the cytosol 
has been shown to increase dramatically upon binding a competent acyl-HSL [25, 26]. 
The increase in LuxR concentration observed in the presence of 3OC6HSL, as compared 
to its concentration without signal, indicates that, like TraR, the stability of LuxR is 
affected by the presence of acyl-HSL.  General improvements in response to various 
acyl-HSLs could result from changes in many of these properties. Acyl-HSL-specific 
response, however, can be extricated from these other properties by looking at S, the ratio 
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of responses, i.e. between the cognate and another acyl-HSL.  Using this measure we 
have shown that the response to C8HSL was enhanced in all of the variants relative to the 
changes in response to 3OC6HSL, suggesting key changes had occurred beyond general 
concentration effects, and likely at the level of acyl-HSL binding.     
 
Past studies involving the mutagenesis of luxR have been instrumental in constructing a 
structural and functional map of LuxR [reviewed in [27]].  Regions of LuxR that are 
essential for its function were identified by screening random point mutations within luxR 
[28, 29].  Mutations that led to nonfunctional LuxR variants clustered between residues 
79-127 and 184-230.  Reversal of the loss-of-function phenotype for several mutations 
within the N-terminal critical region was achieved by adding high concentrations of 
3OC6HSL, suggesting that such mutations weaken the interaction between the sensor 
protein and its cognate signal [28].  None of the residue positions identified here were 
shown to be critical for function in the previous studies. Four of the mutations (T33A, 
I44F, M135I, and M135V) are located outside of the region previously postulated to be 
involved in acyl-HSL binding, albeit well within the predicted N-terminal domain [27]. 
Thus, by evolving LuxR to respond to an acyl-HSL molecule to which it is normally 
insensitive, we have identified residues involved in acyl-HSL specificity and response 
that are distinct from those revealed during loss-of-function mutant studies (see Fig. 2.4).  
This was not entirely unexpected, as many laboratory evolution studies have 
demonstrated that amino acids involved in modulated function are generally distinct 
from, and more tolerant to change, than those required for folding or function [30].   
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Figure 2.4.  Mutations in LuxR responsible for altering acyl-HSL specificity differ from 
those which result in a loss of function.  The 250-residue LuxR protein is composed of an 
N-terminal acyl-HSL-binding and regulation domain and a C-terminal DNA-binding and 
activation domain [27].  Amino acid substitutions identified in this study are shown 
above the bar, and amino acid substitutions previously shown to lead to a loss of acyl-
HSL-mediated LuxR activation are shown below [28, 29, 31, 32].
 
 
 
 
D.1. The T33A, I45F, N95S, S116A, M135I and I174M mutations increase C8HSL 
response by LuxR 
 
Analysis of the thirteen single-site mutants showed that a single mutation from each of 
the first-generation variants was responsible for the observed increase in C8HSL 
response (Table 2.4), with the exception of LuxR-G1F, in which both the M135V and 
I174M mutations increase C8HSL sensitivity.  Recombining these mutations led to LuxR 
variants with further increases in their ability to activate gene expression with C8HSL but 
with varying responses to 3OC6HSL, C5HSL and C14HSL.  The absence of N95S in the 
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second generation may be due to random chance, bias in the construction of the library, 
or its inability to confer any additional advantage when combined with the other 
mutations.    
 
 
D.2.Substitutions at position 135 likely stabilize interactions with straight-chain acyl HSLs 
 
The variants which showed increased response to C8HSL with minimal changes in their 
response to 3OC6HSL (LuxR-G2A, -G2B, -G2C, -G2D and -G2E) all contain a 
substitution at position 135 (Fig. 2.2 and Table 2.2).  Mutation of M135 to isoleucine or 
valine appears to stabilize interactions between LuxR and C8HSL without affecting the 
sensor’s recognition of its cognate signal, 3OC6HSL.  Alignments of LuxR with a 
number of its homologs revealed that proteins that respond to acyl-HSLs containing a 
carbonyl group at the third carbon of their acyl chain often have a methionine residue at 
this position, whereas those that recognize straight-chain acyl-HSLs usually contain an 
isoleucine or a valine residue (see Fig. 2.5).  Thus natural and laboratory evolution appear 
to converge to the same answer. The predominant preference at this position in all LuxR 
homologs seems to be for a hydrophobic residue (isoleucine, valine, leucine or 
methionine).  Alignment to the published structure of TraR shows that 135 is only two  
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Figure 2.5.  A.  Multiple sequence alignments of 19 members of the LuxR family of 
transcriptional regulators.  LuxR residue numbering is shown above the alignment.  
Conserved residues are denoted by shading with black (100% conservation), dark grey 
with white letters (80-99% conservation), and light grey with black letters (60-79% 
conservation).  Site numbering for residue changes identified in this study are shown 
above the aligned column bounded by a blue vertical box.  B.  List of LuxR homologs 
used in the multiple sequence alignment, including the source species and the acyl-HSLs 
to which they are reported to respond preferentially and strongly. 
 
 
positions away from an amino acid required for recognition of the 3-oxo moiety of 
3OC8HSL in TraR [20], and could potentially be involved inmodulating the response to 
acyl-HSLs lacking a 3-oxo moiety.  It also remains possible that residue 135 does make 
contact with the acyl-HSL molecule:  the structure of LuxR has not yet been determined 
and may differ significantly from that of its distantly-related homolog, TraR [33]. 
 
 
D.3.  Acyl-HSL specificity is influenced by mutations at LuxR positions 33 and 45 
 
 
Each of the second-generation variants which exhibited the greatest increases in gene 
expression in response to C14HSL (LuxR-G2D to -G2H) contained the T33A mutation 
(Table 2.2).  The T33A mutation may help LuxR to accommodate acyl-HSLs with acyl 
chains more than six carbons in length.  TraR and LasR, which respond to acyl-HSLs 
having acyl side chains eight and twelve carbons in length, both contain an alanine 
residue at this position [34, 35].  Substitution of I45 by phenylalanine, on the other hand, 
led to an increase in GFPuv production in response to C5HSL in each of the three 
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second-generation variants, LuxR-G2A, -G2B and -G2F, in which it was identified.  
Therefore, I45F might improve interactions with short-chain acyl-HSLs such as C5HSL.    
 
The identification of four LuxR variants showing increased sensitivity to 3OC6HSL was 
unexpected, in as much as wild-type already responds strongly to low nanomolar 
concentrations of this, its cognate signal.  Increases in variant protein levels, as observed 
in the Western blots (Fig. 2.3), due to increases in expression, stability or solubility are 
the most likely explanation.  The crystal structure of TraR was used to map the 
hypothetical positions of the amino acid substitutions identified in this study (Fig. 2.6).  
Curiously, the TraR residues which align with LuxR positions I45 and I174 are located at 
the interface between its signal- and DNA-binding domains. These mutations might act 
by stabilizing interactions between these two domains required for LuxR’s switch-like 
behavior, thereby conferring increases in gene activation. 
 
The acyl-HSL sensitivity of LuxR homologs may not have been maximized during 
natural evolution.  LuxR-type proteins may be tunable over short evolutionary periods to 
meet the physical and chemical nature of the habitats in which the cells encoding them 
are active.  Indeed, the amount of acyl-HSLs that must accumulate for a given quorum-
sensing species to exhibit a quorum response can vary widely from low nanomolar to 
micromolar concentrations [5, 12, 22, 34, 36, 37], and likely reflects the particular 
physiological ecology of the organism.   
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Figure 2.6.  Hypothetical positions of residues in TraR corresponding to those found to 
modulate acyl-HSL specificity in LuxR.  The crystal structure of the LuxR homolog TraR 
(PDB 1L3L) has been determined [26].  The two peptides comprising a TraR dimer are 
shown in red and blue.  The double-stranded DNA to which TraR binds is shown in 
green.  The two 3-oxooctanoyl-homoserine lactone (3OC8HSL) molecules are shown 
using space-filling spherical atoms (yellow represents carbon, red represents nitrogen, 
and blue represents oxygen).  The amino acid residues which align with those identified 
in the LuxR variants exhibiting altered acyl-HSL responses are shown as sticks with 
coloring similar to that used for 3OC8HSL.  The amino acids identified occur 
predominantly within the N-terminal domain and do not appear to make direct contact 
with the signal molecule.   Because LuxR and TraR share less than 20% sequence 
identity at the amino acid level, these assignments are purely hypothetical.  However, the 
overall structures of the two homologs are expected to be in large part similar. Their 
alignment can provide a useful first approximation of residue location within the three-
dimensional structure of any LuxR-type protein. 
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While this study indicates that LuxR can rapidly evolve to respond to a broad range of 
acyl-HSL molecules, it did not reveal which or how many evolutionary changes are 
required to refocus it to a new signal molecule.  Our findings indicate that the easiest 
evolutionary solution to generating a protein that responds to a new signaling molecule is 
by broadening its specificity.  This is consistent with other directed evolution work that 
has shown that refocusing binding to shift, rather than broaden, specificity often requires 
additional evolutionary work [38].  Natural evolution of signal and substrate specificity 
has also been shown to fluctuate between specialized states through broad-specificity 
intermediates, allowing for the acquisition of new functions by expanding the capabilities 
of “old” proteins [39-43].  Laboratory evolution experiments which have successfully 
refocused binding or substrate specificity to a new target have specifically included 
screening for activity with a new substrate and the absence of activity with the enzyme’s 
natural substrate [44, 45].  In future laboratory evolution studies with LuxR, we hope to 
understand the basis for acyl-HSL sensing as well as how diverse acyl-HSL-based 
intercellular communications systems have evolved and continue to evolve.  
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E. Materials and Methods 
 
E.1. Bacterial strains, media and growth conditions   
 
The bacterial strains used in this study were:  Escherichia coli strain DH5α 
(F- φ80dlacZΔM15 Δ(lacZYA-argF) U169 deoR recA1 endA1 hsdR17(rk-, mk+) phoA 
supE44 λ- thi-1 gyrA96 relA1) and E. coli DH5α containing pluxGFPuv 
(DH5α(pluxGFPuv)), a pPROTet.E133-derived LuxR/acyl-HSL-inducible GFPuv 
expression vector encoding chloramphenicol resistance. Competent DH5α and 
DH5α(pluxGFPuv) cells were prepared by using the Z-competent Escherichia coli 
Transformation Kit (Zymo Research, Orange, CA).  E. coli strains were cultured at 37 oC 
in LB medium or on LB agar plates.  Antibiotics were added at the following 
concentrations:  100 μg ⋅ mL-1 chloramphenicol, or 20 μg ⋅ mL-1 kanamycin.  Acyl-HSL 
stock solutions of 1 and 10 mM were prepared by dissolving appropriate amounts in ethyl 
acetate acidified with glacial acetic acid (0.01% v/v), and stored at –20 oC.  Acyl-HSLs 
used in these studies were: 3-oxohexanoyl-DL-homoserine lactone (3OC6HSL; Sigma 
Aldrich, St. Louis, MO), pentanoyl-L-homoserine lactone (C5HSL; B. Hauer), octanoyl-
DL-homoserine lactone (C8HSL; Fluka, St. Louis, MO), and tetradecanoyl-DL-
homoserine lactone (C14HSL, Fluka).  For screening experiments, C8HSL was amended 
to LB agar media prior to solidification to ensure complete mixing.  For liquid-phase 
experiments, acyl-HSL was dispensed into sterile tubes, the ethyl acetate was evaporated 
under a stream of air, and sterile medium was added to the dried acyl-HSL.  All liquid 
media containing acyl-HSL were prepared immediately prior to use.   
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E.2. Plasmid construction 
 
All synthetic oligonucleotide primers used in this chapter are listed in Table 2.5.  We 
constructed the LuxR expression vector, pLuxR, and the signal response screening 
plasmid, pluxGFPuv, using the two-plasmid pPROLar.A122 and pPROTet.E133 system 
from BD Biosciences Clontech (Palo Alto, CA) as plasmid backbones.  Plasmid pLuxR 
encodes LuxR under the control of the hybrid Plac/ara-1 promoter and was constructed by 
cloning PCR-amplified luxR from pKE705 [31], using primers 5-LuxR  and 3-LuxR, into 
KpnI and BamHI digested  pPROLar.A122.  The sequence of pLuxR, including the 
promoter and the luxR gene, was verified by sequencing using the upstream primer 5-
LarSeq2 and internal luxR primer LuxRSeq(int).  The pLuxR plasmid contains a 
kanamycin resistance gene and the p15A replication origin.  Plasmid pluxGFPuv encodes 
a variant of green fluorescent protein (GFPuv from pGFPuv, BD Biosciences Clontech, 
Palo Alto, CA) under the control of the PluxI promoter.  PluxI was PCR-amplified from 
pKE555 [8] using the primers 5-pluxI and 3-pluxI and gfpuv was PCR-amplified from 
pGFPuv using 5-GFPuv and 3-GFPuv.  These PluxI and gfpuv PCR products were 
assembled and amplified by PCR with 5-pluxI and 3-GFPuv and cloned into 
pPROTet.E133 between its AatII and HindIII sites.  The sequence of the entire promoter 
region and gfpuv gene on pluxGFPuv was verified by DNA sequencing using the primers 
5-pPROTetSeq and GFPuvSeq(int). This plasmid contains a chloramphenicol resistance 
gene and the ColE1 replication origin.  The plasmid encoding the C-terminal fusions of c-
myc with LuxR was cloned using the primers 5-LuxR and 3-LuxR-myc with pLuxR as 
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template.  The fusion was cloned into KpnI and BamHI digested  pPROLar.A122 to make 
pLuxR-myc.  Versions of pLuxR-myc encoding the second-generation LuxR variants 
fused to c-myc were cloned similarly to pLuxR-myc using the appropriate pLuxR plasmid 
encoding the mutant luxR as template.  BamHI, HindIII and KpnI were purchased from 
Roche Applied Science (Indianapolis, IN) and AatII was purchased from New England 
Biolabs (Beverly, MA). 
 
Table 2.5.  Oligonucleotide primers used in Chapter 2 
Primer Sequence 
5-LuxR 5-CGAACGGGGTACCCATGAAAAACATAAATGCCGACGACAC-
3 
3-LuxR 5-CGTTCGCGGATCCCGTACTTAATTTTTAAAGTATGGG 
CAATC-3 
5-LarSeq2 5-CCTGAGCAATCACCTATGAACTGTC-3 
LuxRSeq(int) 5-CGAAAACATCAGGTCTTATCACTGGG-3 
5-pluxI 5-CGAACGCGACGTCAGTCCTTTGATTCTAATAAATTGGA 
TTTTTGTCAC-3 
3-pluxI 5-CTTCTCCTTTACTCATACCAACCTCCCTTGCGTTTATTC-3 
5-GFPuv 5-GGGAGGTTGGTATGAGTAAAGGAGAAGAACTTTTCACT-3 
3-GFPuv 5-GTACCCAAGCTTTTATTTGTAGAGCTCATCCATGCCATG-3 
5-pPROTetSeq 5-CCTCTTACGTGCCGATCAACGTC-3 
GFPuvSeq(int) 5-CGAAGGTTATGTACAGGAACGCAC-3 
3-LuxR-myc 5-CGTTCGCGGATCCTTACAGATCCTCTTCGCTGATCAGTTTCT
GTTCAGCTCCACCATTTTTAAAGTATGGGCAATCAATTG-3 
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E.3.  Library construction and screening 
 
Error-prone PCR reactions were performed using AmpliTaq DNA polymerase (Applied 
Biosystems, Foster City, CA) and 50 μM MnCl2 to increase the mutation rate as 
described [46].  The primers 5-luxR and 3-luxR were used to amplify the luxR gene using 
pLuxR as the template. The library was constructed by ligating KpnI and BamHI digested 
pPROLar.A122 with the products of error-prone PCR using T4 DNA ligase (Invitrogen, 
Carlsbad, CA). Vent DNA polymerase (New England Biolabs, Beverly, MA) was used to 
amplify wild-type luxR, which was digested and ligated into pPROLar.A122 for use as a 
control.  The ligation mixtures were transformed into competent DH5α cells harboring 
pluxGFPuv and plated onto LB agar containing the appropriate antibiotics and 50 or 200 
nM C8HSL.  The plates were incubated at 37 oC for 18 hours prior to screening.  To 
identify clones of interest, the agar plates were placed over a UV-transilluminator (VWR 
Scientific, West Chester, PA) at 365 nm and visually inspected for GFPuv fluorescence.  
The plates were stored at 4 oC and reexamined every 2-3 hours until colonies on a control 
plate expressing wild-type LuxR became visibly fluorescent.            
 
Second-generation libraries were constructed by DNA shuffling as described [24].  The 
primers 5-luxR and 3-luxR were used to amplify the mutant luxR genes from six first-
generation mutants using Pfu Turbo DNA polymerase (Stratagene, La Jolla, CA).  After 
purification and quantification, equal amounts of parent amplification products were 
mixed and subjected to a DNAseI digestion.  The 100 μL digest contained ca. 4 μg of the 
parental mix, 10 μL of 0.5 M Tris-HCl (pH 7.4), 5 μL of 0.2 M manganese chloride and 
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0.14 units of DNAse I.  After one minute of digestion at 15oC, the reaction was stopped 
by adding 5 μL of 1 M EDTA and by placing the mixture immediately on ice.  The 
QIAEXII gel extraction kit (Qiagen, Valencia, CA) was used to purify fragments ranging 
from 50 to 150 bp in length.  Fragments were randomly reassembled in a 50 μL reaction.  
Full-length luxR genes were synthesized by diluting the reassembly reaction 50- to 500-
fold and amplified using Pfu Turbo DNA polymerase and the primers 5-luxR and 3-luxR.   
Ligations and transformations were performed similarly to the first generation and plated 
onto LB-agar containing 50 nM C8HSL.  All 102 colonies that fluoresced after 18 hours 
were picked, purified, and inoculated into 1 mL LB containing the appropriate 
antibiotics.  After 24 hours at 37 oC, the cultures were diluted 10-fold into fresh LB, and 
replica-stamped using a 96-well pin replicator onto solid media containing 10, 20, 50, 
100 and 200 nM C8HSL.  Ten mutants that fluoresced in response to 10 or 20 nM 
C8HSL were identified for further characterization. 
 
 
E.4.  Re-cloning and DNA sequencing 
 
All mutants identified during the first- and second- generation screens were re-cloned 
into fresh background plasmids and strains to eliminate secondary-site effects.  For each 
mutant, the luxR allele was amplified using Pfu Turbo polymerase and treated with DpnI.  
The PCR products were digested and ligated into pPROLar.A122 (as above) and 
transformed into competent DH5α cells containing pluxGFPuv. The promoter and luxR 
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gene from all mutants of interest were sequenced using the upstream primer 5-LarSeq2 
and internal luxR primer LuxRSeq(int). 
 
 
E.5.  Site-directed mutagenesis 
 
DNA fragments containing each single point mutation of interest were generated using 
standard methods [47].  In the first step, the 5-LuxR primer and a reverse primer 
containing the desired mutation were used to amplify luxR upstream of the mutation; the 
3-LuxR primer and a forward primer also containing the mutation were used to amplify 
luxR downstream of the mutation.  In the second step, the two overlapping fragments 
were assembled to yield a full length luxR containing a single nucleotide alteration by 
PCR using the products of step one as template and the 5-LuxR and 3-LuxR primer set.  
These PCR products were digested and ligated into KpnI and BamHI digested pLuxR to 
replace the wild-type luxR.  Sequences of each site-directed mutant were verified by 
DNA sequencing. 
 
 
E.6.  Quantitative characterization of LuxR-mediated gene expression of GFPuv 
 
The assay used to measure LuxR-mediated gene activation was adapted from a light-
based bioassay protocol [18].  Cells were first grown from single colonies or glycerol 
stocks in LB overnight, then diluted 200-fold into 100 mL of fresh LB medium 
 76
containing 5 mM potassium phosphate buffer, pH 6.5, and the appropriate antibiotics.  
Such cultures were incubated with shaking at 37 oC until they reached an OD600 of 0.5, 
and then harvested by centrifugation.  Cell pellets were washed and resuspended to an 
OD600 of 0.6 in bioassay medium (0.05% w/v tryptone, 0.03% v/v glycerol, 100 mM 
sodium chloride, 50 mM magnesium sulfate and 5 mM potassium phosphate buffer, pH 
6.5, containing antibiotics.  The suspension was subsequently transferred into 48-well 
plates (VWR International) containing 0.5 mL bioassay medium with acyl-HSL, to a total 
volume of 2.5 mL per well.  Thereafter, the 48-well plates were shaken at 37oC for 4 
hours.  From each well, 200 μL was transferred to wells of a white 96-well microplate 
with a clear bottom.  GFPuv fluorescence (395 nm excitation, 509 nm emission, 495 nm 
cutoff) was measured using a fluorescence microtiterplate reader (Molecular Devices, 
SpectraMAX Gemini XS); cell densities were measured using a microtiterplate reader at 
600 nm.  Fluorescence by cell suspensions was normalized to optical density.  The 
fluorescence output of pPROLar.A122 with pluxGFPuv was used to determine the 
background fluorescence without LuxR, and this background fluorescence value was 
subtracted from all fluorescence measurements obtained with wild-type pLuxR and all 
mutants to determine fluorescence due only to LuxR-dependent gene activation.  For a 
given variant, the same batch of cells was used for comparing responses to (1) different 
concentrations of a given acyl-HSL, or (2) different acyl-HSLs. 
 
 
E.7.  Assays of LuxR abundance in vivo by Western immunodetection 
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To estimate the relative concentrations of LuxR in uninduced and fully induced second-
generation variants, we constructed C-terminal LuxR fusions to the amino acid sequence 
GGAEQKLISEEDL, i.e. the c-myc epitope tag with an N-terminal GGA linker.  pLuxR-
myc was transformed into DH5α(pluxGFPuv), the protein it encodes was determined to 
function similarly to its parent LuxR without the tag.  Strains expressing the C-terminal 
c-myc fusions of wild-type LuxR and the second-generation LuxR variants were grown, 
harvested, resuspended, and incubated in the absence of acyl-HSL or with 1 μM 
3OC6HSL in a similar manner as during the quantitative characterization of LuxR-
mediated gene expression of GFPuv (see above).  After incubation in the presence or 
absence of acyl-HSL and after monitoring OD600 and fluorescence: 1 mL of each cell 
suspension of interest was resuspended in 50 μL SDS loading buffer.  Samples were 
boiled for 5 min and centrifuged for 10 min before the proteins in the clarified fluid were 
size fractionated via standard SDS-PAGE.  Proteins were electrotransferred to 
nitrocellulose membranes (Invitrogen).  After an 8 hour blocking step using tris-buffered 
saline (TBS; 50 mM Tris-HCl, 150 mM NaCl, pH 7.5) buffer containing 5% non-fat 
dried milk, membranes were incubated for 8 h in TBS buffer containing 1% non-fat dried 
milk and 4% bovine serum albumin (BSA, Sigma) with anti-myc mouse antisera 
(Invitrogen).  Antibody-protein complexes were visualized using horseradish peroxidase-
coupled anti-murine second antibody (Invitrogen) and SuperSignal West Pico Substrate 
(Pierce, Rockford, IL).  Chemiluminescence was detected using Kodak BioMax Light 
Film (Rochester, NY).  The developed film was subsequently scanned using a Hewlett 
Packard Scanjet 4400c and HP Precisionscan Pro software (version 3.1).  Protein 
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concentrations, relative to wild-type LuxR, were determined from the scanned image via 
densitometry analysis using Quantity One software (Bio-rad, version 4.1.1). 
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CHAPTER 3 
 
Design and Evaluation of a Dual Selection System for 
Identifying LuxR Variants with New Specificities 
 85 
A.  Abstract 
 
To continue to our directed evolution of LuxR towards variants with new specificities, we 
constructed a selection system capable of both positive (ON) and negative (OFF) 
selection. An ON/OFF selection system is required to identify specific proteins because 
positive selection alone generally leads to variants with broadened specificities.  A dual 
selection module developed previously was adapted to incorporate the PluxI promoter and 
was shown to enrich by 490-fold per round of ON/OFF selection.  Additional rounds of 
selection were necessary to completely eliminate the presence of nonfunctional plasmids.  
This work both demonstrates the potential of this dual selection system to enrich for 
functional LuxR variants from very large libraries (>106) and suggests controls that can 
be used to decrease the probability of identifying false positives.   
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B.  Introduction 
 
The previous chapter described the directed evolution of LuxR variants that respond to a 
broad range of acyl-homoserine lactones (acyl-HSLs).  To identify an evolved LuxR 
variant that retains (or increases) its newly-acquired ability to respond to a non-natural 
signal molecule and decreases its ability to respond to LuxR’s cognate signal, 
3-oxohexahoyl-homoserine lactone (3OC6HSL), a selection system capable of both 
positive and negative selection was developed.   
 
Gain-of-function mutants are identified by positive selection. While it is possible for a 
single amino acid substitution to both increase a protein’s ability to recognize a new 
target and decrease, or prevent, the recognition of its natural target [1-3], it has been 
observed that this occurs infrequently in directed evolution experiments targeting new 
functions [4-6].  Instead, initial rounds of directed evolution often produce variants that 
exhibit broadened specificity [2, 4-11].  Matsumura and Ellington noted that their β-
glucoronidase variants were active with substrates that were very dissimilar to both the 
native and target substrates [5].  Similar observations led Aharoni et al., to postulate that 
the observed broadening of specificity is a common feature of protein evolution [4].  
They also noted that it is evolutionarily advantageous for a protein to be able to increase 
its affinity for a new target without affecting its affinity for its native target molecule.   
 
But what happens when it is necessary to refocus specificity?  Matsumura and Ellington 
used repeated rounds of screening for increases in activity with their target substrate and 
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then characterized several mutants to find the desired inversion of specificity [5].  A more 
direct approach uses screening or selecting for both an increased response to a new target 
and a loss of response to the native target.  The addition of negative rounds of selection or 
screening can be used to identify variants with new specificities without having to sift 
through a large number of variants identified by positive rounds and hoping that a variant 
with decreased affinity for the native molecule is present.   
 
Santoro and Schulz compared positive screening alone to a combination of positive and 
negative screening in their directed evolution experiments targeting Cre recombinase 
variants capable of recognizing a new DNA target [12].  They showed that positive 
screening yielded variants capable of recombining at either the wild-type or mutated 
DNA target.  The combination of both positive and negative screening led to the 
identification of a variant with an increase in recombination at the new target site and a 
decrease in its ability to act at its native site.  The directed evolution of Cre recombinase 
illustrates the importance of including rounds of both positive and negative selective 
pressure in order to identify variants with an explicit specificity profile.  Positive and 
negative screens have also been successfully implemented to identify Cre recombinases 
that recognize a different DNA site [13], tRNA-synthetases [14] and the endopeptidase 
OmpT [3]. 
 
Physical models have also alluded to the importance of including both positive and 
negative “pressure” in order to target specificity [1, 15, 16].  In designing specific 
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protein-protein or protein-DNA interactions, positive design is used to stabilize 
interactions with a desired target while negative design destabilizes undesired 
interactions.  A physical model of DNA binding by zinc fingers showed that these 
proteins are optimized for specificity rather than affinity [1].  This result implies a trade-
off between specificity and affinity may exist and, more importantly, it reinforces the 
experimental evidence that looking only for increases in affinity for a new target will 
infrequently yield variants with refocused specificities.   
 
Before searching libraries for LuxR variants with new specificities, it was imperative that 
we both design a dual selection system and evaluate its ability to identify functional 
clones from a pool of nonfunctional “garbage.”  We have implemented an ON/OFF 
selection system for the directed evolution of LuxR based on the dual selection module 
previously developed by Yokobayashi and Arnold [17] for the identification of a 
functional repressor.  Their selection system uses the expression of the tetracycline 
resistance gene, tetA, to confer survival during ON rounds of selection.  OFF rounds of 
selection use the production of β-lactamase inhibitory protein (Bli) to confer sensitivity to 
β-lactam antibiotics when unwanted transcription occurs.  β-lactamase (bla), which is 
constitutively expressed from the selection plasmid, is inhibited when bound by Bli.  The 
bli gene was extensively modified by Yokobayashi and Arnold [17] to lower the GC 
content of the gene and to decrease the homology of the periplasmic leader sequences 
used by bli and bla.  The reduced homology between the two leader sequences lowers the 
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probability of recombination events that could eliminate bli and undermine the selection 
process by producing false positives. 
 
The primary advantage of using a selection system, as opposed to a screen, is an increase 
in potential library size to more than 106.  While screens can be cumbersome and limit 
library size, selections are often limited by the prevalence of false positives that occur 
when bacteria (or other organisms) are under selective pressure.  By employing a dual 
selection system, which requires proteins to be ON or OFF under different environmental 
conditions, the frequency of false positives is expected to decrease.  We have 
implemented and evaluated a dual selection system for directed evolution of the 
transcriptional activator LuxR and its cognate promoter, PluxI, and have demonstrated that 
it can enrich a functional activator approximately 490-fold per ON/OFF round of 
selection.   
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C.  Results 
 
C.1.  Modification of a  dual selection system for LuxR-mediated gene activation 
 
Our goal was to adapt the generic selection module developed by Yokobayashi and 
Arnold [17] to LuxR-mediated transcriptional activation, such that the ability of LuxR to 
activate gene expression at PluxI, under a given set of conditions, would correspond to the 
ability of a host bacterium to survive in the presence of different antibiotics.  While the 
original dual selection system of Yokobayashi and Arnold [17] encodes both the positive 
(TetA) and negative (Bli) elements on a single selection plasmid, replacement of the 
repressed promoter with the lux promoter did not lead to simultaneous LuxR-mediated 
expression of both elements.  We observed that the amount of basal gene expression of 
the second gene (tetA) in the operon always generated an ON output, irrespective of 
LuxR.  Switching the order of the genes and replacing tetA with cat did not alleviate this 
problem.  In general, promoters that require an activator to recruit RNA polymerase have 
higher levels of basal gene expression than promoters that are repressed by transcription 
factors blocking RNA polymerase binding [18].  Instead of trying to tune the output 
levels of the ON and OFF selection genes simultaneously, we separated the components 
into ON and OFF selection plasmids (Fig. 3.1).  This requires that the selection plasmid 
be inactivated and replaced following each round of selection. However, separate ON and 
OFF selection plasmids act to lower the probability of propagating mutated selection 
plasmids that confer antibiotic resistance without LuxR, i.e. false positives, from one 
round to the next.   
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Figure 3.1.  Schematic of the dual selection system for the directed evolution of LuxR 
variants with altered specificity.  During rounds of ON selection, LuxR variants that are 
active under the desired conditions are identified by their ability to survive in the 
presence of chloramphenicol (Cm) due to LuxR-mediated activation of the 
chloramphenicol acetyl-transferase (cat) gene from the PluxI promoter.  During rounds of 
OFF selection, LuxR variants which are inactive are identified by their ability to survive 
in the presence of carbenicillin (Cb) due to a lack of LuxR-mediated expression of the β-
lactamase inhibitory protein (bli) gene.  During OFF rounds of selection, β-lactamase is 
constitutively expressed in the cells and is inhibited by Bli, rendering the cells sensitive 
to carbenicillin.    
 
 
The ON selection plasmid, pluxCAT, confers chloramphenicol resistance in the presence 
of LuxR-mediated transcriptional activation of the cat gene from the PluxI promoter.  The 
 92 
OFF plasmid, pluxBLIP, renders bacteria in which LuxR is active sensitive to 
carbenicillin by producing Blip, which inactivates the constitutively expressed Bla.   Thus 
an absence of LuxR-mediated gene activation is detected by survival in the presence of 
carbenicillin with the OFF selection plasmid.   
 
 
C.2.  Evalutaion of the dual selection system 
 
To test our modified selection module, we selected a plasmid expressing luxR (pLuxR, 
Fig. 3.2B) from a background of nonfunctional plasmids.  The nonfunctional plasmids 
either lack the luxR gene (pPROLar.A122, Fig. 3.2A) or constitutively express both cat 
and bli (pBLIPCAT, Fig. 3.2C).  While pLuxR confers survival with the ON selection 
plasmid in the presence of 3OC6HSL and survival with the OFF selection plasmid in the 
absence of 3OC6HSL, pPROLar.A122 should survive only OFF selection rounds while 
pBLIPCAT should survive only ON rounds of selection.   
 
The three plasmids, pLuxR, pPROLar.A122 and pBLIPCAT, were mixed with a 
1:500:500 molar ratio and transformed into DH5α cells harboring the ON selection 
plasmid pluxCAT.  The transformed cells were plated on chloramphenicol-containing LB 
plates with 100 nM 3OC6HSL to select for cells in the ON state (pLuxR or pBLIPCAT).  
Cells were recovered by overlaying liquid LB medium and the DNA from these cells was 
isolated by miniprep.  To inactivate the ON selection plasmid, the recovered plasmid 
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DNA was digested with ApaLI, which cleaves pluxCAT and pluxBLIP but does not 
cleave pLuxR, pPROLar.A122 or pBLIPCAT.   
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Figure 3.2.  Plasmid maps of plasmids used to test dual selection system.  A.  
pPROLar.A122 is an “empty” vector.  It does not encode a functional luxR gene and PluxI 
is never activated in cells containing this plasmid,  B.  pLuxR encodes the wild-type luxR 
gene under the control of a Plac/ara-1.  LuxR is constitutively expressed in DH5α, which 
does not contain lacI or araC.  LuxR activates gene expression from PluxI only in the 
presence of 3OC6HSL.  C.  pBLIPCAT constitutively expresses both of the selection 
proteins, CAT and Bli.  CAT and Bli are expressed from this plasmid regardless of 
3OC6HSL concentration.   
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The ApaLI-digested DNA from Round 1-ON was used to transform DH5α cells 
harboring the OFF selection plasmid, pluxBLIP.  Cells were spread on plates containing 
carbenicillin without 3OC6HSL to select for cells in the OFF state (pLuxR or 
pPROLar.A122).   Round 1-OFF cells were recovered, and the DNA was isolated and 
digested as following Round 1-ON.  The purified DNA was transformed into DH5α 
containing pluxCAT to initiate Round 2 of ON/OFF selection.   
 
From each round of selection, 45 colonies were randomly picked and tested for the 
presence of pLuxR, pPROLar.A122 or pBLIPCAT by colony PCR.  Because these 
plasmids each contain the same backbone, PCR with primers that bind outside of the 
inserted region amplifies a section of differing length from each of the three plasmids.  
Amplification of pLuxR via PCR yields a 1100 base pair (bp) fragment, while 
pPROLar.A122 yields a 400 bp fragment and pBLIPCAT a 1650 bp fragment, allowing 
the three plasmids to be easily distinguished from one another.  
 
Following Round 1-ON, 45 of the 45 (100%) colonies picked contained the pBLIPCAT 
plasmid (Fig. 3.3).   This was expected due to the 500-fold excess of this plasmid over 
pLuxR.  Twenty-two of the 45 (49%) colonies from Round 1-OFF contained pLuxR (Fig. 
3.3).  The other 23 colonies contained pPROLar.A122.  A 490-fold enrichment of pLuxR 
was achieved in the first round of ON/OFF selection.   
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As shown in Fig. 3.3, 44 of 45 colonies contained pLuxR after Round 2-ON.  The 
remaining colony harbored pPROLar.A122.  Round 2-OFF returned exactly the same 
ratio of pLuxR to pPROLar.A122 as the second ON selection because both plasmids 
confer the same probability of survival OFF rounds.  A third ON round yielded 100% of 
colonies containing pLuxR 
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Figure 3.3.  Agarose gel of colony PCR products used to determine the composition of 
the plasmid mixture after each round of positive and negative selection.  Forty-five 
colonies were randomly picked and colony PCR with primers that bind to the common 
plasmid backbone of each of the three test plasmids was used to identify if test colonies 
contained pPROLar.A122 (Lar), pLuxR (LuxR) or pBLIPCAT (BLIPCAT).  Controls of 
each plasmid are shown on the left three lanes of each gel.  
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D.  Discussion 
 
Implementation of an ON/OFF selection system for identifying LuxR variants required 
modifying the dual selection system developed by Yokobayashi and Arnold for 
identifying functional repressors [17].  Using a single selection plasmid for both ON and 
OFF rounds of selection was undermined by an excessive basal level of protein 
production from the second gene in the operon.  The reason for the observed increase at 
only the second gene of the operon is unknown, however, an overall increase in the basal 
level of gene expression is not unexpected at a promoter that is modulated by an activator 
instead of a repressor [18].   Activators increase RNA polymerase’s affinity for a given 
promoter and a low level of transcription is expected because the polymerase will 
occasionally bind to the promoter without being recruited by the activator.  On the other 
hand, repressors physically block RNA polymerase from binding to the promoter so basal 
levels of transcription from these promoters are significantly lower.  The modifications 
made here are likely applicable to the evolution of other activator proteins using similar 
dual selection modules.   
 
The use of two separate selection plasmids required their inactivation following each 
round of selection.  This was accomplished by selective digestion with an endonuclease 
that cleaves the selection plasmids but leaves the circuit plasmids intact.  While this step 
increases the labor required for each ON/OFF round of selection, it ensures that any 
selection plasmids that have mutated and confer resistance without LuxR are not 
propagated.  Due to this control, the frequency of false positives that arise due to mutated 
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selection plasmids should be consistent from round to round while the frequency of 
functional clones should increase exponentially.  This reduces the probability of 
identifying false positives at the end of a directed evolution experiment.   
 
The background level of nonfunctional plasmids in Round 2 indicates that the ON rounds 
of selection could have been more stringent; however, an extra round of selection was 
shown to eliminate the nonfunctional plasmids.  To ensure that only functional variants 
are picked for further characterization, the isolated clones could be screened for their 
ability to activate the expression of a non-lethal reporter protein, such as the GFP variant 
used in Chapter 2 [7].  A low frequency of nonfunctional clones would not prevent the 
identification of functional clones with a final screen and could potentially decrease the 
number of selection rounds required because it would be unnecessary to ensure that all 
nonfunctional clones had been eliminated.  Furthermore, a screen would add the ability 
rapidly identify the “best” variants from a pool that meet the minimum requirements 
imposed by the ON/OFF conditions used with dual selection system.     
 
The 490-fold enrichment of functional LuxR variants per round of selection suggests that 
three rounds of ON/OFF selection should allow a functional LuxR variant to be identified 
from a library of more than 100 million.  The proportional increase in functional variants 
in each round of selection is limited by the frequency of false positives that arise each 
round.  Decreasing regions of high sequence similarity can be used to decrease the 
probability that a recombination event will lead to a false positive [17].  If false positives 
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were plaguing the selection system, it would be worthwhile to investigate other 
mechanisms that were allowing the bacteria to survive without the desired gene 
activation, or absence thereof.   
 
With our new selection system for identifying LuxR variantd, the 490-fold enrichment is 
likely sufficient for identifying LuxR variants from the size of libraries that are possible 
to generate.  The removal of the selection plasmids after each round of selection is 
important for decreasing the number of false positives identified.  The following chapters 
describe the use of this dual selection system for identifying LuxR variants that respond 
to a non-cognate acyl-HSL but that have lost their ability to respond to 3OC6HSL and 
LuxR variants that activate gene expression at a mutated lux promoter. 
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E.  Materials and Methods 
 
E.1.  Bacterial strains, media and growth conditions.  
 
 The bacterial strains used in this study were:  Escherichia coli strain DH5α (F- 
φ80dlacZΔM15 Δ(lacZYA-argF) U169 deoR recA1 endA1 hsdR17(rk-, mk+) phoA 
supE44 λ- thi-1 gyrA96 relA1) and E. coli DH5α containing pluxCAT (DH5α(pluxCAT)) 
or pluxblip (DH5α(pluxBLIP)). Competent cells were prepared by using the Z-competent 
Escherichia coli Transformation Kit (Zymo Research, Orange, CA).  E. coli strains were 
cultured at 37 oC in LB medium or on LB agar plates.  Antibiotics were added at the 
following concentrations:  150 μg/mL chloramphenicol, 100 μg/mL carbenicillin, and 
50 μg/mL kanamycin.  3-Oxo-hexanoyl-homoserine lactone (3OC6HSL; Sigma Aldrich, 
St. Louis, Mo) stock solutions of 1 and 10 mM were prepared by dissolving appropriate 
amounts in ethyl acetate acidified with glacial acetic acid (0.01% v/v), and stored at 
-20 oC.  For solid-phase experiments, 3OC6HSL was added to LB agar media prior to 
solidification to ensure complete mixing.   
 
 
E.2. Plasmid construction 
 
The LuxR expression vector, pLuxR, and the signal response plasmid, pluxGFPuv, have 
been described previously [7].  Plasmids pluxCAT and pluxBLIP are similar to 
pluxGFPuv but encode chloramphenicol acetyltransferase (CAT) or β-lactamase 
inhibitory protein (Bli) under the control of the PluxI promoter and contains the β-
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lactamase gene (bla). The pBPROTet plasmid was constructed by replacing the SacI-
AatII cat fragment in pPROTet.E133 with the β-lactamase (bla) encoding SacI-AatII 
fragment from pλPRO12Select[17].  PluxI was PCR-amplified from pluxGFPuv using the 
primers 5-pluxI [7] and 3-lux(CAT) or 3-lux(blip).  cat was PCR-amplified from 
pPROTet.E133 using 5-CAT(lux) and 3-CAT(BamHI) (see Table 3.1 for oligonucleotide 
sequences).  bli was PCR-amplified from pλPRO12Select using 5-BLIP(lux) and 
3-BLIP(HindIII).  The PluxI and cat or bli PCR products were assembled and amplified by 
PCR with 5-pluxI and 3-CAT(BamHI) or 3-BLIP(HindIII) and cloned into pBPROTet 
between its AatII and BamHI or HindIII sites.   
 
The pBLIPCAT plasmid was constructed by PCR-amplifying bli from pλPRO12Select 
using 5-BLIP(KpnI) and 3-BLIP(HindIII) and cat from pPROTet.E133 with 
5-CAT(BLIP) and 3-CAT(BamHI).  These bli and cat PCR products were assembled and 
amplified by PCR with 5-BLIP(KpnI) and 3-CAT(BamHI) and cloned into 
pPROLar.A122 between its KpnI and BamHI sites.   
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Table 3.1.  Oligonucleotide primers used in Chapter 3  
Oligonucleotide Sequence 
5-pluxI 5-CGAACGCGACGTCAGTCCTTTGAT 
TCTAATAAATTGGATTTTTGTCAC-3 
3-pluxI 5-CTTCTCCTTTACTCATACCAACCTCCCTTGCGTTTATTC-3 
5-LarSeq2 5-CCTGAGCAATCACCTATGAACTGTC-3 
3-lux(CAT) 5-GATTTTTTTCTCCATACCAACCTCCCTTGCGTTTATTC-3 
3-lux(BLIP) 5-ACTTTTATATAAAAGCATACCAACCTCCCTTGCGTTTATTC-3 
5-CAT(lux) 5-GGGAGGTTGGTATGGAGAAAAAAATCACTGGATATACC-3 
3-CAT(BamHI) 5-GTTAGCGGACCAGCGAGCTCGATATCAAATTACGCC-3 
5-BLIP(lux) 5-GGGAGGTTGGTATGCTTTTATATAAAATGTGTGACAATCA-3 
3-BLIP(HindIII) 5-GTTAGCAAGCTTTTATACAAGGTCCC-3 
5-BLIP(KpnI) 5–CGAACGGGGTACCCATGCTTTTATATAAAATGTGTGACAATCA-3 
5-CAT(BLIP) 5-GGGACCTTGTATAAAAGCTTGCTAACCGAATAAACGC 
AAGGGAGGTTGGTATGGAGAAAAAAATCACTGGATATACC-3 
3-LuxR+200 5-GTGAGCGAGGAAGCGGAATATATCC-3 
 
 
E.3.  Selection protocol   
 
For positive selection, circuit plasmids were transformed into DH5α cells harboring the 
ON selection plasmid (pluxCAT) and plated on LB agar plates containing 100 nM 
3OC6HSL, kanamycin and chloramphenicol.  For negative selection, circuit plasmids 
were transformed into DH5α cells harboring the OFF selection plasmid (pluxBLIP) and 
plated on LB agar plates containing kanamycin and carbenicillin.  Plates were incubated 
for 18 hours at 37oC.  Selected cells were recovered by overlaying liquid LB medium 
over the agar plates.  Plasmid DNA from the cells was recovered by miniprep 
(QIAGEN).  To inactivate the selection plasmids, the DNA was digested with ApaLI and 
purified.  The digested DNA was subsequently used to transform the next round of 
selection. 
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E.4.  Plasmid identification by colony PCR   
 
Colony PCR was performed to identify each of the functional plasmids after each round 
of selection.  The Colony Fast-Screen Kit (Epicentre) was used according to instructions, 
with two primers: 5-LarSeq2 and 3-LuxR+200.  These primers bind to the backbone 
common to each of the three plasmids in the starting mix and allow the specific 
identification of the plasmids present in each colony.  Positive controls of each of the 
three starting plasmids were run simultaneously. 
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CHAPTER 4 
   
Dual Selection Creates a New Signaling Specificity in the 
Quorum-sensing Transcriptional Activator LuxR 
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 A.  Abstract 
 
The LuxR transcription factor from Vibrio fischeri activates gene expression in response 
to binding the signaling molecule 3-oxo-hexanoyl-homoserine lactone (3OC6HSL).  
LuxR homologs respond to acyl-homoserine lactones (acyl-HSLs) with diverse chemical 
structures.  We previously described a LuxR variant, LuxR-G2E, that activates gene 
expression upon binding a broadened range of acyl-HSLs, including straight-chain acyl-
HSLs.  Here, we use an ON/OFF dual selection system to identify a new LuxR variant 
that retains the response to straight-chain acyl-HSLs, but no longer responds to LuxR’s 
cognate signal, 3OC6HSL.  A single mutation, arginine 67 to methionine in the N-
terminal signal-binding domain, reduces LuxR-G2E’s response to acyl-HSLs having a 
carbonyl substituent at the third carbon of the acyl chain.  This mutation has a similar 
effect when introduced into a LuxR homolog that responds to a different 3-oxo-HSL 
(3OC12HSL), LasR from Pseudomonas aeruginosa.  This specificity-enhancing mutation 
does not affect LuxR response to straight-chain acyl-HSLs and would not have been 
identified by positive selection for activation by these signaling molecules. The dual 
selection system provides a rapid and reliable method for identifying LuxR variants that 
have the desired response, or lack thereof, to a given set of acyl-HSL signals. This work 
demonstrates that accumulation of a small number of point mutations is sufficient to 
switch specificity from one signal to another, passing through a broadly-specific 
intermediate.  LuxR variants with new signaling specificities will be useful components 
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for constructing artificial cell-cell communication systems that program population-level 
behaviors such as pattern formation.    
 
B.  Introduction 
 
Quorum sensing (QS) is the process by which bacteria sense their local population 
density and modify the expression of key genes accordingly [1, 2].  While many QS 
signals have been identified (reviewed by Taga and Bassler [1]), one of the most 
prevalent and well-studied QS systems employs acyl-homoserine lactones (acyl-HSLs) 
[3].  In V. fischeri, the 3-oxo-hexanoyl-homoserine lactone (3OC6HSL, Fig. 4.1) signal is 
synthesized by LuxI [4].  In environments of low cell density, the amphipathic acyl-HSL 
diffuses out of the cell through the membrane [5].  As the local environment becomes 
more crowded, the acyl-HSLs accumulate in the cell, where they bind to the acyl-HSL-
dependent transcriptional activator, LuxR [6, 7].  Upon signal binding, LuxR dimerizes 
[8] and activates transcription at the lux promoter by recruiting RNA polymerase [9].  
Pairs of LuxI/LuxR homologs have been identified in many species of Gram-negative 
Proteobacteria [10, 11], where they regulate genes with diverse functions in response to 
changes in population density [1, 2]. LuxR homologs respond to acyl-HSLs with acyl 
chains of varying lengths and chemical modifications [12, 13] (Fig. 4.1).  
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Figure 4.1.  Diversity of LuxR homologs and acyl-HSLs.  a.  Illustration of the 
divergence of selected LuxR homologs.  Homologs are listed with both species and 
cognate acyl-HSL signal molecule.  Homologs discussed in this work are highlighted and 
the structure of their cognate acyl-HSL signal molecules shown.  The tree was adapted 
from Gray and Garey [10], and Lerat and Moran [11].  b. Structures, names and 
abbreviations of non-cognate acyl-HSLs used in this study. 
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LuxR/LuxI and their homologs have been adopted by biological engineers to effect 
programmed intercellular communication and coordinate the behaviors of cell 
populations [14-18]. In an early demonstration of engineered cell-cell communication, 
Weiss and coworkers expressed LuxR in E. coli to produce ‘receiver’ cells that would 
respond to signals produced by ‘sender’ cells that expressed LuxI [17]. More recently, 
You et al. described a circuit  that employs Lux QS components to sense and control the 
density of a bacterial population by expressing a killer gene, ccdB, from the lux promoter 
[18].  Kobayashi et al. described input/output modules based on the Lux system that 
coupled to a genetic ‘toggle switch’ and programmed density-dependent protein 
production in E. coli [16]. Lux QS components have also been used to build a variety of 
functional modules, including a chemical pulse generator [15] and chemical band-detect 
network [14].  Synthetic systems exhibiting complex behaviors have exploited these 
modules, using variants of LuxR that respond to different concentrations of the acyl-HSL 
signal.  For example, using ‘receiver’ cells containing LuxR-based band-detect circuits 
that express fluorescent proteins over different concentration ranges of the signaling 
molecule, Basu et al. [14] demonstrated that an undifferentiated lawn of the ‘receiver’ 
cells generated a bulls-eye pattern of gene expression around a central colony of ‘sender’ 
cells producing 3OC6HSL.  
 
LuxR/I and their homologs can serve a wide range of communication functions in 
synthetic networks. Applications at the next level of complexity, for example, will 
implement two-way communications between cellular populations [19, 20].  These 
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applications, however, require a high degree of specificity in the LuxR receiver functions, 
since crosstalk among chemical signals can undermine the function of the entire network. 
LuxR homologs have been investigated, but these can show significant crosstalk [21] and 
often also behave differently from LuxR in other ways.  For applications in synthetic 
biology, it would be useful to have a set of ‘standardized parts’—for example, a series of 
LuxR variants which respond to different chemical signals at different levels and 
specificities—from which new networks can be assembled.    
 
Engineering protein specificity is challenging because it requires both stabilizing a 
desired interaction (positive design) and destabilizing undesired interactions (negative 
design) [22].  Directed evolution experiments have also shown that specificity rarely 
arises as a result of positive selection alone [23]. We previously used directed evolution 
to create LuxR variants exhibiting broadened acyl-HSL specificity and increased 
response sensitivity [24].  Random-mutant libraries were screened for increased response 
to octanoyl-homoserine lactone (C8HSL). All the C8HSL-responsive LuxR variants 
showed broad response to acyl-HSLs having acyl chains five to fourteen carbons in 
length; none were specific for the new signal. To generate a LuxR with a new signaling 
specificity, we modified the dual selection system recently described by Yokobayashi and 
Arnold [25] to select for LuxR variants that either activate  gene expression (ON) or do 
not (OFF) under desired sets of conditions.  
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C.  Results  
 
C.1. A dual selection system for evolution of LuxR signaling specificity 
 
To identify LuxR variants that respond specifically to a new signal, we adapted a dual 
selection system developed previously to select for functional genetic networks that 
properly transition gene expression from ON to OFF under desired conditions[25]. The 
selection scheme was outlined in Figure 3.1.  To select for LuxR variants that activate 
gene expression under a given set of conditions, i.e., in the presence of a new acyl-HSL, a 
library of mutagenized luxR genes is selected with the ON selection plasmid pluxCAT, 
which yields chloramphenicol resistance with LuxR-dependent transcriptional activation.  
Identification of variants that show a lack of gene activation (i.e., with the wild-type 
cognate signal) is achieved by transformation with the OFF selection plasmid pluxBLIP, 
which encodes β-lactamase inhibitory protein (Bli) under the control of the lux promoter 
and β-lactamase (Bla) under the control of a constitutive promoter.   Bli inactivates Bla 
and renders cells with active LuxR alleles sensitive to β-lactam antibiotics.  
 
 
C.2.  Directed evolution of LuxR-G2E to respond to C10HSL but not 3OC6HSL 
 
To obtain the new LuxR signaling specificity, we started with a broad-specificity variant 
identified previously, LuxR-G2E (Table 4.1) [24].  To compare gene activation by LuxR 
and our evolved variants with exogenously added acyl-HSLs, we used a reporter plasmid, 
pluxGFPuv, that contains gfpuv under the control of the lux promoter.  Liquid-phase 
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gfpuv bioassays quantitatively measure fluorescence output due to LuxR-mediated 
GFPuv production [24].  LuxR-G2E responds to DL-decanoyl-homoserine lactone 
(DL-C10HSL), while wild-type LuxR does not respond at concentrations to 10 μM.  
Wild-type LuxR and LuxR-G2E respond similarly to 3OC6HSL (Fig. 4.2).  
 
Using error-prone PCR, we created a library of luxR-G2E genes encoding, on average, 
one to two amino acid substitutions in the N-terminal 160 amino acids of LuxR,  shown 
to be responsible for acyl-HSL binding [26].  Two rounds of ON/OFF selection were 
used to enrich for LuxR variants that activate gene expression with C10HSL but not 
3OC6HSL.        
 
The LuxR expression vectors obtained from colonies surviving Round 2 ON/OFF 
selection were used as templates to amplify the mutant luxR genes by PCR with a high-
fidelity polymerase. These genes were ligated into LuxR expression vectors and used for 
a final OFF/ON round of selection.  The LuxR expression plasmids obtained from 
colonies surviving Round 3 selection were transformed with pluxGFPuv and screened for 
their ability to activate gene expression with 100 nM C10HSL.  Eighty of the most 
fluorescent clones were transferred to a 96-well plate and grown overnight.  These clones 
were further screened for the inability to activate GFPuv expression with 3OC6HSL on 
solid media.    
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We sequenced 12 of the 80 fluorescent clones and found four unique LuxR variants that 
exhibited the desired retention of C10HSL response and loss of 3OC6HSL response.  All 
had the substitution of an arginine at position 67 for methionine, along with up to five 
additional new mutations.  One, LuxR-G2E-R67M, has only the R67M mutation in 
addition to the three amino acid substitutions of its parent, LuxR-G2E (Table 4.1).  All 
four unique variants exhibited identical responses with 3OC6HSL, C10HSL, C6HSL and 
C8HSL, indicating that the substitutions other than R67M are likely neutral (data not 
shown).  We therefore focused on LuxR-G2E-R67M for all further characterization.   
 
Table 4.1.  Nucleotide and amino acid changes in luxR/LuxR and lasR/LasR mutants 
  
luxR plasmid  luxR gene 
base substitution 
LuxR protein 
amino acid 
substitution 
Parent (2nd generation C8HSL-responder)  
pLuxR-G2E A97→G 
T162→A 
T346→G 
G405→A 
Thr33→Ala 
 
Ser116→Ala 
Met135→Ile 
Specificity mutant from selection   
pLuxR-G2E-R67M 
 
A97→G 
T162→A 
G200→T 
T346→G 
G405→A 
T498→C 
T510→C 
Thr33→Ala 
 
Arg67→Met 
Ser116→Ala 
Met135→Ile 
 
 
R67M mutation in wild-type  LuxR   
pLuxR-R67M G200→T Arg67→Met 
R61M mutation in wild-type  LasR   
pLasR-R61M GCT181→ATG Arg61→Met 
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C.3.  Gene activation by LuxR, LuxR-G2E and LuxR-G2E-R67M with acyl-HSL signals 
 
The gfpuv gene expression bioassay was used to quantitatively compare the influence of 
3OC6HSL and C10HSL on transcriptional activation by wild-type LuxR, LuxR-G2E and 
LuxR-G2E-R67M (Fig. 4.2).  LuxR and LuxR-G2E exhibited similar responses to 
3OC6HSL; gene activation by LuxR-G2E-R67M, however, was barely above 
background even at concentrations as high as 10 μM 3OC6HSL.  Responses to C10HSL 
showed the opposite trend: wild-type LuxR showed no response, while LuxR-G2E and 
LuxR-G2E-R67M showed similarly high levels of fluorescent protein production.   
 
We then characterized the ability of LuxR-G2E-R67M to activate gene expression with 
four acyl-HSLs not used during directed evolution:  C6HSL, C8HSL, dodecanoyl-
homoserine lactone (C12HSL) and 3-oxo-dodecanoyl-homoserine lactone (3OC12HSL) 
(Fig. 4.2).  LuxR-G2E-R67M has retained the increased ability to respond to straight-
chained acyl-HSLs C6HSL, C8HSL and C12HSL shown by LuxR-G2E; its response to 
3OC12HSL, however, was more than 50-fold weaker than LuxR-G2E’s. Thus, it appears 
that the R67M mutation disrupts interaction with the 3-oxo group.  
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Figure 4.2.  Activation of gfpuv transcription with 3OC6HSL, C10HSL, C6HSL, 
C8HSL, C12HSL and 3OC12HSL by wild-type LuxR (▲),  LuxR-G2E (■) and LuxR-
G2E-R67M (◊). Shown are units of fluorescence due to GFPuv production in E. coli 
containing pluxGFPuv and pLuxR, pLuxR-G2E or pLuxR-G2E-R67M.  The data are 
normalized to optical density and corrected by subtracting background fluorescence from 
a control strain containing pluxGFPuv and pPROLar.A122.    
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C.4. Effect of the R67M substitution in wild-type LuxR and LuxR homolog LasR 
 
To further assess the role of the R67M mutation in 3-oxo recognition, we introduced it 
into wild-type LuxR and compared LuxR-R67M’s ability activate gene expression with 
3OC6HSL and its straight-chain counterpart, C6HSL.  Fig. 4.4 shows that introducing a 
methionine at position 67 of LuxR eliminates its ability to respond to 3OC6HSL but has 
little effect on response to C6HSL. Thus, the R67M substitution appears not to 
significantly affect binding to straight-chain acyl-HSLs.  
 
 
 
 
Figure 4.3.  Activation of gfpuv transcription with 3OC6HSL and C6HSL by wild-type 
LuxR (▲) and LuxR-R67M (□).  Shown are units of fluorescence due to GFPuv 
production in E. coli containing pluxGFPuv and pLuxR or pLuxR-R67M.  The data are 
normalized to optical density and corrected by subtracting background fluorescence from 
a control strain containing pluxGFPuv and pPROLar.A122. 
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LasR is a LuxR homolog from Pseudomonas aeruginosa that responds to 3OC12HSL.  It 
has only 20% identity to LuxR in the N-terminal signal-binding domain.  LasR contains 
an arginine at residue 61, equivalent to R67 in LuxR. Because LasR also activates gene 
expression at the lux promoter [27], we used the same gfpuv gene expression bioassay to 
characterize its ability to activate gene expression in the presence of acyl-HSLs.   If 
R67M in LuxR eliminates an interaction with the 3-oxo group, then the R61M 
substitution in LasR might reduce LasR’s ability to respond to 3OC12HSL. Figure 4.4 
shows that LasR-R61M in fact has decreased response to 3OC12HSL, while its ability to 
respond to C12HSL is largely unaffected.   
 
 
Figure 4.4.  Activation of gfpuv transcription with 3OC12HSL and C12HSL by wild-
type LasR (▲) and LasR-R61M (□). Shown are units of fluorescence due to GFPuv 
production in E. coli containing pluxGFPuv and pLasR or pLasR-R61M.  The data are 
normalized to optical density and corrected by subtracting background fluorescence from 
a control strain containing pluxGFPuv and pPROLar.A122. 
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C.5. Gel mobility shift assays of acyl-HSL stimulated DNA binding 
 
We used gel mobility shift assays to measure the ability of different acyl-HSLs to 
stimulate DNA binding by purified LuxR, LuxR-G2E and LuxR-G2E-R67M (Fig. 4.5).  
In the presence of 3OC6HSL, LuxR binds a 20 base pair (bp) pseudopalindromic DNA 
target known as the lux box, which is centered 42.5 bp upstream of the transcriptional 
start site in the lux promoter [28, 29].  Wild-type LuxR was able to bind a DNA probe 
containing the lux promoter in the presence of 3OC6HSL but not C10HSL, while LuxR-
G2E could bind the same probe with 3OC6HSL or C10HSL (Fig. 4.5a).  LuxR-G2E-
R67M bound the DNA only in the presence of C10HSL.  A titration of 3OC6HSL in the 
presence of 3.5 nM LuxR revealed that 100 nM of L-3OC6HSL was required to shift 
50% of the specific probe (Fig. 4.5b), in agreement with published results [29].  
Approximately 2 μM of L-3OC6HSL was required to shift 50% of the DNA with LuxR-
G2E under similar conditions.  LuxR-G2E-R67M was not observed to shift the DNA 
with up to 12.5 μM L-3OC6HSL.  Wild-type LuxR, on the other hand, did not shift with 
the highest concentration of C10HSL, 12.5 μM.  LuxR-G2E required approximately 1 
μM C10HSL to shift 50% of the probe and LuxR-G2E-R67M achieved 50% binding with 
approximately 10 μM C10HSL.  Hill coefficients determined for each interaction where 
binding was detected range from 0.7 to 1.0 (data not shown), similar to the value of 0.9 
for wild-type LuxR with 3OC6HSL published by Urbanowski et al. [29].  
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Figure 4.5.  Gel mobility shift assays of LuxR, LuxR-G2E and LuxR-G2E-R67M in the 
presence of 3OC6HSL and C10HSL. a.  Gel shift assay of binding to lux promoter DNA.  
All lanes contain approximately 1 fmol of DNA and 3.5 nM LuxR, LuxR-G2E or LuxR-
G2E-R67M.  Acyl-HSL was added to a final concentration of 0.01 μM, 0.05 μM, 
0.10μM, 0.64 μM, 1.26 μM, 6.26μM and 12.5 μM to each lane from left to right.  b.  Data 
for 3OC6HSL are represented by closed diamonds (♦), and C10HSL by open squares (□).  
The amount of the lux promoter probe DNA shifted was determined at each concentration 
of acyl-HSL and averaged.  Error bars represent standard deviation of the mean based on 
at least three measurements.   
 
Western immunoblots further demonstrate the new acyl-HSL specificity of LuxR-G2E-
R67M.  While wild-type LuxR accumulates only in the presence of its cognate signal, 
3OC6HSL, and LuxR-G2E accumulates with either 3OC6HSL or C10HSL, an increase 
in LuxR-G2E-R67M concentration was detected with the addition of C10HSL, but not 
3OC6HSL, reflecting the new signal-binding specificity (Fig. 4.6).   
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Figure 4.6.  Protein accumulation is dependent upon acyl-HSL binding. Shown is a 
representative Western immunoblot of c-myc tagged LuxR, LuxR-G2E and LuxR-G2E-
R67M in the absence of acyl-HSL or with 1 μM 3OC6HSL or C10HSL.   Western 
immunoblots were performed as described [24]. 
 
 
C.6.  Solid-phase test for crosstalk between LuxR and LuxR-G2E-R67M acyl-HSL 
response 
 
A solid-phase assay with two fluorescent cell strains was used to determine whether any 
crosstalk occurred between LuxR and LuxR-G2E-R67M when cells were spread on 
plates containing 50 nM 3OC6HSL, 200 nM C10HSL or both.  Two strains, one 
containing gfpuv under the control of LuxR and the other gfpuv under the control of 
LuxR-G2E-R67M, were plated on separate sides of a Petri dish. In the presence of 
3OC6HSL, GFPuv production was observed as a result of LuxR-mediated gene 
activation (Fig. 4.7a).  No fluorescence was observed from the second strain containing 
LuxR-G2E-R67M.  Only LuxR-G2E-R67M-mediated GFPuv expression was observed 
with C10HSL (Fig. 4.7b).  In the presence of 3OC6HSL and C10HSL, both sides of the 
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plates fluoresced (Fig. 4.7c).  This finding indicates that LuxR and LuxR-G2E-R67M are 
sufficiently specific for their respective acyl-HSL signals to be used in synthetic genetic 
circuits requiring more than one acyl-HSL response system.   
 
 
 
Figure 4.7.  Solid-phase assays show minimal crosstalk between LuxR and 
LuxR-G2E-R67M.  Cells on the left contain pLuxR and pluxGFPuv; cells on the right 
contain pLuxR-G2E-R67M and pluxGFPuv.  a. Plate containing 3OC6HSL shows 
fluorescence only in LuxR-containing cells  b.  Plate containing C10HSL shows 
fluorescence only in LuxR-G2E-R67M-containing cells.  c.  Plate containing 3OC6HSL 
and C10HSL shows fluorescence from both LuxR and LuxR-G2E-R67M. 
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D.  Discussion 
 
To evolve a new signaling specificity, the selection scheme must identify variants that 
respond to the new chemical signal (positive selection) but also have decreased response 
to the cognate signal(s) (negative selection).  Variants of the Tet repressor with altered 
specificity were identified after multiple rounds of positive screening produced several 
variants capable of recognizing a new effector molecule [30].  Subsequent testing of the 
variants by screening with different effectors identified a mutant that no longer responded 
to tectracycline or several tetracycline analogs. Screening and selection systems that 
directly incorporate both positive and negative selection have been used to modify the 
specificities of enzymes, including Cre recombinase [31, 32], tRNA synthetases [33] and 
the endopeptidase OmpT [34].  Both the tRNA synthetase and Cre recombinase 
experiments used production of a reporter protein (GFP, RFP or β-galactosidase) for 
rounds of positive selection. The tRNA synthetase experiments relied on a lack of 
reporter expression during rounds of negative screening.  In contrast, the absence of Cre 
activity was determined by a second reporter gene that was disrupted by site-specific 
recombination, in a negative screening step.  The dual selection system used here also 
requires a specific output (as opposed to a lack thereof) for both positive and negative 
rounds of selection.  
 
Using the dual selection system of Fig. 4.2, we discovered a single arginine to methionine 
substitution at residue 67 that decreased LuxR-G2E’s response to the LuxR cognate 
signal, 3OC6HSL while maintaining its acquired response to C10HSL.  Changes in 
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specificity can be estimated by comparing the ratio of 3OC6HSL and C10HSL 
concentrations required to attain half-maximal levels of gene activation for the different 
LuxR variants.  (In cases where no activation was observed, the highest concentration of 
acyl-HSL measured was used to obtain a lower bound for the specificity change.)  A 
100-fold change in specificity was attained by LuxR-G2E through its increase in 
C10HSL sensitivity.  An additional change in specificity of at least 500-fold was acquired 
upon going from LuxR-G2E to LuxR-G2E-R67M.   Overall, a more than 50,000-fold 
change in specificity of the acyl-HSL response was obtained by evolving wild-type LuxR 
into LuxR-G2E-R67M. Introducing the R67M mutation into wild-type LuxR generated a 
1000-fold change in the ratio of 3OC6HSL to C6HSL response, while the R61M 
mutation in LasR yielded a more conservative 50-fold change in the ratio of 3OC12HSL 
to C12HSL response.   
 
In LuxR, LuxR-G2E and LasR, this R→M substitution decreases binding to acyl-HSLs 
with the 3-oxo group, without affecting the recognition of straight-chain acyl-HSLs.   
Positive selection for response to the new straight-chain C10HSL signal would not have 
uncovered this specificity-enhancing mutation.  A conserved methionine occurs at this 
position in a group of C8HSL-responsive homologs, including CepR, from the 
β-Proteobacteria. Thus this particular amino acid substitution, identified during 
laboratory evolution, was previously discovered during the natural evolution of these 
transcriptional activators to respond to different signaling molecules.  Due to the low 
sequence identity between LuxR and its homologs, however, identification of this residue 
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as a key determinant of acyl-HSL specificity would have been difficult from sequence 
comparisons alone.  The location of this residue in the crystal structure of TraR, the LuxR 
homolog from Agrobacterium tumefaciens and the only LuxR homolog for which a 
structure is available, indicates that it makes van der Waals contacts with the acyl-HSL 
but does not make direct contact with the 3-oxo moiety [35].  Furthermore, an attempt to 
target 3-oxo binding by TraR based on structural information did not yield any variants 
with new specificities[36].  A recent homology model of LuxR that suggests that the acyl 
side chain is flipped in the LuxR/acyl-HSL complex, as compared to the TraR/acyl-HSL 
complex, also failed to implicate residue 67 in 3-oxo recognition [37].   
 
Gel mobility shift assays demonstrated that LuxR and the evolved variants bind DNA 
only in the presence of the specific acyl-HSLs that activate gene expression.  A 250-fold 
change in the ratio of 3OC6HSL and C10HSL concentrations required to shift 50% of the 
DNA probe was observed with LuxR and LuxR-G2E.  While LuxR and LuxR-G2E have 
similar dose-response curves with 3OC6HSL, LuxR-G2E required approximately ten-
fold more signal to achieve 50% binding.  LuxR-G2E-R67M also has a lower affinity for 
C10HSL than its parent, LuxR-G2E, although the activation by these two proteins is very 
similar.   These results show that a decrease in signal binding in vitro does not necessarily 
yield a decrease in gene activation in vivo and supports the use of selection systems that 
directly measure signal-dependent gene expression, rather than DNA or signal binding, to 
generate variants with the precise output required for a given application.  
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Switching from a protein capable of recognizing 3OC6HSL but not C10HSL (LuxR) to 
one that recognizes C10HSL but no longer responds to 3OC6HSL (LuxR-G2E-R67M) 
was achieved via a series of single mutations. The three amino acid substitutions in 
LuxR-G2E each increase LuxR’s response to C8HSL and have additive effects when 
recombined by DNA shuffling [24]. Thus, these three mutations could accumulate in any 
order under selective pressure for increased response to the straight-chain acyl-HSL.  The 
R67M mutation, on the other hand, could only be detected as beneficial after significant 
increases in straight-chain acyl-HSL response had been achieved, because LuxR does not 
respond to C10HSL.   
 
The directed evolution of a LuxR variant with a new specificity therefore involved the 
acquisition of ‘promiscuous’ functions [24] and subsequent ‘respecialization.’  It has 
been postulated that broad-specificity proteins are evolutionary intermediates between 
more specialized states and that they are important for the evolution of proteins with new 
functions [23, 38].  These new functions can provide selective advantages to organisms 
as they adapt to changing environments.   Results from many directed evolution 
experiments indicate that a single mutation is much more likely to confer a  new function 
(e.g., the ability to recognize a new signal or substrate) without abolishing the old 
function [32, 39-41].  If a promiscuous interaction adversely affects the fitness of the 
organism, negative selective pressure will lead to the accumulation of mutations that 
minimize the deleterious interaction and lead to an increasingly specialized protein.  We 
have emulated this process with LuxR and its interactions with 3OC6HSL.   
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This work has also established the use of the dual selection system for the directed 
evolution of a transcriptional activator and suggests it can serve generally for engineering 
transcriptional regulators with specific ON/OFF responses.  The use of evolved LuxR 
variants in designer genetic circuits has been established [14], and will likely increase as 
new variants are engineered.  Figure 4.7 illustrates the lack of crosstalk between wild-
type LuxR and LuxR-G2E-R67M.  This mutant will be a useful component for 
intercellular communication circuits that require multiple chemical ‘wires’ between cell 
strains. Its evolution demonstrates that the acyl-HSL binding specificity of LuxR can be 
tuned using the ON/OFF selection to suit a particular application.  Engineers targeting 
applications that involve engineered cell-cell communication, including biofabrication, 
tissue engineering and targeted gene therapies, may find these proteins to be valuable 
additions to their ‘toolbox’ of circuit components.   
   
 
E. Materials and Methods 
 
E.1. Bacterial strains, media and growth conditions 
 
The bacterial strains used in this study are Escherichia coli strains DH5α 
(F- φ80dlacZΔM15 Δ(lacZYA-argF) U169 deoR recA1 endA1 hsdR17(rk-, mk+) phoA 
supE44 λ- thi-1 gyrA96 relA1 and BL21 (F-  dcm+ Hte ompT hsdS(rB- mB-) gal endA 
Tetr).  E. coli strains were cultured at 37oC in LB medium or on LB agar plates.  Acyl-
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HSLs used in these studies were: 3-oxohexanoyl-DL-homoserine lactone (3OC6HSL; 
Sigma Aldrich, St. Louis, MO), hexanoyl-DL-homoserine lactone (C6HSL; Fluka, St. 
Louis, MO), octanoyl-DL-homoserine lactone (C8HSL; Fluka), decanoyl-DL-homoserine 
lactone (C10HSL, Fluka), dodecanoyl-DL-homoserine lactone (C12HSL; Fluka) and 3-
oxododecanoyl-L-homoserine lactone (3OC12HSL; Quorum Science, Corville, IA).  
Antibiotics were added at the following concentrations to maintain the plasmids:  100 
μg/mL carbenicillin, 20 μg/mL kanamycin, and 100 μg/mL chloramphenicol.  During 
selection experiments antibiotics were added as follows:  100 μg/mL carbenicillin, 50 
μg/mL kanamycin, and 150 μg/mL chloramphenicol.   
 
 
E.2. Plasmid construction 
 
The LuxR expression vector, pLuxR, and the signal response plasmid, pluxGFPuv, have 
been described previously[24].  Plasmids pluxCAT and pluxBLIP are described in 
Chapter 3.  
 
pLuxR(SalI) is similar to pLuxR except that the SalI endonuclease site upstream of the 
Plac/ara-1 promoter was removed and new a SalI endonuclease site was engineered into 
luxR at nucleotide positions 493-498 (amino acid positions 164-165) such that no amino 
acid changes were introduced.   pluxRSalI was constructed by synthetic overlap 
extension PCR.   
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E.3. Library construction and selection 
 
Error-prone PCR reactions were performed using AmpliTaq DNA polymerase (Applied 
Biosystems, Foster City, CA) and 300 μM MnCl2 to increase the mutation rate as 
described [42].  The primers 5-luxRv2 
(5-AGAGGAGAAAGGTACCCATGAAAAACA-3) and LuxR(SalI)-r2 (5-
GCTATATTTATTTTTCGATAATTGTCGACTAGAGAAGGAAC-3) were used to 
amplify the first 500 bp of the luxR-G2E gene using pLuxR-G2E as the template. The 
library was constructed by ligating KpnI and SalI digested pLuxRSalI with the products 
of error-prone PCR using T4 DNA ligase (Invitrogen, Carlsbad, CA).  For the first ON 
round of selection (Round 1-ON), the ligation mixtures were transformed into competent 
DH5α cells harboring pluxCAT (DH5α(pluxCAT))and plated onto LB agar plates 
containing 50 μg/mL kanamycin, 150 μg/mL chloramphenicol and 100 nM C10HSL.  
Similar plates were used for subsequent ON rounds.  Plates used for OFF rounds 
contained 50 μg/mL kanamycin, 100 μg/mL carbenicillin and 100 nM 3OC6HSL. For 
each round, cells were also plated with kanamycin and carbenicillin to estimate the 
library size by quantifying the number of colonies that survive under non-selective 
conditions.  For both ON and OFF selections, LB agar plates were incubated at 37 oC for 
14 hours and then harvested with LB.  The plasmid DNA was recovered via miniprep 
(QIAGEN, Valencia, CA), digested with ScaI to inactivate pluxCAT or pluxBLIP, 
purified by spin column (Zymo Research, Orange, CA), and used to transform the 
competent cells for the next round.  The plasmid DNA recovered from Round 2-ON was 
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used as the template for recloning to remove any false positives in which changes had 
occurred outside luxR-G2E.  The luxR-G2E alleles were amplified using Pfu Turbo 
polymerase (Stratagene) and treated with DpnI.  The PCR products were digested and 
ligated into pLuxRSalI (as above) and transformed into competent DH5α cells containing 
pluxBLIP and subjected to a third round of OFF selection (Round 3-OFF).  The cells 
were harvested and a final ON round of selection (Round 3-ON) was performed as 
described above.  The DNA purified from Round 3-ON was digested with ScaI and used 
with pluxGFPuv to transform DH5α.  The transformation was plated onto LB agar 
containing kanamycin, chloramphenicol and 100 nM C10HSL.  Fluorescent colonies 
were identified as described previously [24] and grown in 1 mL cultures in deep-well 
microplates overnight at 37 oC.     
 
 
E.4. Characterization of LuxR variants 
 
Quantitative characterization of LuxR-mediated gene expression of GFPuv was 
performed as reported previously [24].  
 
LuxR, LuxR-G2E and LuxR-G2E-R67M were purified as described [29] with slight 
modification: all buffers contained a lower concentration of 0.05% Tween-20.  LuxR-
G2E-R67M was purified in the presence of 5 μM DL-C10HSL.  Gel shift experiments 
were also performed similarly to those described by Urbanowsi et al. [29].  The DNA 
probes were PCR products 173 bp in length from amplification of pluxGFPuv with 5-
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pluxI and 3-pluxI [24].  Probes were generated by end-labeling the PCR products using 
[γ32-P]-ATP plus T4 polynuceotide kinase.  Protein-DNA binding reactions contained 
approximately 1 fmol of the DNA probe in a final volume of 16 μL of DNA binding 
buffer (20 mM Tris-HCL, [pH 7.4], 50 mM KCl, 1 mM EDTA, 1 mM dithiothreitol, 100 
μg bovine serum albumin/mL, and 5% ficoll 400) with 100 μg/mL 
poly(dI-dC)·poly(dI-dC) (GE Healthcare) competitor DNA.  Purified protein and acyl-
HSL were added as indicated and incubated for 25 min at 25 oC.  The reaction mixtures 
were run on a native 5% Tris-glycine-EDTA gel at 4 oC.  Following electrophoresis, the 
probes were detected using Kodak BioMax XAR Film (Rochester, NY) and quantified 
from the scanned image via densitometry analysis using AlphaEaseFc image analysis 
software (Alpha Innotech). 
 
 
 E.5. Solid-phase fluorescence assays    
 
For the solid-phase experiment, separate cultures of E. coli DH5α containing either 
pLuxR and pluxGFPuv or pLuxR-G2E-R67M and pluxGFPuv were grown to stationary 
phase, diluted four-fold and blotted on top of LB-agar plates with a sterile sponge. Plates 
were incubated at 37 oC. Fluorescence images were captured with a digital camera while 
the plates were illuminated by a 360 nm ultraviolet light source. 
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CHAPTER 5 
   
ON/OFF Selection for LuxR Variants with  
Altered DNA-binding Specificities 
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A.  Abstract 
 
Variants of the acyl-homoserine lactone-dependent transcriptional activator LuxR with 
altered DNA-binding specificities were identified using a directed evolution scheme 
incorporating both positive (ON) and negative (OFF) selection.   LuxR variants that 
activate gene expression at new promoters are powerful additions to the regulatory 
components available to genetic circuit engineers.  Currently, the use of more than one 
LuxR homolog in a single cell is limited by the crosstalk between these systems at the 
level of DNA-binding specificity.  To identify LuxR variants that activate gene 
expression at a mutant promoter, PluxG5A., a library of luxR variants was selected for 
antibiotic resistance due to gene activation.   Surviving clones were selected for 
decreased activation at the wild-type lux promoter.  Two variants, LuxR-R212H and 
R212C/Q232H, were identified and in vivo bioassays showed that the promoter 
specificity of LuxR-R212C/Q232H was broadened to include PluxG5A as well as PluxI 
while LuxR-R212H showed a 10-fold preference for PluxG5A, a 50,000-fold change in 
promoter specificity was achieved by the R212H mutation.  The R212C and Q232H 
mutations were shown to be synergistic; the R212C mutation likely confers the desired 
change in DNA-binding affinity but destabilizes the protein, and the Q232H mutation 
appears to compensate for this defect.  Selection of a second-generation library did not 
identify mutants with increased specificity for PluxG5A, indicating new library design 
strategies are required to engineer LuxR variants with inverted promoter specificity.    
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B.  Introduction 
 
LuxR is a 28 kDa acyl-homoserine lactone (acyl-HSL)-dependent transcriptional 
activator from Vibrio fischeri [1-3].   LuxR recognizes a diffusible, quorum-sensing 
signal molecule, 3-oxo-hexanoyl-homoserine lactone (3OC6HSL) [4, 5], and activates 
gene expression at the lux promoter (PluxI) by recruiting RNA polymerase [6, 7].  Gene 
activation by LuxR requires a 20 base pair (bp) operator site within PluxI known as the lux 
box (Fig 5.1a,b) [6, 8].  The lux box is centered 42.5 bp upstream of the PluxI 
transcriptional start site and its position has been shown to be essential for gene activation 
[6].  Sequence analyses have predicted that LuxR binds to its DNA target via an α-helix-
turn-α-helix (HTH) motif between amino acid residues 200 and 224 [9].  The HTH motif 
is a common DNA-binding fold found in a myriad of bacterial activators and repressors 
[10, 11].   
 
Alanine scanning mutagenesis of the C-terminal domain of LuxR was used to identify 
residues involved in DNA binding and activation [9, 12].  Several mutants unable to bind 
DNA or activate transcription were identified, including alanine substitutions at positions 
191, 193, 212, 217, 225, 229, 230, 238 and 240.  Alanine substitutions at positions 201 
and 206 affect transcriptional activation but not DNA binding.   
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Figure 5.1.  a. List of LuxR homologs and their cognate DNA targets.  Organism, 
promoter, LuxR homolog name and DNA sequences of the lux-type boxes are shown.  
The 5 and -5 positions of the lux-type boxes are underlined and bold.   b. Sequences of 
the wild-type lux box and the mutant, luxG5A, used in this study.  A transition was made at 
a single bp in each half site of the operator.  The 5 and -5 positions mutated in the luxG5A 
box are highlighted.   
 
 
 
To date, more than 50 LuxR homologs have been identified within the Gram-negative 
phylum Proteobacteria [13].  Each LuxR homolog modulates gene expression following 
acyl-homoserine lactone (acyl-HSL) binding.  All acyl-HSL signals contain a homoserine 
lactone ring; varied acyl side chain moieties allow species-specific signal recognition.   
While LuxR homologs have evolved to specifically respond to different acyl-HSL 
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signals, homologs from different species have been shown to interchangeably activate 
gene expression at other lux-type promoters.  Both LuxR and LasR, a homolog from 
Pseudomonas aeruginosa, can activate gene expression at the other’s target promoter in 
Escherichia coli [14].  The lux-type boxes identified from a range of species show 
significant sequence diversity (Fig. 5.1a).  However, elements within these sites, 
including highly conserved nucleotides at positions 3, 4, 5, -3, -4, and -5, appear to be 
sufficient for DNA binding by most LuxR homologs.  As LuxR and its homologs are 
purified, their specific DNA-binding specificities are being investigated [15, 16].  
Precisely which sequences are recognized by LuxR and its homologs is not known.   
 
LuxR and its homologs have been used in several synthetic genetic circuits to confer 
intercellular communication capabilities  [17-20].  As the desired circuits become 
increasingly complex, the ability to use of more than one acyl-HSL response regulator in 
a single cell type will be advantageous.  While it may be possible to identify LuxR 
homologs that do not show any crosstalk with respect to promoter specificity, an 
alternative approach is to use directed evolution to generate variants of LuxR that activate 
gene expression at a mutant promoter.  A benefit of this approach is the production of a 
set of ‘standardized’ parts for engineering intercellular communications circuits.    
 
We have previously identified a LuxR variant with a new acyl-HSL binding specificity 
(Chapter 4).  LuxR variants with switched acyl-HSL specificities were targeted using a 
dual selection system that allows for ON/OFF selection.  We sought to continue this work 
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by targeting the DNA-binding specificity of LuxR to identify variants that recognize a 
new DNA target and that have decreased affinities for the wild-type lux box.  Directed 
evolution of the DNA-binding specificity of a Cre recombinase using positive screening 
alone and a combination of positive and negative screening showed that both positive and 
negative selective pressure were required to switch Cre’s DNA-binding specificity.  We 
hypothesized that a similar approach, using our dual selection system, would allow us to 
identify LuxR variants with novel DNA-binding specificities.  LuxR variants that show 
increased gene activation at a mutated lux box and decreased activation at the wild-type 
lux box were identified using our ON/OFF selection system.  Both variants with 
broadened DNA-binding specificity and variants with a preference for the new target 
were identified.   
 
 
C.  Results  
 
C.1. Dual selection for evolution of LuxR promoter specificity 
 
We targeted the 5 and -5 positions of the lux box for generating a mutated DNA target.  
This position is highly conserved in lux-type boxes.  In constructing the luxG5A box, we 
chose to maintain the palindrome and replace these residues in a conservative manner, 
purine for purine and pyrimidine for pyrimidine (Fig. 5.1b).  A transition is less likely to 
cause large structural differences than either of the possible transversions.  Liquid-phase 
bioassays measuring fluorescence due to LuxR-mediated GFPuv production showed 
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wild-type LuxR was unable to activate gene expression at a lux promoter containing the 
luxG5A box (PluxG5A) with up to 50 μM 3OC6HSL (Fig. 5.3).  
 
To select for LuxR variants capable of recognizing the luxG5A box and activating gene 
expression at PluxG5A, we used a gain-of-function (ON) selection plasmid encoding 
chloramphenicol acetyl-transferase (CAT) under the control of PluxG5A (Fig. 5.2).  
Selection of functional clones relies on LuxR-dependent activation of cat leading to 
chloramphenicol resistance.  To select for mutants with decreased affinities for wild-type 
PluxI, we used a loss-of-function (OFF) selection plasmid encoding the β-lactamase 
inhibitory protein (Bli) under the control of PluxI and a constitutively expressed β-
lactamase (bla) gene (Fig. 5.2).  Selection of clones which are unable to activate gene 
expression relies on the absence of LuxR-dependent activation of Bli, which inactivates 
Bla and confers carbenicillin sensitivity.   
 
A library generated by random mutagenesis of the DNA encoding the C-terminal third of 
LuxR, amino acid residues 166-250, was generated by error-prone PCR.   The C-terminal 
domain was targeted because it has been shown to contain the DNA-binding and 
activation domains [21-23].  Clones transformed with this library were selected for 
chloramphenicol resistance due to gene activation at PluxG5A with 5 μM 3OC6HSL.  The 
plasmid DNA was recovered from the surviving cells and subjected to digestion with 
ScaI to selectively inactivate the selection plasmid, pluxG5ACAT.  In a second ON round 
of selection, several clones survived with a 10-fold lower concentration of 3OC6HSL 
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(500 nM) and reduced incubation time of 14 hours.  All subsequent rounds of ON 
selection used this set of more stringent conditions. 
 
 
 
 
 
Figure 5.2.  Schematic of the dual selection system for the directed evolution of LuxR 
variants with altered DNA-binding specificity.  During positive rounds of selection, 
LuxR-mediated activation at a lux promoter containing the mutated luxG5A box, PluxG5A, 
leads to chloramphenicol acetyl-transferase (CAT) expression and chloramphenicol 
resistance.  Variants with decreased activation at the wild-type lux promoter are identified 
during rounds of negative selection by their ability to survive with carbenicillin.  
Unwanted gene activation by LuxR leads to carbenicillin sensitivity due to β-lactamase 
inhibitory protein (Blip) production and its inhibition of constitutively expressed β-
lactamase (Bla) protein.   
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We transformed the luxR mutant-encoding plasmids recovered after Round 2-ON with 
the OFF selection plasmid, pluxBLIP, and selected colonies surviving with carbenicillin 
and 10 nM 3OC6HSL.  Cells expressing wild-type LuxR with this concentration of acyl-
HSL are not viable.  DNA recovered from the surviving Round 2-ON cells was used for a 
third ON round of selection.  At this point, approximately 25% of the library survived 
with chloramphenicol and 500 nM 3OC6HSL.   
 
To ensure that the observed resistance was a result of changes within luxR, we used the 
DNA recovered from Round 3-ON and PCR-amplified the luxR genes with a high-
fidelity polymerase.  The amplified luxR genes were subjected to a final round of ON 
selection.  At this point, more than two-thirds of the cells survived in the presence of 
chloramphenicol and 500 nM 3OC6HSL.  To identify the best PluxG5A-activating LuxR 
variants, luxR expression plasmids isolated from colonies surviving the final round of 
selection were transformed with a plasmid encoding GFPuv under the control of PluxG5A, 
pluxG5AGFPuv.  More than 60% of the colonies fluoresced with 500 nM 3OC6HSL.  
Fifteen strains that fluoresced with 100 nM 3OC6HSL were isolated.    
 
DNA sequencing of the 15 clones identified two unique luxR mutants.   All of the 
mutants contained a mutation at residue 212 of LuxR.  Three of the genes identified 
contained two mutations:  R212→C and Q232→H.  The other 12 genes identified all 
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encode a single R212→H substitution.  This result suggests that the 212 position is 
critical for recognition of the luxG5A box.    
 
Because error-prone PCR cannot access all of the possible amino acids at a given 
position, we targeted position 212 for saturation mutagenesis.  The NNN saturation 
library was transformed with pluxG5AGFPuv and plated with 100 nM 3OC6HSL.  Ten of 
the most fluorescent clones were isolated and their luxR genes sequenced.  Of the ten, 
seven encoded R212→H and three encoded R212→S.   
 
 
C.2.  Second-generation library selection 
 
A second-generation library was generated by error-prone PCR of the C-terminal domain 
encoding region of luxR-R212H.  The library was determined to have an average 
mutation rate of approximately 4.5 nucleotide substitutions per luxR-R212H gene.  
Selections were carried out as described above with concentrations of 100 nM 3OC6HSL 
added for ON rounds of selection and 50 nM 3OC6HSL for OFF rounds.  More than 
200,000 clones were selected under these conditions.  No positive clones were identified. 
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C.3. Characterization of luxR mutants 
 
To compare transcriptional activation at PluxI and PluxG5A by wild-type LuxR and the 
evolved LuxR variants, we used a liquid-phase bioassay and measured fluorescence due 
to GFPuv production with a range of concentrations of 3OC6HSL (Fig. 5.3).   The two 
variants identified via ON/OFF selection, LuxR-R212C/Q232H and LuxR-R212H, 
showed similar dose-responses with PluxG5A.  Levels of LuxR-R212C/Q232H-mediated 
fluorescence at PluxI and PluxG5A were indistinguishable.  LuxR-R212H showed a 
preference for PluxG5A, requiring approximately ten-fold more 3OC6HSL to achieve 
similar levels of activation at PluxI.  LuxR-R212S also showed a subtle preference for 
PluxG5A (~five-fold) but required a two-fold higher 3OC6HSL concentration to activate 
gene expression at both promoters compared to LuxR-R212H.   
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Figure 5.3.  Activation of gfpuv 
transcription from PluxI ( ) and PluxG5A 
(▲) by wild-type LuxR, LuxR-
R212C/Q232H, LuxR-R212H and 
LuxR-R212S with 3OC6HSL. Shown 
are units of fluorescence due to GFPuv 
production in E. coli containing 
pluxGFPuv and pLuxR, pLuxR-
R212C/Q232H, LuxR-R212H or 
pLuxR-R212S.  The data are 
normalized to optical density and 
corrected by subtracting background 
fluorescence from a control strain 
containing pluxGFPuv and 
pPROLar.A122.    
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C.4. LuxR-R212C/Q232H activation at PluxG5A requires both mutations  
 
To assess the role of the individual mutations in LuxR-R212C/Q232H, the single mutants 
R212C and Q232H were constructed by site-directed mutagenesis.  Quantitative liquid-
phase characterization showed that the LuxR-R212C single mutant does not activate gene 
expression at PluxI or PluxG5A with up to 50 μM 3OC6HSL (Fig. 5.4).  LuxR-Q232H 
showed increased levels of activation at both the wild-type and the mutated lux promoter, 
however, activation at PluxG5A required more than 100-fold more 3OC6HSL than the 
double mutant, LuxR-R212C/Q232H.  These two mutations must work synergistically to 
confer the increased response at PluxG5A.     
 
 
Figure 5.4.   Activation of gfpuv transcription from PluxI ( ) and PluxG5A (▲) by single 
mutants LuxR-R212C and LuxR-Q232H with 3OC6HSL.  Shown are units of 
fluorescence due to GFPuv production in E. coli containing pLuxR-R212C or pLuxR-
Q232H.  The data are normalized to optical density and corrected by subtracting 
background fluorescence from a control strain containing pluxGFPuv and 
pPROLar.A122. 
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C.5. Accumulation of LuxR variants in vivo 
 
Each of the LuxR variants was tagged with a c-myc epitope and assayed for its abundance 
in vivo using Western immunoblots.  In the absence of 3OC6HSL, minimal levels of 
protein were observed for LuxR and each of the variants (data not shown).  Accumulation 
of wild-type LuxR, LuxR-R212H, LuxR-R212C/Q232H, LuxR-R212S and LuxR-Q232H 
increased with the addition of 3OC6HSL (Fig. 5.5).   LuxR-R212C did not increase in 
abundance with the addition of 3OC6HSL.   The concentrations of LuxR-R212H, LuxR-
R212C/Q232H and LuxR-R212S were lower than wild-type LuxR.  LuxR-R212H 
showed the largest decrease in protein expression, to <10% of wild-type levels.  
LuxR-R212C/Q232H and LuxR-R212S accumulate to approximately 50% of wild-type 
levels.  In contrast, the amount of LuxR-Q232H detected with 3OC6HSL was at more 
than five-fold higher than wild-type LuxR, indicating this mutation stabilizes LuxR.    
 
 
Figure 5.5.  Protein accumulation is dependent upon acyl-HSL binding. Shown is a 
representative Western immunoblot of c-myc tagged LuxR (WT), evolved DNA-binding 
variants and single-mutants with 10 μM 3OC6HSL.   Minimal protein accumulation, 
similar to the amount shown for LuxR-R212C with 3OC6HSL, was observed for each of 
the proteins in the absence of acyl-HSL. 
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C.6. DNA-binding experiments  
 
Wild-type LuxR, LuxR-R212C/Q232H, LuxR-R212H and LuxR-R212S were purified, 
and their ability to bind DNA in vitro was assayed using electromobility shift assays 
(EMSAs).  As expected from the in vivo bioassay data, all of the variants showed lower 
affinities for DNA probes containing either the PluxI or PluxG5A promoter than wild-type 
LuxR with PluxI.  To observe DNA binding by the evolved variants, micromolar protein 
concentrations were required.  Due to the elevated protein concentrations it was 
necessary to increase the amount of nonspecific DNA used in these studies to ensure the 
observed shifts were due to specific DNA-protein interactions.  Under these stringent 
conditions, wild-type LuxR has a KD of approximately 75 nM (Fig. 5.6), approximately 
150-fold higher than the previously reported value of 0.5 nM [3].  LuxR did not bind to a 
DNA target containing the luxG5A box at concentrations up to 2 μM.  The three DNA-
binding variants showed similar affinities for the luxG5A box.  Approximately 15% of the 
probe was bound with 2 μM protein (Fig. 5.6).  Further increases in protein concentration 
led to excessive levels of non-specific binding and precipitation of the protein.  The KD of 
the mutants for the new site was estimated to be more than 1000-fold higher than LuxR’s 
dissociation constant with its cognate DNA target.  All three variants also showed a 
preference for the luxG5A box.  LuxR-R212C/Q232H did not detectably bind the wild-type 
lux box and LuxR-R212H reproducibly bound 1-2% of the wild-type probe at the highest 
protein concentration used in this study.  Approximately 6% of the wild-type DNA probe  
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Figure 5.6.  Electromobility shift 
assays of LuxR and the evolved 
variants with PluxI and PluxG5A.  Gel 
shift assays are shown on the left and 
quantitative plots of the fraction of 
shifted DNA versus protein 
concentration are shown on the right.  
All lanes contained approximately 5 
fmol of a 176 bp DNA fragment 
containing wither PluxI or PluxG5A, the 
indicated concentration of LuxR, 
LuxR-R212C/Q232H, LuxR-R212H 
and LuxR-R212S and 25 μM DL-
3OC6HSL.   
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was bound by 2 μM LuxR-R212S.  With only a two-fold preference for the mutant luxG5A 
box, LuxR-R212S has the most broadened DNA-binding specificity.   
 
C.7.  RhlR-mediated gene activation at PluxI and PluxG5A 
 
An alignment of LuxR homologs showed that a LuxR homolog from P. aeruginosa, 
RhlR, has a serine residue at the amino acid position that aligns with 212 in LuxR.  RhlR-
mediated GFPuv production from PluxI and PluxG5A was measured using the same bioassay 
as LuxR.  As shown in Figure 5.7, RhlR activated gene expression at both promoters.  
Approximately five-fold higher concentrations of RhlR’s cognate acyl-HSL, butanoyl-
homoserine lactone (C4HSL), were required to achieve similar levels of gene activation 
at the wild-type lux promoter compared to PluxG5A. This result indicates that a serine 
residue at this position may confer a broadening of DNA-binding specificity in both RhlR 
and LuxR.   
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Figure 5.7.  RhlR-mediated GFPuv gene expression at PluxI and PluxG5A.  Shown are units 
of fluorescence due to GFPuv production in E. coli containing pRhlR with pluxGFPuv or 
pluxG5AGFPuv.  The data are normalized to optical density and corrected by subtracting 
background fluorescence from a control strain containing pluxGFPuv and 
pPROLar.A122. 
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D.  Discussion 
 
Examples of HTH engineering for new DNA-binding specificity in the literature are 
scarce, and the examples that are available have relied on structural information 
regarding the interactions between the protein and its target DNA site [24-34].  A crystal 
structure of LuxR is not available, and although LuxR and its homologs share higher 
sequence identity in their DNA-binding domains than their acyl-HSL binding domains, 
the sequence similarity between the C-terminal domains of LuxR and TraR, the only 
LuxR homolog for which a complete crystal structure is available, is very low (<20%).  
This is likely due to the fact that tra box contains an internal deletion on each side of the 
inverted repeat, as compared to the lux box (Fig. 5.1a) [14].   
 
We generated a library of luxR mutants via error-prone PCR and used an ON/OFF 
selection system to identify LuxR variants that both activate gene expression at a 
promoter containing a mutated lux box, PluxG5A,  and that show decreased gene activation 
at the wild-type lux promoter.   The dual selection system was employed to prevent the 
identification of LuxR variants with increased gene activation at both PluxI and PluxG5A.  
Our selection identified two variants, LuxR-R212H and LuxR-R212C/Q232H.  The 
conditions used for OFF rounds of selection were not sufficiently stringent to require the 
variants identified to be specific for the PluxG5A promoter, and both LuxR variants exhibit 
broadened promoter specificity.  However, a 50-fold increase in 3OC6HSL concentration 
required to reach half-maximal gene expression at PluxI was observed with LuxR-
R212C/Q232H and a 500-fold increase was observed with LuxR-R212H.  Therefore, the 
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dual selection system successfully identified variants with decreased gene activation at 
PluxI.  A third variant, LuxR-R212S, was identified by screening a library that randomized 
codon 212.   These results indicate that residue 212 is a modulator of specific interactions 
with positions 5 and -5 of the lux box.  Mutating this residue to an alanine was previously 
shown to inactivate LuxR [9, 12] and an alignment of this residue with the published 
structure of TraR shows that the residue may make direct contact with the phosphate 
group between nucleotides 4 and 5 of the lux box (Fig. 5.8).  This residue has not been 
previously implicated in affecting the DNA-binding specificity of any LuxR homolog.   
 
Lux-type boxes containing the A/T bp targeted in this work have only been identified in 
Pseudomonas strains.  LasR has been shown to bind and activate gene expression at 
promoters containing either an A/T or G/C bp at this position, although it contains an 
alanine residue at position 212 [16, 35].  The presence of a serine residue in RhlR at the 
amino acid position that aligns with residue 212 in LuxR prompted us to test its ability to 
activate gene expression at both PluxI and PluxG5A.  As with LuxR-R212S, RhlR showed a 
preference for PluxG5A, requiring approximately five-fold more 3OC6HSL to achieve 
similar levels of activation at PluxI.  The finding that RhlR and LasR have relaxed DNA-
binding specificities with regards to positions 5, -5 is interesting in light of the fact that 
the presence of three acyl-HSL response regulators coexist in this bacterial species.  
Intuitively, one might expect three regulators to have higher DNA-binding specificity to 
avoid activating gene expression at the ‘wrong’ promoter. The ability to distinguish the 
different target promoters of the three LuxR homologs must arise from differences at 
 156 
other nucleotide positions. A recent study showed that two of the LuxR homologs found 
in P. aeruginosa, LasR and QscR, identify their respective promoters by recognizing bp 8 
and -8 [36].  
  
 
 
 
Figure 5.8. Positions of residues in TraR corresponding to residues 212 and 232 in LuxR. 
The crystal structure of the LuxR homologue TraR (PDB 1L3L) has been determined 
[11]. The tra box DNA target and the C-terminal domains of two TraR peptides are 
shown.  The two peptides comprising a TraR dimer are shown in green and blue. The tra 
box is shown as sticks (grey represents carbon, red represents nitrogen, blue represents 
oxygen and orange represents phosphorus). The amino acid residues which align with 
R212 and Q232 are shown space-filling spheres with coloring similar to that used for 
DNA. The phosphate group between positions 4 and 5 of the lux box is shown as space 
filling spheres.  The glutamic acid (E196) residue located proximally to Q232 is also 
shown.   
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Changes in specificity can be estimated by comparing the ratio of 3OC6HSL 
concentrations required to attain half-maximal levels of gene activation at the PluxI and 
PluxG5A promoters for the different LuxR variants.  A 5,000-fold change in specificity was 
attained by LuxR-R212C/Q232H.  Both LuxR-R212H and LuxR-R212S showed a more 
than 50,000-fold change in promoter specificity.   
 
 
The observation from the gel shift experiments that each of the evolved variants has a 
higher DNA-binding affinity for PluxG5A that PluxI was unexpected.  Our bioassays showed 
that LuxR-R212C/Q232H activates gene expression equally well at either promoter but it 
did not bind PluxI in vitro.  This discrepancy indicates that the conformational changes or 
interactions with RNA polymerase required for activation may also affect DNA binding. 
The finding that a truncated LuxR consisting only of the C-terminal domain required 
RNA polymerase to bind DNA demonstrated that LuxR’s interactions with RNA 
polymerase can influence its ability to bind the lux box [23].  This finding suggests that 
selection or screening systems that directly measure the desired output, i.e., gene 
activation, may be better for optimizing genetic regulatory networks than assays targeting 
DNA binding directly. 
 
The finding that the R212C single-mutant is nonfunctional and that the Q232H mutation 
does not confer altered promoter specificity on its own indicates that the R→C mutation 
promotes recognition of the luxG5A box, but that it is also deleterious with regards to 
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activating gene expression.  The observation that LuxR-R212C does not accumulate in 
vivo indicates that its inability to activate gene expression is due to decreased protein 
stability or misfolding.  LuxR-R212C/Q232H, LuxR-R212H, and LuxR-R212S were also 
shown to accumulate to lower protein concentrations.  In general, mutations at position 
212 negatively affect protein stability and/or folding, and positively affect PluxG5A 
recognition.  The Q232H mutation likely compensates for the defect caused by the 
R212C mutation.  The Q232H mutation could confer the observed increase in activation 
in one or more ways including increasing protein stability or solubility, stabilizing 
interactions with RNA polymerase, and increasing DNA affinity.  The five-fold higher 
protein concentration observed with LuxR-Q232H, compared to wild type, suggests that 
the increase in gene activation observed with LuxR-Q232H is a result of increased 
protein stability.  Alignment to the published structure of TraR suggests that the Q232H 
mutation may stabilize the dimeric form of the protein through an electrostatic interaction 
with glutamic acid 196 on the adjacent polypeptide chain (Fig. 5.8).     
 
The majority of published HTH engineering experiments have used solutions already 
present in Nature, including swapping an entire DNA recognition helix or replacing all of 
the amino acids that contact a specific DNA target recognized by a close homolog.  This 
strategy is not always successful [24], and does not generate DNA-binding proteins that 
recognize novel DNA sequences.  Attempts at engineering HTH proteins that bind to 
previously unrecognized sequences have previously relied solely on libraries that 
randomize the amino acids shown to make contacts with the DNA.  In most cases, 
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modest gains can be accomplished in this manner.  New specificities, however, are rare.   
Our results suggest that DNA-binding proteins that recognize new DNA targets can be 
identified from libraries generated by random mutagenesis.  This strategy is especially 
useful when structural information is unavailable.  Furthermore, the identification of 
mutations at residues not targeted in site-saturation libraries, which have arisen 
adventitiously [37],  are critical for binding the new target suggests that screening or 
selecting a library generated by random mutagenesis is a viable complementary approach 
for identifying DNA-binding mutants even when a crystal structure is available.   
 
The identification of a LuxR variant with two synergistic mutations that increase 
activation at PluxG5A indicates that multiple mutations may be required to switch DNA-
binding specificity.  We used our best first-generation mutant as parent and selected more 
than 200,000 clones transformed with a luxR-R212H library for additional improvements 
in promoter specificity.  We did not identify any positive clones from these experiments.  
This suggests that either switching LuxR’s specificity from the G/C bp to an A/T bp at 
positions 5 and -5 is not chemically possible, or that a LuxR variant meeting the criteria 
determined by the selection conditions was not present in the second-generation library.  
The second, more plausible explanation indicates that a new library design is necessary.  
Alanine scanning mutagenesis of a 29 residue “miniature” DNA-binding protein 
demonstrated the importance of a well-packed hydrophobic core for DNA binding and 
specificity [38].  Therefore, making further gains in engineering the DNA-binding 
specificity with HTH motifs may require the generation of libraries that target a large 
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number of residues, including both those that interact directly with the DNA and those 
that form the core of the protein.  The dual selection system is ideal for this use because 
libraries of more than 108 unique clones could be selected for variants with new DNA-
binding specificities.  If, like the R212C mutation, residues that alter the DNA-binding 
specificity frequently destabilize the protein, an alternative library design strategy is to 
start with a stabilized parent [39].  We have previously identified LuxR variants with 
increased sensitivities to 3OC6HSL that exhibit much higher protein concentrations than 
wild-type LuxR in the presence of acyl-HSL. One of these stabilized variants may 
provide the necessary advantage required to identify new LuxR variants with switched 
DNA-binding specificities. 
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E. Materials and Methods 
 
E.1. Bacterial strains, media and growth conditions 
 
The bacterial strains used in this study are Escherichia coli strains DH5α 
(F- φ80dlacZΔM15 Δ(lacZYA-argF) U169 deoR recA1 endA1 hsdR17(rk-, mk+) phoA 
supE44 λ- thi-1 gyrA96 relA1 and BL21 (F-  dcm+ Hte ompT hsdS(rB- mB-) gal endA 
Tetr).  E. coli strains were cultured at 37 oC in LB medium or on LB agar plates.  
Antibiotics were added at the following concentrations to maintain the plasmids:  
100 μg/mL carbenicillin, 20 μg/mL kanamycin, and 100 μg/mL chloramphenicol.  During 
selection experiments antibiotics were added as follows:  100 μg/mL carbenicillin, 
50 μg/mL kanamycin, and 150 μg/mL chloramphenicol. 3-Oxohexanoyl-DL-homoserine 
lactone (3OC6HSL; Sigma Aldrich, St. Louis, MO) stock solutions were prepared by 
dissolving appropriate amounts in ethyl acetate acidified with glacial acetic acid (0.01% 
v/v), and stored at -20 oC.  
 
 
E.2. Plasmid construction 
 
The positive selection and GFPuv reporter plasmids containing PluxG5A, pluxG5ACAT 
pluxG5AGFPuv, were constructed from pluxGFPuv [40] and pluxCAT (described in 
Chapter 3) using standard site-directed mutagenesis techniques.  The oligonucleotides 
used were:  luxBoxB-f (5-CTTAACATAAGCACCTATAGGATCGTATAGGTTTAC 
GCAAGAAAATGG-3) and its reverse complement, luxBoxB-r. 
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E.3. Mutagenesis of luxR 
 
Mutagenesis of the region of luxR encoding the C-terminal third of the protein was 
carried out using error-prone PCR [41] to yield a mutation frequency of approximately 2 
nucleotide substitutions per luxR gene.  The LuxRSalI-f (see above) and 3-LuxR [40] 
primers were used to amplify the desired region.  The pool of mutagenized luxR genes 
was cloned into pLuxRSalI between its SalI and BamHI sites.  
 
The forward and reverse primers used for saturation mutagenesis at position 212 were:  
5-LuxRSat212 (5-GGGATATTTCAAAAATATTAGGCTGCAGTGAGNNNACTGTC 
ACTTTCC-3), and 3-LuxRSat(int) (5-CTGCAGCCTAATATTTTTGAAATATCCC-3).  
The 3' end of luxR containing the randomized 212 codon was amplified from pLuxSalI 
with LuxRSat212 and 3-LuxR+200 (5-GTGAGCGAGGAAGCGGAATATATCC-3).  
The 5' end of the gene was amplified with 5-LuxR [40] and 3-LuxRSat(int).  Overlap 
extension PCR using the PCR products from the two reactions described above, 5-LuxR 
and 3-LuxR was used to construct the entire luxR gene containing the randomized 212 
codon.  The library was ligated into pLuxRSalI following digestion with KpnI and 
BamHI.   
 
LuxR single-mutants containing the R212C and Q232H mutations were constructed using 
standard site-directed methods. 
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E.4. Selection of LuxR variants with new DNA-binding properties 
 
In Round 1-ON, competent cells harboring pluxG5ACAT were transformed with a pool of 
mutagenized pLuxRSalI and plated on LB-agar amended with 5 μM 3OC6HSL, 
150 μg/mL chloramphenicol and 50 μg/mL kanamycin.  Surviving colonies were 
harvested after 20 h at 37oC by overlaying LB medium.  pLuxSalI plasmids were 
recovered from the selected cells via miniprep (QIAGEN) and endonuclease digestion of 
pluxG5ACAT with ScaI.  The recovered DNA was transformed into DH5α cells harboring 
the pluxG5ACAT plasmid for Round 2-ON.  In Round 2-ON (and all subsequent ON 
selections), the LB-agar contained 500 nM 3OC6HSL.  Surviving colonies were 
harvested after 14 h at 37 oC.  The plasmid DNA recovered and pluxG5ACAT inactivated 
via digestion.  The luxR expression plasmids recovered after Round 2-ON were 
transformed into DH5α cells harboring pluxWTBlip and plated with 10 nM 3OC6HSL, 
100 μg/mL carbenicillin and 50 μg/mL kanamycin (Round 2-OFF).  Cells surviving after 
14 h at 37oC were harvested and treated similarly to after Round 1-ON and Round 2-ON.  
Re-cloning of the library following Round 3-ON was carried out with a proofreading 
polymerase (Pfu, Stratagene), 5-LuxR and 3-LuxR.  PCR products were ligated into 
pLuxRSalI following digestion with KpnI and BamHI.  pLuxRSalI plasmids recovered 
after the Round 4-ON were transformed into DH5α with pluxG5AGFPuv and plated with 
100 nM 3OC6HSL, 100 μg/mL chloramphenicol and 50 μg/mL kanamycin.  Eighty 
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colonies were picked and plated with a titration of 3OC6HSL.  The 15 best colonies, 
based on fluorescence, were chosen for subsequent characterization.    
 
Plasmids encoding the selected LuxR variants were isolated by transforming miniprep 
DNA into plasmid-free DH5α and plating onto LB-plates supplemented with kanamycin.  
The plasmids encoding the LuxR variants of interest were also transformed with 
pluxGFPuv so that their ability to activate gene expression at the wild-type lux promoter 
could be assessed.   
 
 
E.5.  Characterization of selected LuxR variants 
 
Bioassays to quantitatively characterize LuxR-mediated gene expression of GFPuv from 
both PluxI and PluxG5A were performed as described [40].  Western blots to assay the 
abundance of the LuxR variants in vivo as described [40]. 
 
LuxR variants were purified as described [3].  Modifications to the published procedure 
include:  the concentration of tween-20 in all buffers was lowered to 0.05% v/v.    
 
Gel mobility shift assays were performed similarly to the methods described as described 
in Chapter 4.  The DNA probes containing either the wt lux box or luxG5A box were 173 
bp in length and amplified from pluxGFPuv or pluxG5AGFPuv with 5-LuxI and 3-LuxI 
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[40].  Probes were generated by end-labeling the PCR products using [γ32-P]-ATP plus 
T4 polynuceotide kinase.  Protein-DNA binding reactions contained approximately 5 
fmol of the DNA probe, 200 μg/mL poly(dI-dC)•poly(dI-dC) and 250 μg/mL sonicated 
salmon sperm DNA in a final volume of 10 μL of DNA binding buffer (20 mM Tris-HCl, 
[pH 7.4], 50 mM KCl, 1 mM EDTA, 1 mM dithiothreitol, 100 μg bovine serum 
albumin/mL, and 5% ficoll 400).  Purified protein and acyl-HSL were added as indicated 
and incubated for 25 min at 25 oC.  The reaction mixtures were run on a native 5% Tris-
glycine-EDTA gel at 4 oC.  Following electrophoresis, the probes were detected using 
Kodak BioMax XAR Film (Rochester, NY) and quantified from the scanned image via 
densitometry analysis using AlphaEaseFc image analysis software (Alpha Innotech). 
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CHAPTER 6 
 
Conclusions 
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We have generated variants of the quorum sensing transcriptional regulator LuxR with new 
signal and DNA-binding specificities for use in synthetic genetic circuits.  One of our 
hypersensitive variants has already been used as a component in a multicellular band-detect 
network that generates programmed pattern formation on a solid surface.  We anticipate 
that our new LuxR variants will be the cornerstones of future efforts to construct more 
complex intercellular communications systems.  Furthermore, laboratory evolution of 
specific signal- and DNA-binding interactions has provided insight into how these systems 
have evolved in Nature and the biochemical mechanisms involved in distinguishing 
between chemically similar targets.   
 
Through the directed evolution of LuxR, we have identified several amino acid residues 
that modulate acyl-HSL and DNA-binding specificity that had not been identified 
previously.  It will be interesting to reassess these mutations as more structural details 
become available.  Would we have been able to identify these sites as specificity 
determinants if a crystal structure was available?  While this scenario is unlikely, perhaps 
the structures of wild-type LuxR and variants from this work will provide some insight into 
how these mutations confer the observed change in LuxR-mediated gene activation. 
 
The generation of transcriptional activators with new functions in the absence of structural 
information demonstrates that directed evolution is a valid design strategy for producing 
new regulatory components.  These evolved variants add new functionalities to make a 
‘standardized’ set of components that share many biochemical properties but respond to 
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different signals or regulate gene expression at different promoters with a range of 
sensitivities.   The wide range of circuit parameters attainable with these new components 
will aid in the generation of increasingly complex synthetic genetic circuits. 
 
The dual selection system, which successfully identified both acyl-HSL and DNA-binding 
LuxR variants, is a generally applicable technology and can easily be modified for the 
directed evolution of other transcription factors.  The potential to select libraries of 108 or 
more may enable, for the first time, the directed evolution of an entire genetic circuit by 
simultaneously randomizing multiple components and selecting for the desired output. 
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APPENDIX A 
 
Plasmid, gene and protein sequences  
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A.  Sequences  of wild-type LuxR, LuxR homologs, evolved LuxR variants and the 
pLuxR expression vector 
 
A.1.  General information 
 
LuxR (Genbank number AAD48473) is composed of 250 amino acids (750 bp).  The 
N-terminal domain of the protein, residues 1 to ∼160 residues, is involved in acyl-HSL 
binding.  The C-terminal domain, residues ∼180-250, is involved in DNA-binding and 
activation.  The LuxR expression vector, pLuxR, was derived from the commercially 
available pPROLar.A122 plasmid and contains luxR under the control of a Plac/ara-1 hybrid 
promoter.  This plasmid was used for all cloning procedures as well as for protein 
expression. 
 
Two synonymous mutations, T498→C and T510→C, were used to introduce a SalI 
restriction site into the luxR gene between the N- and C-terminal domains so that each 
domain could be targeted independently.  The pLuxR plasmid was also modified to remove 
a SalI site upstream of the Plac/ara-1 promoter.   All luxR mutants presented in Chapters 4 
and 5 contain the internal SalI restriction site.  In random mutagenesis experiments 
targeting the acyl-HSL binding specificity of LuxR, error-prone PCR was used to amplify 
the region stretching from the KpnI site to the SalI site to include the first 167 amino acids 
of LuxR.  In random mutagenesis experiments targeting the DNA-binding specificity of 
LuxR, error-prone PCR was used to amplify the region stretching from the SalI site to the 
BamHI site.   
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Figure A.1. lists the nucleotide sequence of full-length, wild-type luxR. 
 
Figure A.2. lists the amino acid sequence of full length, wild-type LuxR. 
 
Figure A.3. lists the nucleotide sequence of the pLuxR vector containing wild-type luxR. 
 
Figure A.4.  shows the plasmid map of the pLuxR vector.   
 
Figure A.5. lists the nucleotide sequences of the luxR homologs used in this work.  The 
wild-type luxR gene is substituted by the wild-type lasR gene in pLasR.  The wild-type 
rhlR gene replaces luxR in pRhlR.  A BamHI site within the rhlR gene prevented the use of 
this site when cloning the RhlR expression vector.  A HindIII site directly upstream of the 
BamHI site in pPROLar.A122 is the 3' restriction site in pRhlR.   
 
Figure A.6. lists the amino acid sequence of full length, wild-type LasR and RhlR. 
 
Table A.1. lists the sequences of the luxR mutants generated by random mutagenesis in 
Chapter 2.  
 
Table A.2. lists the sequences of the luxR single-mutants constructed in Chapter 2. 
 
Table A.3. lists nucleotide and amino acid substitutions of luxR/LuxR and lasR/LasR 
mutants described in Chapter 4.   
 
Table A.4. lists nucleotide and amino acid substitutions of luxR/LuxR mutants described in 
Chapter 5.   
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Figure A.1.  Nucleotide sequence of full-length, wild-type luxR.  
 
1   ATGAAAAACA TAAATGCCGA CGACACATAC AGAATAATTA ATAAAATTAA 
51  AGCTTGTAGA AGCAATAATG ATATTAATCA ATGCTTATCT GATATGACTA 
101 AAATGGTACA TTGTGAATAT TATTTACTCG CGATCATTTA TCCTCATTCT 
151 ATGGTTAAAT CTGATATTTC AATTCTAGAT AATTACCCTA AAAAATGGAG 
201 GCAATATTAT GATGACGCTA ATTTAATAAA ATATGATCCT ATAGTAGATT 
251 ATTCTAACTC CAATCATTCA CCAATTAATT GGAATATATT TGAAAACAAT  
301 GCTGTAAATA AAAAATCTCC AAATGTAATT AAAGAAGCGA AAACATCAGG 
351 TCTTATCACT GGGTTTAGTT TCCCTATTCA TACGGCTAAC AATGGCTTCG 
401 GAATGCTTAG TTTTGCACAT TCAGAAAAAG ACAACTATAT AGATAGTTTA 
451 TTTTTACATG CGTGTATGAA CATACCATTA ATTGTTCCTT CTCTAGTTGA 
501 TAATTATCGA AAAATAAATA TAGCAAATAA TAAATCAAAC AACGATTTAA 
551 CCAAAAGAGA AAAAGAATGT TTAGCGTGGG CATGCGAAGG AAAAAGCTCT  
601 TGGGATATTT CAAAAATATT AGGCTGCAGT GAGCGTACTG TCACTTTCCA 
651 TTTAACCAAT GCGCAAATGA AACTCAATAC AACAAACCGC TGCCAAAGTA 
701 TTTCTAAAGC AATTTTAACA GGAGCAATTG ATTGCCCATA CTTTAAAAAT  
 
 
 
Figure A.2. Amino acid sequence of full-length, wild-type LuxR. 
 
1   MKNINADDTY RIINKIKACR SNNDINQCLS DMTKMVHCEY YLLAIIYPHS  
50  MVKSDISILD NYPKKWRQYY DDANLIKYDP IVDYSNSNHS PINWNIFENN 
100 AVNKKSPNVI KEAKTSGLIT GFSFPIHTAN NGFGMLSFAH SEKDNYIDSL 
150 FLHACMNIPL IVPSLVDNYR KINIANNKSN NDLTKREKEC LAWACEGKSS 
200 WDISKILGCS ERTVTFHLTN AQMKLNTTNR CQSISKAILT GAIDCPYFKN  
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Figure A.3. Nucleotide sequence of the pLuxR vector containing wild-type luxR. 
 
1   GTCGACTCGA GCATAGCATT TTTATCCATA AGATTAGCGG ATCTAACCTT 
51   TACAATTGTG AGCGCTCACA ATTATGATAG ATTCAATTGT GAGCGGATAA 
101 CAATTTCACA CAGAATTCAT TAAAGAGGAG AAAGGTACCC ATGAAAAACA 
151  TAAATGCCGA CGACACATAC AGAATAATTA ATAAAATTAA AGCTTGTAGA 
201  AGCAATAATG ATATTAATCA ATGCTTATCT GATATGACTA AAATGGTACA 
251 TTGTGAATAT TATTTACTCG CGATCATTTA TCCTCATTCT ATGGTTAAAT  
301 CTGATATTTC AATTCTAGAT AATTACCCTA AAAAATGGAG GCAATATTAT 
351 GATGACGCTA ATTTAATAAA ATATGATCCT ATAGTAGATT ATTCTAACTC 
401 CAATCATTCA CCAATTAATT GGAATATATT TGAAAACAAT GCTGTAAATA 
451 AAAAATCTCC AAATGTAATT AAAGAAGCGA AAACATCAGG TCTTATCACT 
501 GGGTTTAGTT TCCCTATTCA TACGGCTAAC AATGGCTTCG GAATGCTTAG 
551 TTTTGCACAT TCAGAAAAAG ACAACTATAT AGATAGTTTA TTTTTACATG  
601 CGTGTATGAA CATACCATTA ATTGTTCCTT CTCTAGTTGA TAATTATCGA 
651 AAAATAAATA TAGCAAATAA TAAATCAAAC AACGATTTAA CCAAAAGAGA 
701 AAAAGAATGT TTAGCGTGGG CATGCGAAGG AAAAAGCTCT TGGGATATTT 
751 CAAAAATATT AGGCTGCAGT GAGCGTACTG TCACTTTCCA TTTAACCAAT 
801 GCGCAAATGA AACTCAATAC AACAAACCGC TGCCAAAGTA TTTCTAAAGC 
851 AATTTTAACA GGAGCAATTG ATTGCCCATA CTTTAAAAAT TAAGTACGGG  
901 ATCCCTGCAG GCCTCAGGGC CCGATCGATG CGGCCGCTTA ATTAATTAAT 
951 CTAGAGGCAT CAAATAAAAC GAAAGGCTCA GTCGAAAGAC TGGGCCTTTC 
1001 GTTTTATCTG TTGTTTGTCG GTGAACGCTC TCCTGAGTAG GACAAATCCG 
1051 CCGCCCTAGA CCTAGGGGAT ATATTCCGCT TCCTCGCTCA CTGACTCGCT 
1101 ACGCTCGGTC GTTCGACTGC GGCGAGCGGA AATGGCTTAC GAACGGGGCG 
1151 GAGATTTCCT GGAAGATGCC AGGAAGATAC TTAACAGGGA AGTGAGAGGG  
1201 CCGCGGCAAA GCCGTTTTTC CATAGGCTCC GCCCCCCTGA CAAGCATCAC 
1251 GAAATCTGAC GCTCAAATCA GTGGTGGCGA AACCCGACAG GACTATAAAG 
1301 ATACCAGGCG TTTCCCCCTG GCGGCTCCCT CGTGCGCTCT CCTGTTCCTG 
1351 CCTTTCGGTT TACCGGTGTC ATTCCGCTGT TATGGCCGCG TTTGTCTCAT 
1401 TCCACGCCTG ACACTCAGTT CCGGGTAGGC AGTTCGCTCC AAGCTGGACT 
1451 GTATGCACGA ACCCCCCGTT CAGTCCGACC GCTGCGCCTT ATCCGGTAAC  
1501 TATCGTCTTG AGTCCAACCC GGAAAGACAT GCAAAAGCAC CACTGGCAGC 
1551 AGCCACTGGT AATTGATTTA GAGGAGTTAG TCTTGAAGTC ATGCGCCGGT 
1601 TAAGGCTAAA CTGAAAGGAC AAGTTTTGGT GACTGCGCTC CTCCAAGCCA 
1651 GTTACCTCGG TTCAAAGAGT TGGTAGCTCA GAGAACCTTC GAAAAACCGC 
1701 CCTGCAAGGC GGTTTTTTCG TTTTCAGAGC AAGAGATTAC GCGCAGACCA 
1751 AAACGATCTC AAGAAGATCA TCTTATTAAT CAGATAAAAT ATTACTAGAT 
1801 TTCAGTGCAA TTTATCTCTT CAAATGTAGC ACCTGAAGTC AGCCCCATAC 
1851 GATATAAGTT GTTACTAGTG CTTGGATTCT CACCAATAAA AAACGCCCGG 
1901 CGGCAACCGA GCGTTCTGAA CAAATCCAGA TGGAGTTCTG AGGTCATTAC 
1951 TGGATCTATC AACAGGAGTC CAAGCGAGCT CTCGAACCCC AGAGTCCCGC 
2001 TCAGAAGAAC TCGTCAAGAA GGCGATAGAA GGCGATGCGC TGCGAATCGG 
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2051 GAGCGGCGAT ACCGTAAAGC ACGAGGAAGC GGTCAGCCCA TTCGCCGCCA 
2101 AGCTCTTCAG CAATATCACG GGTAGCCAAC GCTATGTCCT GATAGCGGTC 
2151 CGCCACACCC AGCCGGCCAC AGTCGATGAA TCCAGAAAAG CGGCCATTTT 
2201 CCACCATGAT ATTCGGCAAG CAGGCATCGC CATGGGTCAC GACGAGATCC 
2251 TCGCCGTCGG GCATGCGCGC CTTGAGCCTG GCGAACAGTT CGGCTGGCGC 
2301 GAGCCCCTGA TGCTCTTCGT CCAGATCATC CTGATCGACA AGACCGGCTT 
2351 CCATCCGAGT ACGTGCTCGC TCGATGCGAT GTTTCGCTTG GTGGTCGAAT  
2401 GGGCAGGTAG CCGGATCAAG CGTATGCAGC CGCCGCATTG CATCAGCCAT 
2451 GATGGATACT TTCTCGGCAG GAGCAAGGTG AGATGACAGG AGATCCTGCC 
2501 CCGGCACTTC GCCCAATAGC AGCCAGTCCC TTCCCGCTTC AGTGACAACG 
2551 TCGAGCACAG CTGCGCAAGG AACGCCCGTC GTGGCCAGCC ACGATAGCCG 
2601 CGCTGCCTCG TCCTGCAGTT CATTCAGGGC ACCGGACAGG TCGGTCTTGA 
2651 CAAAAAGAAC CGGGCGCCCC TGCGCTGACA GCCGGAACAC GGCGGCATCA 
2701 GAGCAGCCGA TTGTCTGTTG TGCCCAGTCA TAGCCGAATA GCCTCTCCAC 
2751 CCAAGCGGCC GGAGAACCTG CGTGCAATCC ATCTTGTTCA ATCATGCGAA 
2801 ACGATCCTCA TCCTGTCTCT TGATCAGATC TTGATCCCCT GCGCCATCAG 
2851 ATCCTTGGCG GCAAGAAAGC CATCCAGTTT ACTTTGCAGG GCTTCCCAAC 
2901 CTTACCAGAG GGCGCCCCAG CTGGCAATTC CGACGTCTGT GTGGAATTGT 
2951 GAGCGGATAA CAATTTCACA CAGGGCCCTC GGACACCGAG GAGAATGTCA 
3001 AGAGGCGAAC ACACAACGTC TTGGAGCGCC AGAGGAGGAA CGAGCTAAAA 
3051 CGGAGCTTTT TTGCCCTGCG TGACCAGATC CCGGAGTTGG AAAACAATGA 
3101 AAAGGCCCCC AAGGTAGTTA TCCTTAAAAA AGCCACAGCA TACATCCTGT 
3151 CCGTCCAAGC AGAGGAGCAA AAGCTCATTT CTGAAGAGGA CTTGTTGCGG 
3201 AAACGACGAG AACAGTTGAA ACACAAACTT GAACAGCTAC GGAACTCTTG 
3251 TGCGTAAGGA AAAGTAAGGA AAACGATTCC TTCTAACAGA AATGTCCTGA  
3301 GCAATCACCT ATGAACT 
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Figure A.4. Plasmid map of the pLuxR vector containing wild-type lux. 
 
 
pLuxRfig
3317 bp
luxR
Kan(r)
P(lac/ara-1)
P15A ori
T0 Term
T1 Term
AatII (2932)
BamHI (899)
KpnI (134)
pLuxR
Plac/ara-1
luxR
KanR
SalI (1)
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Figure A.5.  Nucleotide sequences of the luxR homologs used in this work 
 
lasR 
1  ATGGCCTTGG TTGACGGTTT TCTTGAGCTG GAACGCTCAA GTGGAAAATT 
51 GGAGTGGAGC GCCATCCTGC AGAAGATGGC GAGCGACCTT GGATTCTCGA 
101 AGATCCTGTT CGGCCTGTTG CCTAAGGACA GCCAGGACTA CGAGAACGCC 
151 TTCATCGTCG GCAACTACCC GGCCGCCTGG CGCGAGCATT ACGACCGGGC 
201 TGGCTACGCG CGGGTCGACC CGACGGTCAG TCACTGTACC CAGAGCGTAC 
251 TGCCGATTTT CTGGGAACCG TCCATCTACC AGACGCGAAA GCAGCACGAG 
301 TTCTTCGAGG AAGCCTCGGC CGCCGGCCTG GTGTATGGGC TGACCATGCC 
351 GCTGCATGGT GCTCGCGGCG AACTCGGCGC GCTGAGCCTC AGCGTGGAAG 
401 CGGAAAACCG GGCCGAGGCC AACCGTTTCA TAGAGTCGGT CCTGCCGACC 
451 CTGTGGATGC TCAAGGACTA CGCACTGCAG AGCGGTGCCG GACTGGCCTT 
501 CGAACATCCG GTCAGCAAAC CGGTGGTTCT GACCAGCCGG GAGAAGGAAG 
551 TGTTGCAGTG GTGCGCCATC GGCAAGACCA GTTGGGAGAT ATCGGTTATC  
601 TGCAACTGCT CGGAAGCCAA TGTGAACTTC CATATGGGAA ATATTCGGCG 
651 GAAGTTCGGT GTGACCTCCC GCCGCGTAGC GGCCATTATG GCCGTTAATT 
701 TGGGTCTTAT TACTCTCTGA  
 
rhlR 
 
1    ATGAGGAATG ACGGAGGCTT TTTGCTGTGG TGGGACGGTT TGCGTAGCGA 
51   GATGCAGCCG ATCCACGACA GCCAGGGCGT GTTCGCCGTC CTGGAAAAGG 
101  AAGTGCGGCG CCTGGGCTTC GATTACTACG CCTATGGCGT GCGCCACACG 
151  ATTCCCTTCA CCCGGCCGAA GACCGAGGTC CATGGCACCT ATCCCAAGGC 
201  CTGGCTGGAG CGATACCAGA TGCAGAACTA CGGGGCCGTG GATCCGGCGA 
251  TCCTCAACGG CCTGCGCTCC TCGGAAATGG TGGTCTGGAG CGACAGCCTG 
301  TTCGACCAGA GCCGGATGCT CTGGAACGAG GCTCGCGATT GGGGCCTCTG 
351  TGTCGGCGCG ACCTTGCCGA TCCGCGCGCC GAACAATTTG CTCAGCGTGC 
401  TTTCCGTGGC GCGCGACCAG CAGAACATCT CCAGCTTCGA GCGCGAGGAA 
451  ATCCGCCTGC GGCTGCGTTG CATGATCGAG TTGCTGACCC AGAAGCTGAC 
501  CGACCTGGAG CATCCGATGC TGATGTCCAA CCCGGTCTGC CTGAGCCATC 
551  GCGAACGCGA GATCCTGCAA TGGACCGCCG ACGGCAAGAG TTCCGGGGAA 
601  ATCGCCATCA TCCTGAGCAT CTCCGAGAGC ACGGTGAACT TCCACCACAA 
651  GAACATCCAG AAGAAGTTCG ACGCGCCGAA CAAGACGCTG GCTGCCGCCT 
701  ACGCCGCGGC GCTGGGTCTC ATCTGA 
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Figure A.6.  Amino acid sequences of the LuxR homologs used in this work 
 
LasR 
1  MALVDGFLEL ERSSGKLEWS AILQKMASDL GFSKILFGLL PKDSQDYENA 
51 FIVGNYPAAW REHYDRAGYA RVDPTVSHCT QSVLPIFWEP SIYQTRKQHE 
101 FFEEASAAGL VYGLTMPLHG ARGELGALSL SVEAENRAEA NRFIESVLPT 
151 LWMLKDYALQ SGAGLAFEHP VSKPVVLTSR EKEVLQWCAI GKTSWEISVI 
201 CNCSEANVNF HMGNIRRKFG VTSRRVAAIM AVNLGLITL  
 
 
RhlR 
 
1 MRNDGGFLLW WDGLRSEMQP IHDSQGVFAV LEKEVRRLGF DYYAYGVRHT 
51 IPFTRPKTEV HGTYPKAWLE RYQMQNYGAV DPAILNGLRS SEMVVWSDSL 
101 FDQSRMLWNE ARDWGLCVGA TLPIRAPNNL LSVLSVARDQ QNISSFEREE 
151 IRLRLRCMIE LLTQKLTDLE HPMLMSNPVC LSHREREILQ WTADGKSSGE 
201 IAIILSISES TVNFHHKNIQ KKFDAPNKTL AAAYAAALGL I 
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Table A.1.  Nucleotide and amino acid changes in the recovered luxR/LuxR mutants 
described in Chapter 2 
 
luxR  luxR gene 
base and substitution 
LuxR protein 
amino acid residue and substitution 
First Generation    
pLuxR-G1A A97→G 
A159→G 
Thr33→Ala 
Synonymous 
pLuxR-G1B 
 
A133→T 
T501→C 
Ile45→Phe 
Synonymous 
pLuxR-G1C A284→G 
A414→C 
Asn95→Ser 
Synonymous 
pLuxR-G1D A286→G 
G405→A 
Ile96→Val 
Met135→Ile 
pLuxR-G1E T346→G 
A683→G 
Ser116→Ala 
Thr228→Ala 
pLuxR-G1F T162→A 
A403→G 
A522→G 
Synonymous  
Met135→Val 
Ile174→Met 
Second Generation   
pLuxR-G2A A133→T 
A403→G 
Ile45→Phe 
Met135→Val 
pLuxR-G2B A133→T 
G405→A 
A522→G 
Ile45→Phe 
Met135→Ile 
Ile174→Met 
pLuxR-G2C T346→G 
G405→A 
Ser116→Ala 
Met135→Ile 
pLuxR-G2D A97→G 
T162→A 
A286→G 
G405→A 
A414→C 
Thr33→Ala 
Synonymous  
Ile96→Val 
Met135→Ile 
Synonymous 
pLuxR-G2E A97→G 
T162→A 
T346→G 
G405→A 
Thr33→Ala 
Synonymous  
Ser116→Ala 
Met135→Ile 
pLuxR-G2F A97→G 
A133→T 
T162→A 
T346→G 
Thr33→Ala 
Ile45→Phe 
Synonymous  
Ser116→Ala 
pLuxR-G2G A97→G 
A286→G 
T346→G 
Thr33→Ala 
Ile96→Val 
Ser116→Ala 
pLuxR-G2H A97→G 
A284→G 
T346→G 
A522→G 
Thr33→Ala 
Asn95→Ser 
Ser116→Ala 
Ile174→Met 
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Table A.2.  Single-mutants mutants described in Chapter 2 
 
luxR gene 
base and substitution 
LuxR 
amino acid residue and substitution 
A97→G Thr33→Ala 
A133→T Ile45→Phe 
A159→G Synonymous 
T162→A Synonymous 
A284→G Asn95→Ser 
A286→G Ile96→Val 
T346→G Ser116→Ala 
A403→G Met135→Val 
G405→A Met135→Ile 
A414→C Synonymous 
T501→C Synonymous 
A522→G Ile174→Met 
A683→G Thr228→Ala 
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Table A.3.  Nucleotide and amino acid changes in luxR/LuxR and lasR/LasR mutants 
described in Chapter 4 
 
luxR  luxR gene 
base and substitution 
LuxR protein 
amino acid residue and substitution 
Parent (2nd generation C8HSL-responder)  
pLuxR-G2E A97→G 
T162→A 
T346→G 
G405→A 
Thr33→Ala 
Synonymous  
Ser116→Ala 
Met135→Ile 
Specificity mutants from selections  
pLuxR-G2E-R67M 
(recovered 7/12) 
A97→G 
T162→A 
G200→T 
T346→G 
G405→A 
Thr33→Ala 
Synonymous  
Arg67→Met 
Ser116→Ala 
Met135→Ile 
pLuxR-C10Sp1 
 
A97→G 
T114→C 
T162→A 
A172→G 
G200→T 
T346→G 
G405→A  
A423→G 
Thr33→Ala 
Synonymous 
Synonymous  
Ile58→Val 
Arg67→Met 
Ser116→Ala 
Met135→Ile 
Synonymous 
pLuxR-C10Sp2 
 
A34→G 
A97→G 
A101→G 
T162→A 
G200→T 
T255→A 
A298→C 
T346→G 
A355→G 
G405→A 
Ile12→Val 
Thr33→Ala 
Lys34→Arg 
Synonymous  
Arg67→Met 
Synonymous 
Asn100→His 
Ser116→Ala 
Ile119→Val 
Met135→Ile 
pLuxR-C10Sp_8 
 
A97→G 
T162→A 
G200→T 
A314→G 
T346→G 
G405→A 
A470→G 
T498→C 
T510→C 
Thr33→Ala 
Synonymous  
Arg67→Met 
Lys105→Arg  
Ser116→Ala 
Met135→Ile 
Asn157→Ser 
Synonymous (SalI) 
Synonymous (SalI) 
Introduction of R67M mutation into wild-type  LuxR 
pLuxR-R67M G200→T Arg67→Met 
Introduction of R61M (aligns with R67M of LuxR) mutation into wild-type LasR 
pLasR-R61M GCT181→ATG Arg61→Met 
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Table A.4.  Nucleotide and amino acid changes in luxR/LuxR variants described in 
Chapter 5 
 
luxR  luxR gene 
base and substitution 
LuxR protein 
amino acid residue and substitution 
Parent   
pLuxR(SalI) T498→C 
T501→C 
Synonymous (SalI) 
Synonymous (SalI) 
DNA-binding mutants from selections  
pLuxR-R212C/Q232H C634→T 
A695→T 
R212→C 
Q232→H 
pLuxR-R212H G635→A R212→H 
DNA-binding mutants from saturation of residue 212  
pLuxR-R212S C634→A R212→S 
Single-mutants   
pLuxR-R212C C634→T R212→C 
pLuxR-Q232H A695→T Q232→H 
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B. Sequences of the fluorescent reporters used for screening and characterization of 
LuxR variants. 
 
B.1. General information 
 
The pluxGFPuv plasmid was constructed for screening LuxR variants that activate gene 
expression in the presence of non-cognate signal molecules, based on LuxR-mediated 
expression of a green fluorescent protein (GFP) variant.  GFPuv (Clontech) was used 
because it can be excited by standard long-wavelength ultraviolet light such that a plate of 
colonies can be easily screened for GFPuv production by illuminating the plate with in a 
standard gel box and visually inspecting for green colonies.   
 
A variant of pluxGFPuv containing a mutated lux promoter was constructed for the final 
round of screening used to identify the best variants from the pool of variants selected for 
their ability to activate gene expression at the new promoter.  The promoter differs from 
PluxI at two positions: the 5 and -5 position of the lux box were altered simultaneously to 
maintain the inverted repeat structure.   
 
A liquid-phase bioassay system was developed that assesses LuxR-mediated gene 
activation by quantitatively determining the level of fluorescence due to GFPuv.    
 
Reporter proteins containing two other fluorescent reporters were constructed for use with 
microscopes.  The GFPmut3 variant has an excitation maximum at 489.   The DsRed 
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construct was used to show a lack of crosstalk between LuxR and the evolved acyl-HSL 
specificity mutant, LuxR-G2E-R67M. 
 
Figure A.7. lists the nucleotide sequence of the wild-type PluxI promoter.   
 
Figure A.8. lists the nucleotide sequences of the wild-type lux box and mutant luxG5A box.   
 
Figure A.9. lists the nucleotide sequences of the fluorescent reporters, gfpuv,gfpmut3 and 
dsred-express. 
 
Figure A.10. lists the amino acid sequences of the fluorescent reporters, GFPuv, GFPmut3 
and DsRed-express. 
 
Figure A.11. lists the nucleotide sequence of the pluxGFPuv reporter plasmid. 
 
Figure A.12. shows the plasmid map of pluxGFPuv. 
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Figure A.7.  Nucleotide sequence of the wild-type PluxI promoter. 
 
1  AGTCCTTTGA TTCTAATAAA TTGGATTTTT GTCACACTAT TGTATCGCTG  
51  GGAATACAAT TACTTAACAT AAGCACCTGT AGGATCGTAC AGGTTTACGC 
101 AAGAAAATGG TTTGTTATAG TCGAATAAAC GCAAGGGAGG TTGGT 
 
 
 
Figure A.8.  Nucleotide sequences of the wild-type lux box and mutant luxG5A box. 
 
 
lux box  
 
1  ACCTGTAGGA TCGTACAGGT 
 
 
luxG5A box  
 
1  ACCTATAGGA TCGTATAGGT 
 
 189 
Figure A.9.  Nucleotide sequences of the fluorescent reporters, gfpuv,gfpmut3 and dsred-
express,  used in this study. 
 
gfpuv 
1  ATGAGTAAAG GAGAAGAACT TTTCACTGGA GTTGTCCCAA TTCTTGTTGA 
51 ATTAGATGGT GATGTTAATG GGCACAAATT TTCTGTCAGT GGAGAGGGTG 
101 AAGGTGATGC AACATACGGA AAACTTACCC TTAAATTTAT TTGCACTACT 
151 GGAAAACTAC CTGTTCCATG GCCAACACTT GTCACTACTT TCTCTTATGG 
201 TGTTCAATGC TTTTCCCGTT ATCCGGATCA TATGAAACGG CATGACTTTT 
251 TCAAGAGTGC CATGCCCGAA GGTTATGTAC AGGAACGCAC TATATCTTTC 
301 AAAGATGACG GGAACTACAA GACGCGTGCT GAAGTCAAGT TTGAAGGTGA 
351 TACCCTTGTT AATCGTATCG AGTTAAAAGG TATTGATTTT AAAGAAGATG 
401 GAAACATTCT CGGACACAAA CTCGAGTACA ACTATAACTC ACACAATGTA 
451 TACATCACGG CAGACAAACA AAAGAATGGA ATCAAAGCTA ACTTCAAAAT 
501 TCGCCACAAC ATTGAAGATG GATCCGTTCA ACTAGCAGAC CATTATCAAC 
551 AAAATACTCC AATTGGCGAT GGCCCTGTCC TTTTACCAGA CAACCATTAC  
601 CTGTCGACAC AATCTGCCCT TTCGAAAGAT CCCAACGAAA AGCGTGACCA 
651 CATGGTCCTT CTTGAGTTTG TAACTGCTGC TGGGATTACA CATGGCATGG 
701 ATGAGCTCTA CAAATAA  
 
 
gfpmut3 
 
1  ATGCGTAAAG GAGAAGAACT TTTCACTGGA GTTGTCCCAA TTCTTGTTGA  
51 ATTAGATGGT GATGTTAATG GGCACAAATT TTCTGTCAGT GGAGAGGGTG 
101 AAGGTGATGC AACATACGGA AAACTTACCC TTAAATTTAT TTGCACTACT 
151 GGAAAACTAC CTGTTCCATG GCCAACACTT GTCACTACTT TCGGTTATGG 
201 TGTTCAATGC TTTGCGAGAT ACCCAGATCA TATGAAACAG CATGACTTTT 
251 TCAAGAGTGC CATGCCCGAA GGTTATGTAC AGGAAAGAAC TATATTTTTC  
301 AAAGATGACG GGAACTACAA GACACGTGCT GAAGTCAAGT TTGAAGGTGA 
351 TACCCTTGTT AATAGAATCG AGTTAAAAGG TATTGATTTT AAAGAAGATG 
401 GAAACATTCT TGGACACAAA TTGGAATACA ACTATAACTC ACACAATGTA 
451 TACATCATGG CAGACAAACA AAAGAATGGA ATCAAAGTTA ACTTCAAAAT 
501 TAGACACAAC ATTGAAGATG GAAGCGTTCA ACTAGCAGAC CATTATCAAC 
551 AAAATACTCC AATTGGCGAT GGCCCTGTCC TTTTACCAGA CAACCATTAC  
601 CTGTCCACAC AATCTGCCCT TTCGAAAGAT CCCAACGAAA AGAGAGACCA 
651 CATGGTCCTT CTTGAGTTTG TAACAGCTGC TGGGATTACA CATGGCATGG 
701 ATGAACTATA CAAATAA 
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dsred-express 
 
1 ATGGCCTCCT CCGAGGACGT CATCAAGGAG TTCATGCGCT TCAAGGTGCG 
51 CATGGAGGGC TCCGTGAACG GCCACGAGTT CGAGATCGAG GGCGAGGGCG  
101  AGGGCCGCCC CTACGAGGGC ACCCAGACCG CCAAGCTGAA GGTGACCAAG 
151 GGCGGCCCCC TGCCCTTCGC CTGGGACATC CTGTCCCCCC AGTTCCAGTA 
201 CGGCTCCAAG GTGTACGTGA AGCACCCCGC CGACATCCCC GACTACAAGA 
251 AGCTGTCCTT CCCCGAGGGC TTCAAGTGGG AGCGCGTGAT GAACTTCGAG 
301 GACGGCGGCG TGGTGACCGT GACCCAGGAC TCCTCCCTGC AGGACGGCTC 
351 CTTCATCTAC AAGGTGAAGT TCATCGGCGT GAACTTCCCC TCCGACGGCC 
401  CCGTAATGCA GAAGAAGACT ATGGGCTGGG AGGCCTCCAC CGAGCGCCTG 
451 TACCCCCGCG ACGGCGTGCT GAAGGGCGAG ATCCACAAGG CCCTGAAGCT 
501 GAAGGACGGC GGCCACTACC TGGTGGAGTT CAAGTCCATC TACATGGCCA  
551  AGAAGCCCGT GCAGCTGCCC GGCTACTACT ACGTGGACTC CAAGCTGGAC 
601 ATCACCTCCC ACAACGAGGA CTACACCATC GTGGAGCAGT ACGAGCGCGC 
651 CGAGGGCCGC CACCACCTGT TCCTG 
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Figure A.10.  Amino acid sequence of the fluorescent reporters GFPuv, GFPmut3 and 
DsRed-express, used in this study. 
 
GFPuv 
1  MSKGEELFTG VVPILVELDG DVNGHKFSVS GEGEGDATYG KLTLKFICTT  
51 GKLPVPWPTL VTTFSYGVQC FSRYPDHMKR HDFFKSAMPE GYVQERTISF  
101 KDDGNYKTRA EVKFEGDTLV NRIELKGIDF KEDGNILGHK LEYNYNSHNV 
151 YITADKQKNG IKANFKIRHN IEDGSVQLAD HYQQNTPIGD GPVLLPDNHY 
201 LSTQSALSKD PNEKRDHMVL LEFVTAAGIT HGMDELYK 
 
GFPmut3 
 
1  MSKGEELFTG VVPILVELDG DVNGHKFSVS GEGEGDATYG KLTLKFICTT  
51 GKLPVPWPTL VTTFGYGVQC FARYPDHMKQ HDFFKSAMPE GYVQERTIFF 
101 KDDGNYKTRA EVKFEGDTLV NRIELKGIDF KEDGNILGHK LEYNYNSHNV 
151 YIMADKQKNG IKVNFKIRHN IEDGSVQLAD HYQQNTPIGD GPVLLPDNHY 
201 LSTQSALSKD PNEKRDHMVL LEFVTAAGIT HGMDELYK 
 
DsRed-express 
 
1 MASSEDVIKE FMRFKVRMEG SVNGHEFEIE GEGEGRPYEG TQTAKLKVTK 
51  GGPLPFAWDI LSPQFQYGSK VYVKHPADIP DYKKLSFPEG FKWERVMNFE 
101 DGGVVTVTQD SSLQDGSFIY KVKFIGVNFP SDGPVMQKKT MGWEASTERL 
151 YPRDGVLKGE IHKALKLKDG GHYLVEFKSI YMAKKPVQLP GYYYVDSKLD 
201 ITSHNEDYTI VEQYERAEGR HHLFL 
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Figure A.11. Nucleotide sequence of the pluxGFPuv reporter plasmid. 
 
1  GACGTCAGTC CTTTGATTCT AATAAATTGG ATTTTTGTCA CACTATTGTA 
51 TCGCTGGGAA TACAATTACT TAACATAAGC ACCTGTAGGA TCGTACAGGT 
101 TTACGCAAGA AAATGGTTTG TTATAGTCGA ATAAACGCAA GGGAGGTTGG 
151 TATGAGTAAA GGAGAAGAAC TTTTCACTGG AGTTGTCCCA ATTCTTGTTG 
201 AATTAGATGG TGATGTTAAT GGGCACAAAT TTTCTGTCAG TGGAGAGGGT 
251 GAAGGTGATG CAACATACGG AAAACTTACC CTTAAATTTA TTTGCACTAC 
301 TGGAAAACTA CCTGTTCCAT GGCCAACACT TGTCACTACT TTCTCTTATG 
351 GTGTTCAATG CTTTTCCCGT TATCCGGATC ATATGAAACG GCATGACTTT 
401 TTCAAGAGTG CCATGCCCGA AGGTTATGTA CAGGAACGCA CTATATCTTT 
451 CAAAGATGAC GGGAACTACA AGACGCGTGC TGAAGTCAAG TTTGAAGGTG 
501 ATACCCTTGT TAATCGTATC GAGTTAAAAG GTATTGATTT TAAAGAAGAT 
551 GGAAACATTC TCGGACACAA ACTCGAGTAC AACTATAACT CACACAATGT 
601 ATACATCACG GCAGACAAAC AAAAGAATGG AATCAAAGCT AACTTCAAAA 
651 TTCGCCACAA CATTGAAGAT GGATCCGTTC AACTAGCAGA CCATTATCAA 
701 CAAAATACTC CAATTGGCGA TGGCCCTGTC CTTTTACCAG ACAACCATTA 
751 CCTGTCGACA CAATCTGCCC TTTCGAAAGA TCCCAACGAA AAGCGTGACC 
801 ACATGGTCCT TCTTGAGTTT GTAACTGCTG CTGGGATTAC ACATGGCATG 
851 GATGAGCTCT ACAAATAAAA GCTTGGATCC CTGCAGGCCT CAGGGCCCGA 
901 TCGATGCGGC CGCTTAATTA ATTAATCTAG AGGCATCAAA TAAAACGAAA 
951 GGCTCAGTCG AAAGACTGGG CCTTTCGTTT TATCTGTTGT TTGTCGGTGA 
1001 ACGCTCTCCT GAGTAGGACA AATCCGCCGC CCTAGACCTA GGCGTTCGGC 
1051 TGCGGCGAGC GGTATCAGCT CACTCAAAGG CGGTAATACG GTTATCCACA 
1101 GAATCAGGGG ATAACGCAGG AAAGAACATG TGAGCAAAAG GCCAGCAAAA 
1151 GGCCAGGAAC CGTAAAAAGG CCGCGTTGCT GGCGTTTTTC CATAGGCTCC 
1201 GCCCCCCTGA CGAGCATCAC AAAAATCGAC GCTCAAGTCA GAGGTGGCGA 
1251 AACCCGACAG GACTATAAAG ATACCAGGCG TTTCCCCCTG GAAGCTCCCT 
1301 CGTGCGCTCT CCTGTTCCGA CCCTGCCGCT TACCGGATAC CTGTCCGCCT 
1351 TTCTCCCTTC GGGAAGCGTG GCGCTTTCTC AATGCTCACG CTGTAGGTAT 
1401 CTCAGTTCGG TGTAGGTCGT TCGCTCCAAG CTGGGCTGTG TGCACGAACC 
1451 CCCCGTTCAG CCCGACCGCT GCGCCTTATC CGGTAACTAT CGTCTTGAGT 
1501 CCAACCCGGT AAGACACGAC TTATCGCCAC TGGCAGCAGC CACTGGTAAC 
1551 AGGATTAGCA GAGCGAGGTA TGTAGGCGGT GCTACAGAGT TCTTGAAGTG 
1601 GTGGCCTAAC TACGGCTACA CTAGAAGGAC AGTATTTGGT ATCTGCGCTC 
1651 TGCTGAAGCC AGTTACCTTC GGAAAAAGAG TTGGTAGCTC TTGATCCGGC 
1701 AAACAAACCA CCGCTGGTAG CGGTGGTTTT TTTGTTTGCA AGCAGCAGAT 
1751 TACGCGCAGA AAAAAAGGAT CTCAAGAAGA TCCTTTGATC TTTTCTACGG 
1801 GGTCTGACGC TCAGTGGAAC GAAAACTCAC GTTAAGGGAT TTTGGTCATG 
1851 ACTAGTGCTT GGATTCTCAC CAATAAAAAA CGCCCGGCGG CAACCGAGCG 
1901 TTCTGAACAA ATCCAGATGG AGTTCTGAGG TCATTACTGG ATCTATCAAC 
1951 AGGAGTCCAA GCGAGCTCGA TATCAAATTA CGCCCCGCCC TGCCACTCAT 
2001 CGCAGTACTG TTGTAATTCA TTAAGCATTC TGCCGACATG GAAGCCATCA 
2051 CAGACGGCAT GATGAACCTG AATCGCCAGC GGCATCAGCA CCTTGTCGCC 
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2101 TTGCGTATAA TATTTGCCCA TGGTGAAAAC GGGGGCGAAG AAGTTGTCCA 
2151 TATTGGCCAC GTTTAAATCA AAACTGGTGA AACTCACCCA GGGATTGGCT 
2201 GAGACGAAAA ACATATTCTC AATAAACCCT TTAGGGAAAT AGGCCAGGTT 
2251 TTCACCGTAA CACGCCACAT CTTGCGAATA TATGTGTAGA AACTGCCGGA 
2301 AATCGTCGTG GTATTCACTC CAGAGCGATG AAAACGTTTC AGTTTGCTCA 
2351 TGGAAAACGG TGTAACAAGG GTGAACACTA TCCCATATCA CCAGCTCACC  
2401 GTCTTTCATT GCCATACGAA ATTCCGGATG AGCATTCATC AGGCGGGCAA 
2451 GAATGTGAAT AAAGGCCGGA TAAAACTTGT GCTTATTTTT CTTTACGGTC 
2501 TTTAAAAAGG CCGTAATATC CAGCTGAACG GTCTGGTTAT AGGTACATTG 
2551 AGCAACTGAC TGAAATGCCT CAAAATGTTC TTTACGATGC CATTGGGATA 
2601 TATCAACGGT GGTATATCCA GTGATTTTTT TCTCCATTTT AGCTTCCTTA 
2651 GCTCCTGAAA ATCTCGATAA CTCAAAAAAT ACGCCCGGTA GTGATCTTAT  
2701 TTCATTATGG TGAAAGTTGG AACCTCTTAC GTGCCGATCA ACGTCTCATT 
2751 TTCGCCAGAT ATC 
 
 
 
Figure A.12.  Plasmid map of the pluxGFPuv reporter plasmid. 
pluxCAT fig
2973 bp
bla
CAT
PluxI
ColE1
T1
T0
pl GFPuv
2763 bp
luxI
gfpuv
T1
T0
ColE1
cat
AatII (1)
HindIII (869)
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C. Sequences of plasmids, genes and proteins comprising the dual selection system for 
the directed evolution of LuxR.   
 
C.1.  General information 
 
Two separate selection plasmids were constructed for ON and OFF round of selection 
using the dual selection system.  The ON selection plasmid, pluxCAT, yields 
chloramphenicol resistance with LuxR-dependent transcriptional activation.  
Chloramphenicol acetyl-transferase (cat) is expressed when LuxR activates gene 
expression at PluxI. 
 
The OFF selection plasmid, pluxBLIP, encodes β-lactamase inhibitory protein (Bli) under 
the control of the lux promoter and β-lactamase (Bla) under the control of a constitutive 
promoter.   Bli inactivates Bla and renders cells with active LuxR alleles sensitive to 
β-lactam antibiotics. 
 
Both pluxCAT and pluxBLIP contain the ColE1 replication origin and the bla antibiotic 
resistance gene. 
 
The pBLIPCAT plasmid encodes both bli and cat under the control of the Plac/ara-1 
promoter.  In DH5α, both the positive and negative selection elements are constitutively 
expressed, such that cells are always resistant to chloramphenicol and sensitive to 
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carbenicillin.  This plasmid confers an “always ON” phenotype and was used in the 
characterization of the dual selection system.   
 
Figure A.13. lists nucleotide sequence of the genes used in the dual selection system  
 
Figure A.14. lists the amino acid sequences encoded by the cat, bla and bli genes. 
 
Figure A.15. lists the nucleotide sequence of the positive (ON) selection plasmid, 
pluxCAT, containing the wild-type PluxI promoter. 
 
Figure A.16. shows the plasmid map of the positive (ON) selection plasmid, pluxCAT, 
containing the wild-type PluxI promoter. 
 
Figure A.17. lists the nucleotide sequence of the negative (OFF) selection plasmid, 
pluxBLIP, containing the wild-type PluxI promoter. 
 
Figure A.18. shows the plasmid map of the negative (OFF) selection plasmid, pluxBLIP, 
containing the wild-type PluxI promoter. 
 
Figure A.19. lists the nucleotide sequence of pBLIPCAT. 
 
Figure A.20. shows the plasmid map of pBLIPCAT.  
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Figure A.13.  Nucleotide sequence of the genes used in the dual selection system. 
 
 
cat 
 
1  ATGGAGAAAA AAATCACTGG ATATACCACC GTTGATATAT CCCAATGGCA 
51 TCGTAAAGAA CATTTTGAGG CATTTCAGTC AGTTGCTCAA TGTACCTATA 
101 ACCAGACCGT TCAGCTGGAT ATTACGGCCT TTTTAAAGAC CGTAAAGAAA 
151 AATAAGCACA AGTTTTATCC GGCCTTTATT CACATTCTTG CCCGCCTGAT 
201 GAATGCTCAT CCGGAATTTC GTATGGCAAT GAAAGACGGT GAGCTGGTGA 
251 TATGGGATAG TGTTCACCCT TGTTACACCG TTTTCCATGA GCAAACTGAA  
301 ACGTTTTCAT CGCTCTGGAG TGAATACCAC GACGATTTCC GGCAGTTTCT 
351 ACACATATAT TCGCAAGATG TGGCGTGTTA CGGTGAAAAC CTGGCCTATT 
401 TCCCTAAAGG GTTTATTGAG AATATGTTTT TCGTCTCAGC CAATCCCTGG 
451 GTGAGTTTCA CCAGTTTTGA TTTAAACGTG GCCAATATGG ACAACTTCTT 
501 CGCCCCCGTT TTCACCATGG GCAAATATTA TACGCAAGGC GACAAGGTGC 
551 TGATGCCGCT GGCGATTCAG GTTCATCATG CCGTCTGTGA TGGCTTCCAT  
601 GTCGGCAGAA TGCTTAATGA ATTACAACAG TACTGCGATG AGTGGCAGGG 
651 CGGGGCGTAA  
 
 
bla 
 
1  ATGAGTATTC AACATTTCCG TGTCGCCCTT ATTCCCTTTT TTGCGGCATT 
51 TTGCCTTCCT GTTTTTGCTC ACCCAGAAAC GCTGGTGAAA GTAAAAGATG 
101 CTGAAGATCA GTTGGGTGCA CGAGTGGGTT ACATCGAACT GGATCTCAAC 
151 AGCGGTAAGA TCCTTGAGAG TTTTCGCCCC GAAGAACGTT TTCCAATGAT 
201 GAGCACTTTT AAAGTTCTGC TATGTGGCGC GGTATTATCC CGTATTGACG 
251 CCGGGCAAGA GCAACTCGGT CGCCGCATAC ACTATTCTCA GAATGACTTG 
301 GTTGAGTACT CACCAGTCAC AGAAAAGCAT CTTACGGATG GCATGACAGT 
351 AAGAGAATTA TGCAGTGCTG CCATAACCAT GAGTGATAAC ACTGCGGCCA 
401 ACTTACTTCT GACAACGATC GGAGGACCGA AGGAGCTAAC CGCTTTTTTG 
451 CACAACATGG GGGATCATGT AACTCGCCTT GATCGTTGGG AACCGGAGCT 
501 GAATGAAGCC ATACCAAACG ACGAGCGTGA CACCACGATG CCTGTAGCAA 
551 TGGCAACAAC GTTGCGCAAA CTATTAACTG GCGAACTACT TACTCTAGCT 
601 TCCCGGCAAC AATTAATAGA CTGGATGGAG GCGGATAAAG TTGCAGGACC 
651 ACTTCTGCGC TCGGCCCTTC CGGCTGGCTG GTTTATTGCT GATAAATCTG 
701 GAGCCGGTGA GCGTGGGTCT CGCGGTATCA TTGCAGCACT GGGGCCAGAT 
751 GGTAAGCCCT CCCGTATCGT AGTTATCTAC ACGACGGGGA GTCAGGCAAC 
801 TATGGATGAA CGAAATAGAC AGATCGCTGA GATAGGTGCC TCACTGATTA 
851 AGCATTGGTA A 
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bli 
 
1  ATGCTTTTAT ATAAAATGTG TGACAATCAA AATTATGGGG TTACTTACAT 
51 GAAGTTTTTA TTGGCATTTT CGCTTTTAAT ACCATCCGTG GTTTTTGCAA 
101 GTAGTGCAGG TGTTATGACA GGAGCAAAAT TCACGCAGAT CCAGTTTGGT 
151 ATGACACGTC AGCAGGTCCT CGACATAGCA GGTGCTGAGA ACTGTGAGAC 
201 TGGTGGATCG TTCGGTGACA GCATCCATTG TCGTGGACAT GCAGCAGGAG 
251 ACTATTATGC ATACGCAACC TTCGGCTTCA CCAGCGCAGC TGCAGACGCA 
301 AAGGTGGATT CGAAAAGCCA GGAAAAACTG CTTGCACCAA GCGCACCAAC 
351 TCTTACTCTT GCTAAGTTCA ACCAAGTCAC TGTTGGTATG ACTAGAGCAC 
401 AAGTACTTGC TACCGTCGGA CAGGGTTCTT GTACCACTTG GAGTGAGTAC 
451 TATCCAGCAT ATCCATCGAC GGCAGGAGTG ACTCTCAGCC TGTCCTGCTT 
501 CGATGTGGAC GGTTACTCGT CGACGGGGTT CTACCGAGGC TCGGCGCACC 
551 TCTGGTTCAC GGACGGGGTG CTTCAGGGCA AGCGGCAGTG GGACCTTGTA  
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Figure A.14.  Amino acid sequence of the proteins used in the dual selection system. 
 
 
CAT 
 
1  MEKKITGYTT VDISQWHRKE HFEAFQSVAQ CTYNQTVQLD ITAFLKTVKK 
51 NKHKFYPAFI HILARLMNAH PEFRMAMKDG ELVIWDSVHP CYTVFHEQTE 
101 TFSSLWSEYH DDFRQFLHIY SQDVACYGEN LAYFPKGFIE NMFFVSANPW 
151 VSFTSFDLNV ANMDNFFAPV FTMGKYYTQG DKVLMPLAIQ VHHAVCDGFH 
201 VGRMLNELQQ YCDEWQGGA 
 
Bla 
 
1  MSIQHFRVAL IPFFAAFCLP VFAHPETLVK VKDAEDQLGA RVGYIELDLN 
51 SGKILESFRP EERFPMMSTF KVLLCGAVLS RIDAGQEQLG RRIHYSQNDL 
101 VEYSPVTEKH LTDGMTVREL CSAAITMSDN TAANLLLTTI GGPKELTAFL 
151 HNMGDHVTRL DRWEPELNEA IPNDERDTTM PVAMATTLRK LLTGELLTLA 
201 SRQQLIDWME ADKVAGPLLR SALPAGWFIA DKSGAGERGS RGIIAALGPD 
251 GKPSRIVVIY TTGSQATMDE RNRQIAEIGA SLIKHW 
 
Bli 
 
1  MLLYKMCDNQ NYGVTYMKFL LAFSLLIPSV VFASSAGVMT GAKFTQIQFG 
51 MTRQQVLDIA GAENCETGGS FGDSIHCRGH AAGDYYAYAT FGFTSAAADA 
101 KVDSKSQEKL LAPSAPTLTL AKFNQVTVGM TRAQVLATVG QGSCTTWSEY 
151 YPAYPSTAGV TLSLSCFDVD GYSSTGFYRG SAHLWFTDGV LQGKRQWDLV 
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Figure A.15. Nucleotide sequence of the positive (ON) selection plasmid, pluxCAT, 
containing the wild-type PluxI promoter. 
 
1  GACGTCAGTC CTTTGATTCT AATAAATTGG ATTTTTGTCA CACTATTGTA 
51 TCGCTGGGAA TACAATTACT TAACATAAGC ACCTGTAGGA TCGTACAGGT 
101 TTACGCAAGA AAATGGTTTG TTATAGTCGA ATAAACGCAA GGGAGGTTGG 
151 TATGGAGAAA AAAATCACTG GATATACCAC CGTTGATATA TCCCAATGGC 
201 ATCGTAAAGA ACATTTTGAG GCATTTCAGT CAGTTGCTCA ATGTACCTAT 
251 AACCAGACCG TTCAGCTGGA TATTACGGCC TTTTTAAAGA CCGTAAAGAA 
301 AAATAAGCAC AAGTTTTATC CGGCCTTTAT TCACATTCTT GCCCGCCTGA 
351 TGAATGCTCA TCCGGAATTT CGTATGGCAA TGAAAGACGG TGAGCTGGTG 
401 ATATGGGATA GTGTTCACCC TTGTTACACC GTTTTCCATG AGCAAACTGA 
451 AACGTTTTCA TCGCTCTGGA GTGAATACCA CGACGATTTC CGGCAGTTTC 
501 TACACATATA TTCGCAAGAT GTGGCGTGTT ACGGTGAAAA CCTGGCCTAT 
551 TTCCCTAAAG GGTTTATTGA GAATATGTTT TTCGTCTCAG CCAATCCCTG  
601 GGTGAGTTTC ACCAGTTTTG ATTTAAACGT GGCCAATATG GACAACTTCT 
651 TCGCCCCCGT TTTCACCATG GGCAAATATT ATACGCAAGG CGACAAGGTG 
701 CTGATGCCGC TGGCGATTCA GGTTCATCAT GCCGTCTGTG ATGGCTTCCA 
751 TGTCGGCAGA ATGCTTAATG AATTACAACA GTACTGCGAT GAGTGGCAGG 
801 GCGGGGCGTA ATTTGATATC GAGCTCGCTT GGAAGCTTGG ATCCCTGCAG 
851 GCCTCAGGGC CCGATCGATG CGGCCGCTTA ATTAATTAAT CTAGAGGCAT 
901 CAAATAAAAC GAAAGGCTCA GTCGAAAGAC TGGGCCTTTC GTTTTATCTG 
951 TTGTTTGTCG GTGAACGCTC TCCTGAGTAG GACAAATCCG CCGCCCTAGA 
1001 CCTAGGCGTT CGGCTGCGGC GAGCGGTATC AGCTCACTCA AAGGCGGTAA 
1051 TACGGTTATC CACAGAATCA GGGGATAACG CAGGAAAGAA CATGTGAGCA 
1101 AAAGGCCAGC AAAAGGCCAG GAACCGTAAA AAGGCCGCGT TGCTGGCGTT 
1151 TTTCCATAGG CTCCGCCCCC CTGACGAGCA TCACAAAAAT CGACGCTCAA 
1201 GTCAGAGGTG GCGAAACCCG ACAGGACTAT AAAGATACCA GGCGTTTCCC 
1251 CCTGGAAGCT CCCTCGTGCG CTCTCCTGTT CCGACCCTGC CGCTTACCGG 
1301 ATACCTGTCC GCCTTTCTCC CTTCGGGAAG CGTGGCGCTT TCTCAATGCT 
1351 CACGCTGTAG GTATCTCAGT TCGGTGTAGG TCGTTCGCTC CAAGCTGGGC 
1401 TGTGTGCACG AACCCCCCGT TCAGCCCGAC CGCTGCGCCT TATCCGGTAA 
1451 CTATCGTCTT GAGTCCAACC CGGTAAGACA CGACTTATCG CCACTGGCAG 
1501 CAGCCACTGG TAACAGGATT AGCAGAGCGA GGTATGTAGG CGGTGCTACA 
1551 GAGTTCTTGA AGTGGTGGCC TAACTACGGC TACACTAGAA GGACAGTATT 
1601 TGGTATCTGC GCTCTGCTGA AGCCAGTTAC CTTCGGAAAA AGAGTTGGTA 
1651 GCTCTTGATC CGGCAAACAA ACCACCGCTG GTAGCGGTGG TTTTTTTGTT 
1701 TGCAAGCAGC AGATTACGCG CAGAAAAAAA GGATCTCAAG AAGATCCTTT 
1751 GATCTTTTCT ACGGGGTCTG ACGCTCAGTG GAACGAAAAC TCACGTTAAG 
1801 GGATTTTGGT CATGACTAGT GCTTGGATTC TCACCAATAA AAAACGCCCG 
1851 GCGGCAACCG AGCGTTCTGA ACAAATCCAG ATGGAGTTCT GAGGTCATTA 
1901 CTGGATCTAT CAACAGGAGT CCAAGCGAGC TCAAACTTGG TCTGACAGTT 
1951 ACCAATGCTT AATCAGTGAG GCACCTATCT CAGCGATCTG TCTATTTCGT 
2001 TCATCCATAG TTGCCTGACT CCCCGTCGTG TAGATAACTA CGATACGGGA 
2051 GGGCTTACCA TCTGGCCCCA GTGCTGCAAT GATACCGCGA GACCCACGCT 
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2101 CACCGGCTCC AGATTTATCA GCAATAAACC AGCCAGCCGG AAGGGCCGAG 
2151 CGCAGAAGTG GTCCTGCAAC TTTATCCGCC TCCATCCAGT CTATTAATTG 
2201 TTGCCGGGAA GCTAGAGTAA GTAGTTCGCC AGTTAATAGT TTGCGCAACG 
2251 TTGTTGCCAT TGCTACAGGC ATCGTGGTGT CACGCTCGTC GTTTGGTATG 
2301 GCTTCATTCA GCTCCGGTTC CCAACGATCA AGGCGAGTTA CATGATCCCC 
2351 CATGTTGTGC AAAAAAGCGG TTAGCTCCTT CGGTCCTCCG ATCGTTGTCA 
2401 GAAGTAAGTT GGCCGCAGTG TTATCACTCA TGGTTATGGC AGCACTGCAT 
2451 AATTCTCTTA CTGTCATGCC ATCCGTAAGA TGCTTTTCTG TGACTGGTGA 
2501 GTACTCAACC AAGTCATTCT GAGAATAGTG TATGCGGCGA CCGAGTTGCT 
2551 CTTGCCCGGC GTCAATACGG GATAATACCG CGCCACATAG CAGAACTTTA 
2601 AAAGTGCTCA TCATTGGAAA ACGTTCTTCG GGGCGAAAAC TCTCAAGGAT 
2651 CTTACCGCTG TTGAGATCCA GTTCGATGTA ACCCACTCGT GCACCCAACT  
2701 GATCTTCAGC ATCTTTTACT TTCACCAGCG TTTCTGGGTG AGCAAAAACA 
2751 GGAAGGCAAA ATGCCGCAAA AAAGGGAATA AGGGCGACAC GGAAATGTTG 
2801 AATACTCATA CTCTTCCTTT TTCAATATTA TTGAAGCATT TATCAGGGTT 
2851 ATTGTCTCAT GAGCGGATAC ATATTTGAAT GTATTTAGAA AAATAAACAA 
2901 ATAGGGGTTC CGCGCACATT TCCCCGAAAA GTGCCACCT  
 
Note:  pluxG5ACAT, a version of this plasmid containing the luxG5A box (see A.2.2 for 
sequence information), was utilized for the directed evolution of DNA-binding specificity 
by LuxR. 
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Figure A.16.  Plasmid map of the pluxCAT selection plasmid containing the wild-type PluxI 
promoter. 
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Figure A.17. Nucleotide sequence of the negative (OFF) selection plasmid, pluxBLIP, 
containing the wild-type PluxI promoter. 
 
1  GACGTCAGTC CTTTGATTCT AATAAATTGG ATTTTTGTCA CACTATTGTA 
51 TCGCTGGGAA TACAATTACT TAACATAAGC ACCTGTAGGA TCGTACAGGT 
101 TTACGCAAGA AAATGGTTTG TTATAGTCGA ATAAACGCAA GGGAGGTTGG 
151 TATGCTTTTA TATAAAATGT GTGACAATCA AAATTATGGG GTTACTTACA 
201 TGAAGTTTTT ATTGGCATTT TCGCTTTTAA TACCATCCGT GGTTTTTGCA 
251 AGTAGTGCAG GTGTTATGAC AGGAGCAAAA TTCACGCAGA TCCAGTTTGG 
301 TATGACACGT CAGCAGGTCC TCGACATAGC AGGTGCTGAG AACTGTGAGA 
351 CTGGTGGATC GTTCGGTGAC AGCATCCATT GTCGTGGACA TGCAGCAGGA 
401 GACTATTATG CATACGCAAC CTTCGGCTTC ACCAGCGCAG CTGCAGACGC 
451 AAAGGTGGAT TCGAAAAGCC AGGAAAAACT GCTTGCACCA AGCGCACCAA 
501 CTCTTACTCT TGCTAAGTTC AACCAAGTCA CTGTTGGTAT GACTAGAGCA 
551 CAAGTACTTG CTACCGTCGG ACAGGGTTCT TGTACCACTT GGAGTGAGTA 
601 CTATCCAGCA TATCCATCGA CGGCAGGAGT GACTCTCAGC CTGTCCTGCT 
651 TCGATGTGGA CGGTTACTCG TCGACGGGGT TCTACCGAGG CTCGGCGCAC 
701 CTCTGGTTCA CGGACGGGGT GCTTCAGGGC AAGCGGCAGT GGGACCTTGT 
751 ATAAAAGCTT GGATCCCTGC AGGCCTCAGG GCCCGATCGA TGCGGCCGCT 
801 TAATTAATTA ATCTAGAGGC ATCAAATAAA ACGAAAGGCT CAGTCGAAAG 
851 ACTGGGCCTT TCGTTTTATC TGTTGTTTGT CGGTGAACGC TCTCCTGAGT 
901 AGGACAAATC CGCCGCCCTA GACCTAGGCG TTCGGCTGCG GCGAGCGGTA 
951 TCAGCTCACT CAAAGGCGGT AATACGGTTA TCCACAGAAT CAGGGGATAA 
1001 CGCAGGAAAG AACATGTGAG CAAAAGGCCA GCAAAAGGCC AGGAACCGTA 
1051 AAAAGGCCGC GTTGCTGGCG TTTTTCCATA GGCTCCGCCC CCCTGACGAG 
1101 CATCACAAAA ATCGACGCTC AAGTCAGAGG TGGCGAAACC CGACAGGACT 
1151 ATAAAGATAC CAGGCGTTTC CCCCTGGAAG CTCCCTCGTG CGCTCTCCTG 
1201 TTCCGACCCT GCCGCTTACC GGATACCTGT CCGCCTTTCT CCCTTCGGGA 
1251 AGCGTGGCGC TTTCTCAATG CTCACGCTGT AGGTATCTCA GTTCGGTGTA 
1301 GGTCGTTCGC TCCAAGCTGG GCTGTGTGCA CGAACCCCCC GTTCAGCCCG 
1351 ACCGCTGCGC CTTATCCGGT AACTATCGTC TTGAGTCCAA CCCGGTAAGA 
1401 CACGACTTAT CGCCACTGGC AGCAGCCACT GGTAACAGGA TTAGCAGAGC 
1451 GAGGTATGTA GGCGGTGCTA CAGAGTTCTT GAAGTGGTGG CCTAACTACG 
1501 GCTACACTAG AAGGACAGTA TTTGGTATCT GCGCTCTGCT GAAGCCAGTT 
1551 ACCTTCGGAA AAAGAGTTGG TAGCTCTTGA TCCGGCAAAC AAACCACCGC 
1601 TGGTAGCGGT GGTTTTTTTG TTTGCAAGCA GCAGATTACG CGCAGAAAAA 
1651 AAGGATCTCA AGAAGATCCT TTGATCTTTT CTACGGGGTC TGACGCTCAG 
1701 TGGAACGAAA ACTCACGTTA AGGGATTTTG GTCATGACTA GTGCTTGGAT 
1751 TCTCACCAAT AAAAAACGCC CGGCGGCAAC CGAGCGTTCT GAACAAATCC 
1801 AGATGGAGTT CTGAGGTCAT TACTGGATCT ATCAACAGGA GTCCAAGCGA 
1851 GCTCAAACTT GGTCTGACAG TTACCAATGC TTAATCAGTG AGGCACCTAT 
1901 CTCAGCGATC TGTCTATTTC GTTCATCCAT AGTTGCCTGA CTCCCCGTCG 
1951 TGTAGATAAC TACGATACGG GAGGGCTTAC CATCTGGCCC CAGTGCTGCA 
2001 ATGATACCGC GAGACCCACG CTCACCGGCT CCAGATTTAT CAGCAATAAA 
2051 CCAGCCAGCC GGAAGGGCCG AGCGCAGAAG TGGTCCTGCA ACTTTATCCG 
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2101 CCTCCATCCA GTCTATTAAT TGTTGCCGGG AAGCTAGAGT AAGTAGTTCG 
2151 CCAGTTAATA GTTTGCGCAA CGTTGTTGCC ATTGCTACAG GCATCGTGGT 
2201 GTCACGCTCG TCGTTTGGTA TGGCTTCATT CAGCTCCGGT TCCCAACGAT 
2251 CAAGGCGAGT TACATGATCC CCCATGTTGT GCAAAAAAGC GGTTAGCTCC 
2301 TTCGGTCCTC CGATCGTTGT CAGAAGTAAG TTGGCCGCAG TGTTATCACT 
2351 CATGGTTATG GCAGCACTGC ATAATTCTCT TACTGTCATG CCATCCGTAA 
2401 GATGCTTTTC TGTGACTGGT GAGTACTCAA CCAAGTCATT CTGAGAATAG 
2451 TGTATGCGGC GACCGAGTTG CTCTTGCCCG GCGTCAATAC GGGATAATAC 
2501 CGCGCCACAT AGCAGAACTT TAAAAGTGCT CATCATTGGA AAACGTTCTT 
2551 CGGGGCGAAA ACTCTCAAGG ATCTTACCGC TGTTGAGATC CAGTTCGATG 
2601 TAACCCACTC GTGCACCCAA CTGATCTTCA GCATCTTTTA CTTTCACCAG 
2651 CGTTTCTGGG TGAGCAAAAA CAGGAAGGCA AAATGCCGCA AAAAAGGGAA 
2701 TAAGGGCGAC ACGGAAATGT TGAATACTCA TACTCTTCCT TTTTCAATAT 
2751 TATTGAAGCA TTTATCAGGG TTATTGTCTC ATGAGCGGAT ACATATTTGA 
2801 ATGTATTTAG AAAAATAAAC AAATAGGGGT TCCGCGCACA TTTCCCCGAA 
2851 AAGTGCCACC T  
 
 
 
Figure A.18.  Plasmid map of the pluxBLIP selection plasmid containing the wild-type 
PluxI promoter. 
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Figure A.19. Nucleotide sequence of the selection test plasmid pBLIPCAT. 
 
 
1  GTCGACTCGA GCATAGCATT TTTATCCATA AGATTAGCGG ATCTAACCTT 
51 TACAATTGTG AGCGCTCACA ATTATGATAG ATTCAATTGT GAGCGGATAA 
101 CAATTTCACA CAGAATTCAT TAAAGAGGAG AAAGGTACCC ATGCTTTTAT 
151 ATAAAATGTG TGACAATCAA AATTATGGGG TTACTTACAT GAAGTTTTTA 
201 TTGGCATTTT CGCTTTTAAT ACCATCCGTG GTTTTTGCAA GTAGTGCAGG 
251 TGTTATGACA GGAGCAAAAT TCACGCAGAT CCAGTTTGGT ATGACACGTC 
301 AGCAGGTCCT CGACATAGCA GGTGCTGAGA ACTGTGAGAC TGGTGGATCG 
351 TTCGGTGACA GCATCCATTG TCGTGGACAT GCAGCAGGAG ACTATTATGC 
401 ATACGCAACC TTCGGCTTCA CCAGCGCAGC TGCAGACGCA AAGGTGGATT 
451 CGAAAAGCCA GGAAAAACTG CTTGCACCAA GCGCACCAAC TCTTACTCTT 
501 GCTAAGTTCA ACCAAGTCAC TGTTGGTATG ACTAGAGCAC AAGTACTTGC 
551 TACCGTCGGA CAGGGTTCTT GTACCACTTG GAGTGAGTAC TATCCAGCAT 
601 ATCCATCGAC GGCAGGAGTG ACTCTCAGCC TGTCCTGCTT CGATGTGGAC 
651 GGTTACTCGT CGACGGGGTT CTACCGAGGC TCGGCGCACC TCTGGTTCAC 
701 GGACGGGGTG CTTCAGGGCA AGCGGCAGTG GGACCTTGTA TAAAAGCTTG 
751 CTAACCGAAT AAACGCAAGG GAGGTTGGTA TGGAGAAAAA AATCACTGGA 
801 TATACCACCG TTGATATATC CCAATGGCAT CGTAAAGAAC ATTTTGAGGC 
851 ATTTCAGTCA GTTGCTCAAT GTACCTATAA CCAGACCGTT CAGCTGGATA 
901 TTACGGCCTT TTTAAAGACC GTAAAGAAAA ATAAGCACAA GTTTTATCCG 
951 GCCTTTATTC ACATTCTTGC CCGCCTGATG AATGCTCATC CGGAATTTCG 
1001 TATGGCAATG AAAGACGGTG AGCTGGTGAT ATGGGATAGT GTTCACCCTT 
1051 GTTACACCGT TTTCCATGAG CAAACTGAAA CGTTTTCATC GCTCTGGAGT 
1101 GAATACCACG ACGATTTCCG GCAGTTTCTA CACATATATT CGCAAGATGT 
1151 GGCGTGTTAC GGTGAAAACC TGGCCTATTT CCCTAAAGGG TTTATTGAGA 
1201 ATATGTTTTT CGTCTCAGCC AATCCCTGGG TGAGTTTCAC CAGTTTTGAT 
1251 TTAAACGTGG CCAATATGGA CAACTTCTTC GCCCCCGTTT TCACCATGGG 
1301 CAAATATTAT ACGCAAGGCG ACAAGGTGCT GATGCCGCTG GCGATTCAGG 
1351 TTCATCATGC CGTCTGTGAT GGCTTCCATG TCGGCAGAAT GCTTAATGAA 
1401 TTACAACAGT ACTGCGATGA GTGGCAGGGC GGGGCGTAAT TTGATATCGA 
1451 GCTCGCTGGA TCCCTGCAGG CCTCAGGGCC CGATCGATGC GGCCGCTTAA 
1501 TTAATTAATC TAGAGGCATC AAATAAAACG AAAGGCTCAG TCGAAAGACT 
1551 GGGCCTTTCG TTTTATCTGT TGTTTGTCGG TGAACGCTCT CCTGAGTAGG 
1601 ACAAATCCGC CGCCCTAGAC CTAGGGGATA TATTCCGCTT CCTCGCTCAC 
1651 TGACTCGCTA CGCTCGGTCG TTCGACTGCG GCGAGCGGAA ATGGCTTACG 
1701 AACGGGGCGG AGATTTCCTG GAAGATGCCA GGAAGATACT TAACAGGGAA 
1751 GTGAGAGGGC CGCGGCAAAG CCGTTTTTCC ATAGGCTCCG CCCCCCTGAC 
1801 AAGCATCACG AAATCTGACG CTCAAATCAG TGGTGGCGAA ACCCGACAGG 
1851 ACTATAAAGA TACCAGGCGT TTCCCCCTGG CGGCTCCCTC GTGCGCTCTC 
1901 CTGTTCCTGC CTTTCGGTTT ACCGGTGTCA TTCCGCTGTT ATGGCCGCGT 
1951 TTGTCTCATT CCACGCCTGA CACTCAGTTC CGGGTAGGCA GTTCGCTCCA 
2001 AGCTGGACTG TATGCACGAA CCCCCCGTTC AGTCCGACCG CTGCGCCTTA 
2051 TCCGGTAACT ATCGTCTTGA GTCCAACCCG GAAAGACATG CAAAAGCACC 
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2101 ACTGGCAGCA GCCACTGGTA ATTGATTTAG AGGAGTTAGT CTTGAAGTCA 
2151 TGCGCCGGTT AAGGCTAAAC TGAAAGGACA AGTTTTGGTG ACTGCGCTCC 
2201 TCCAAGCCAG TTACCTCGGT TCAAAGAGTT GGTAGCTCAG AGAACCTTCG 
2251 AAAAACCGCC CTGCAAGGCG GTTTTTTCGT TTTCAGAGCA AGAGATTACG 
2301 CGCAGACCAA AACGATCTCA AGAAGATCAT CTTATTAATC AGATAAAATA 
2351 TTACTAGATT TCAGTGCAAT TTATCTCTTC AAATGTAGCA CCTGAAGTCA 
2401 GCCCCATACG ATATAAGTTG TTACTAGTGC TTGGATTCTC ACCAATAAAA 
2451 AACGCCCGGC GGCAACCGAG CGTTCTGAAC AAATCCAGAT GGAGTTCTGA 
2501 GGTCATTACT GGATCTATCA ACAGGAGTCC AAGCGAGCTC TCGAACCCCA 
2551 GAGTCCCGCT CAGAAGAACT CGTCAAGAAG GCGATAGAAG GCGATGCGCT 
2601 GCGAATCGGG AGCGGCGATA CCGTAAAGCA CGAGGAAGCG GTCAGCCCAT 
2651 TCGCCGCCAA GCTCTTCAGC AATATCACGG GTAGCCAACG CTATGTCCTG  
2701 ATAGCGGTCC GCCACACCCA GCCGGCCACA GTCGATGAAT CCAGAAAAGC 
2751 GGCCATTTTC CACCATGATA TTCGGCAAGC AGGCATCGCC ATGGGTCACG 
2801 ACGAGATCCT CGCCGTCGGG CATGCGCGCC TTGAGCCTGG CGAACAGTTC 
2851 GGCTGGCGCG AGCCCCTGAT GCTCTTCGTC CAGATCATCC TGATCGACAA 
2901 GACCGGCTTC CATCCGAGTA CGTGCTCGCT CGATGCGATG TTTCGCTTGG 
2951 TGGTCGAATG GGCAGGTAGC CGGATCAAGC GTATGCAGCC GCCGCATTGC 
3001 ATCAGCCATG ATGGATACTT TCTCGGCAGG AGCAAGGTGA GATGACAGGA 
3051 GATCCTGCCC CGGCACTTCG CCCAATAGCA GCCAGTCCCT TCCCGCTTCA 
3101 GTGACAACGT CGAGCACAGC TGCGCAAGGA ACGCCCGTCG TGGCCAGCCA 
3151 CGATAGCCGC GCTGCCTCGT CCTGCAGTTC ATTCAGGGCA CCGGACAGGT 
3201 CGGTCTTGAC AAAAAGAACC GGGCGCCCCT GCGCTGACAG CCGGAACACG 
3251 GCGGCATCAG AGCAGCCGAT TGTCTGTTGT GCCCAGTCAT AGCCGAATAG 
3301 CCTCTCCACC CAAGCGGCCG GAGAACCTGC GTGCAATCCA TCTTGTTCAA 
3351 TCATGCGAAA CGATCCTCAT CCTGTCTCTT GATCAGATCT TGATCCCCTG 
3401 CGCCATCAGA TCCTTGGCGG CAAGAAAGCC ATCCAGTTTA CTTTGCAGGG 
3451 CTTCCCAACC TTACCAGAGG GCGCCCCAGC TGGCAATTCC GACGTCTGTG 
3501 TGGAATTGTG AGCGGATAAC AATTTCACAC AGGGCCCTCG GACACCGAGG 
3551 AGAATGTCAA GAGGCGAACA CACAACGTCT TGGAGCGCCA GAGGAGGAAC 
3601 GAGCTAAAAC GGAGCTTTTT TGCCCTGCGT GACCAGATCC CGGAGTTGGA 
3651 AAACAATGAA AAGGCCCCCA AGGTAGTTAT CCTTAAAAAA GCCACAGCAT 
3701 ACATCCTGTC CGTCCAAGCA GAGGAGCAAA AGCTCATTTC TGAAGAGGAC 
3751 TTGTTGCGGA AACGACGAGA ACAGTTGAAA CACAAACTTG AACAGCTACG 
3801 GAACTCTTGT GCGTAAGGAA AAGTAAGGAA AACGATTCCT TCTAACAGAA 
3851 ATGTCCTGAG CAATCACCTA TGAACT 
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Figure A.20.  Plasmid map of the selection test plasmid pBLIPCAT. 
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